One    O
chemical    O
compound    O
found    O
in    O
"    O
T.    O
terrestris    O
"    O
is    O
protodioscin    B-Glycoside114887305
(    O
PTN    O
)    O
.    O

Several    O
chemical    O
compounds    O
have    O
been    O
isolated    O
from    O
the    O
root    O
;    O
baicalein    O
,    O
baicalin    B-Glycoside114887305
,    O
wogonin    O
,    O
norwogonin    O
,    O
oroxylin    O
A    O
and    O
β-sitosterol    O
are    O
the    O
major    O
ones    O
.    O

Other    O
active    O
constituents    O
include    O
baicalin    B-Glycoside114887305
,    O
apigenin    O
,    O
oroxylin    O
A    O
,    O
scutellarein    O
,    O
and    O
skullcapflavone    O
.    O

Human    O
ingestion    O
of    O
solanidine    O
also    O
occurs    O
via    O
the    O
consumption    O
of    O
the    O
glycoalkaloids    B-Glycoside114887305
,    O
α-solanine    B-Glycoside114887305
and    O
α-chaconine    B-Glycoside114887305
,    O
present    O
in    O
potatoes    O
.    O

8-Oxo-2'-deoxyguanosine    B-Glycoside114887305

DNA    O
damage    O
is    O
an    O
alteration    O
in    O
the    O
chemical    O
structure    O
of    O
DNA    O
,    O
such    O
as    O
a    O
break    O
in    O
a    O
strand    O
of    O
DNA    O
,    O
a    O
base    O
missing    O
from    O
the    O
backbone    O
of    O
DNA    O
,    O
or    O
a    O
chemically    O
changed    O
base    O
as    O
8-OHdG    B-Glycoside114887305

A    O
marker    O
of    O
DNA    O
oxidation    O
,    O
8-Oxo-2'-deoxyguanosine    B-Glycoside114887305
,    O
has    O
been    O
found    O
to    O
be    O
increased    O
in    O
both    O
the    O
plasma    O
and    O
urine    O
of    O
depressed    O
patients    O
.    O

(    O
see    O
e.g.    O
8-Oxo-2'-deoxyguanosine    B-Glycoside114887305
)    O

Poncirin    B-Glycoside114887305

Complex    O
formation    O
may    O
be    O
the    O
reason    O
why    O
tomatine    O
has    O
a    O
much    O
lower    O
oral    O
toxicity    O
than    O
other    O
glycoalkaloids    B-Glycoside114887305
.    O

The    O
symptoms    O
of    O
acute    O
tomatine    O
poisoning    O
in    O
animals    O
are    O
similar    O
to    O
the    O
symptoms    O
of    O
poisoning    O
by    O
solanine    B-Glycoside114887305
,    O
a    O
potato    O
glycoalkaloid    B-Glycoside114887305
.    O

Human    O
ingestion    O
of    O
solanidine    O
also    O
occurs    O
via    O
the    O
consumption    O
of    O
the    O
glycoalkaloids    B-Glycoside114887305
,    O
α-solanine    B-Glycoside114887305
and    O
α-chaconine    B-Glycoside114887305
,    O
present    O
in    O
potatoes    O
.    O

This    O
wild    O
species    O
contains    O
leptine    O
glycoalkaloid    B-Glycoside114887305
which    O
make    O
it    O
resistant    O
to    O
the    O
Colorado    O
potato    O
beetle    O
(    O
"    O
Leptinotarsa    O
decemlineata    O
"    O
)    O
,    O
a    O
pest    O
of    O
potato    O
crops    O
.    O

Phenolics    O
found    O
in    O
"    O
Crepis    O
"    O
include    O
luteolin    O
-    O
type    O
flavonoids    O
and    O
caffeoyl    O
quinic    O
acid    O
derivatives    O
such    O
as    O
chlorogenic    B-Glycoside114887305
acid    I-Glycoside114887305
and    O
dicaffeoylquinic    B-Glycoside114887305
acid    I-Glycoside114887305
.    O

Piceid    B-Glycoside114887305
,    O
a    O
resveratrol    O
glucoside    O

Piceid    B-Glycoside114887305
is    O
a    O
resveratrol    O
derivative    O
in    O
grape    O
juices    O

"    O
beni    O
"    O
(    O
紅    O
)    O
,    O
a    O
Japanese    O
color    O
commonly    O
called    O
"    O
safflower    O
red    O
"    O
or    O
"    O
carthamin    B-Glycoside114887305
"    O
in    O
English    O

FN3    O
K    O
catalyzes    O
phosphorylation    O
of    O
fructosamine    B-Glycoside114887305
formed    O
by    O
glycation    O
,    O
the    O
nonenzymatic    O
reaction    O
of    O
glucose    O
with    O
primary    O
amines    O
followed    O
by    O
Amadori    O
rearrangement    O
.    O

There    O
is    O
some    O
data    O
suggesting    O
that    O
1,5-AG    O
values    O
are    O
useful    O
to    O
fill    O
the    O
gap    O
and    O
offer    O
complementary    O
information    O
to    O
HbA1c    O
and    O
fructosamine    B-Glycoside114887305
tests    O
.    O

5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole    B-Glycoside114887305
(    O
DRB    O
)    O
is    O
a    O
chemical    O
compound    O
that    O
inhibits    O
transcription    O
elongation    O
by    O
RNA    O
Polymerase    O
II    O
.    O

The    O
term    O
ozogamicin    O
in    O
the    O
names    O
of    O
monoclonal    O
antibodies    O
or    O
antibody    O
-    O
drug    O
conjugates    O
indicates    O
that    O
they    O
are    O
linked    O
to    O
a    O
cytotoxic    O
agent    O
from    O
the    O
class    O
of    O
calicheamicin    B-Glycoside114887305
,    O
as    O
in    O
:    O

The    O
calicheamicins    B-Glycoside114887305
are    O
a    O
class    O
of    O
enediyne    O
antitumor    O
antibiotics    O
derived    O
from    O
the    O
bacterium    O
"    O
Micromonospora    O
echinospora    O
"    O
,    O
with    O
calicheamicin    O
γ1    O
being    O
the    O
most    O
notable    O
.    O

Among    O
the    O
molecules    O
synthesized    O
by    O
Danishefsky    O
at    O
Columbia    O
University    O
are    O
epothilones    O
and    O
calicheamicin    B-Glycoside114887305
,    O
which    O
are    O
natural    O
products    O
with    O
promise    O
as    O
anti    O
-    O
cancer    O
agents    O
.    O

Nelarabine    B-Glycoside114887305
for    O
cancer    O
treatment    O
.    O

File    O
:    O
Nelarabine    O
Nelarabine    B-Glycoside114887305

Senna    B-Glycoside114887305

Senna    B-Glycoside114887305
glycoside    I-Glycoside114887305
,    O
a    O
laxative    O

Aescin    B-Glycoside114887305
or    O
escin    B-Glycoside114887305
is    O
a    O
mixture    O
of    O
saponins    O
with    O
anti    O
-    O
inflammatory    O
,    O
vasoconstrictor    O
and    O
vasoprotective    O
effects    O
found    O
in    O
"    O
Aesculus    O
hippocastanum    O
"    O
(    O
the    O
horse    O
chestnut    O
)    O
.    O

Apiin    B-Glycoside114887305
(    O
apigenin    O
7-"O    O
"-    O
apioglucoside    O
)    O
,    O
isolated    O
from    O
parsley    O
and    O
celery    O

TB10Cs1H1    O
is    O
predicted    O
to    O
guide    O
the    O
pseudouridylation    B-Glycoside114887305
of    O
LSU3    O
ribosomal    O
RNA    O
(    O
rRNA    O
)    O
at    O
residue    O
Ψ659    O
.    O

TB9Cs3H1    O
is    O
predicted    O
to    O
guide    O
the    O
pseudouridylation    B-Glycoside114887305
of    O
LSU3    O
ribosomal    O
RNA    O
(    O
rRNA    O
)    O
at    O
residue    O
Ψ1208    O
.    O

TB8Cs3H1    O
is    O
predicted    O
to    O
guide    O
the    O
pseudouridylation    B-Glycoside114887305
of    O
SSU    O
ribosomal    O
RNA    O
(    O
rRNA    O
)    O
at    O
residue    O
Ψ1423    O
.    O

TB9Cs2H1    O
is    O
predicted    O
to    O
guide    O
the    O
pseudouridylation    B-Glycoside114887305
of    O
LSU3    O
ribosomal    O
RNA    O
(    O
rRNA    O
)    O
at    O
residue    O
Ψ617    O
.    O

TB10Cs2H1    O
is    O
predicted    O
to    O
guide    O
the    O
pseudouridylation    B-Glycoside114887305
of    O
LSU3    O
ribosomal    O
RNA    O
(    O
rRNA    O
)    O
at    O
residue    O
Ψ1167    O
.    O

TB10Cs1H3    O
is    O
predicted    O
to    O
guide    O
the    O
pseudouridylation    B-Glycoside114887305
of    O
SSU    O
ribosomal    O
RNA    O
(    O
rRNA    O
)    O
at    O
residue    O
Ψ40    O
.    O

TB10Cs3H1    O
is    O
predicted    O
to    O
guide    O
the    O
pseudouridylation    B-Glycoside114887305
of    O
SSU    O
ribosomal    O
RNA    O
(    O
rRNA    O
)    O
at    O
residue    O
Ψ263    O
.    O

TB10Cs3H2    O
is    O
predicted    O
to    O
guide    O
the    O
pseudouridylation    B-Glycoside114887305
of    O
LSU3    O
ribosomal    O
RNA    O
(    O
rRNA    O
)    O
at    O
residue    O
Ψ397    O
.    O

TB11Cs4H2    O
is    O
predicted    O
to    O
guide    O
the    O
pseudouridylation    B-Glycoside114887305
of    O
SSU    O
ribosomal    O
RNA    O
(    O
rRNA    O
)    O
at    O
residue    O
Ψ1907    O
.    O

TB9Cs4H2    O
is    O
predicted    O
to    O
guide    O
the    O
pseudouridylation    B-Glycoside114887305
of    O
LSU3    O
ribosomal    O
RNA    O
(    O
rRNA    O
)    O
at    O
residue    O
Ψ1336    O
.    O

Pseudouridine    B-Glycoside114887305
(    O
abbreviated    O
by    O
the    O
Greek    O
letter    O

The    O
relevant    O
nature    O
of    O
dyskerin    O
throughout    O
most    O
species    O
is    O
to    O
catalyze    O
the    O
post    O
-    O
transcriptional    O
pseudouridylation    B-Glycoside114887305
of    O
specific    O
uridine    B-Glycoside114887305
found    O
in    O
non    O
-    O
coding    O
RNAs    O
,    O
such    O
as    O
ribosomal    O
RNA    O
(    O
rRNA    O
)    O
.    O

#    O
The    O
T    O
arm    O
is    O
a    O
4-    O
to    O
5-    O
bp    O
stem    O
containing    O
the    O
sequence    O
TΨC    O
where    O
Ψ    O
is    O
pseudouridine    B-Glycoside114887305
,    O
a    O
modified    O
uridine    B-Glycoside114887305
.    O

The    O
first    O
anticodon    O
base    O
,    O
or    O
wobble    O
-    O
position    O
,    O
is    O
sometimes    O
modified    O
to    O
inosine    O
(    O
derived    O
from    O
adenine    O
)    O
,    O
pseudouridine    B-Glycoside114887305
or    O
lysidine    B-Glycoside114887305
(    O
derived    O
from    O
cytosine    O
)    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
ATP    O
and    O
pseudouridine    B-Glycoside114887305
,    O
whereas    O
its    O
two    O
products    O
are    O
ADP    O
and    O
pseudouridine    O
5'-phosphate    O
.    O

Thus    O
,    O
while    O
pseudouridine    B-Glycoside114887305
and    O
2’-O    O
-    O
methylations    O
stabilize    O
the    O
local    O
RNA    O
structure    O
,    O
D    O
does    O
the    O
opposite    O
.    O

Osladine    B-Glycoside114887305
is    O
a    O
naturally    O
occurring    O
,    O
high    O
-    O
intensity    O
sweetener    O
isolated    O
from    O
the    O
rhizome    O
of    O
"    O
Polypodium    O
vulgare    O
"    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
xanthosine    B-Glycoside114887305
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
7-methylxanthosine    O
.    O

Likewise    O
guaijaverin    O
is    O
the    O
3-"O    O
"-    O
arabinoside    O
,    O
hyperoside    B-Glycoside114887305
is    O
the    O
3-"O    O
"-    O
galactoside    B-Glycoside114887305
,    O
isoquercitin    B-Glycoside114887305
is    O
the    O
3-"O    O
"-    O
glucoside    O
and    O
spiraeoside    B-Glycoside114887305
is    O
the    O
4′-"O    O
"-    O
glucoside    O
.    O

Lactose    O
permease    O
can    O
be    O
classified    O
as    O
a    O
symporter    O
,    O
which    O
uses    O
the    O
proton    O
gradient    O
towards    O
the    O
cell    O
to    O
transport    O
β-galactosides    B-Glycoside114887305
such    O
as    O
lactose    O
in    O
the    O
same    O
direction    O
into    O
the    O
cell    O
.    O

Senescence    O
-    O
associated    O
beta    O
-    O
galactosidase    O
(    O
SA-β-gal    O
or    O
SABG    O
)    O
is    O
a    O
hypothetical    O
hydrolase    O
enzyme    O
that    O
catalyzes    O
the    O
hydrolysis    O
of    O
β-galactoside    B-Glycoside114887305
into    O
monosaccharides    O
only    O
in    O
senescent    O
cells    O
.    O

During    O
those    O
tests    O
,    O
one    O
individual    O
exhibited    O
low    O
frequency    O
hearing    O
loss    O
that    O
might    O
have    O
been    O
related    O
to    O
treatment    O
with    O
the    O
antibiotic    O
amikacin    B-Glycoside114887305
although    O
the    O
researchers    O
believed    O
the    O
more    O
likely    O
cause    O
was    O
slight    O
differences    O
in    O
testing    O
setup    O
.    O

aminoglycosides    O
(    O
gentamicin    O
,    O
amikacin    B-Glycoside114887305
,    O
tobramycin    O
,    O
but    O
"    O
not    O
"    O
kanamycin    O
)    O

Empirical    O
regimens    O
must    O
contain    O
antibiotics    O
broadly    O
active    O
against    O
Gram    O
-    O
negative    O
aerobic    O
bacteria    O
(    O
quinolones    O
:    O
i.e.    O
,    O
ciprofloxacin    O
,    O
levofloxacin    O
,    O
a    O
third-    O
or    O
fourth    O
-    O
generation    O
cephalosporin    O
with    O
pseudomonal    O
coverage    O
:    O
e.g.    O
,    O
cefepime    O
,    O
ceftazidime    O
,    O
or    O
an    O
aminoglycoside    O
:    O
i.e.    O
gentamicin    O
,    O
amikacin    B-Glycoside114887305
)    O
.    O

Amikacin    B-Glycoside114887305

Antibiotics    O
such    O
as    O
streptomycin    O
,    O
amikacin    B-Glycoside114887305
,    O
tetracycline    O
,    O
doxycycline    O
,    O
carbapenems    O
,    O
ceftazidime    O
,    O
amoxicillin    O
/    O
clavulanic    O
acid    O
,    O
piperacillin    O
,    O
chloramphenicol    O
,    O
and    O
sulfathiazole    O
have    O
been    O
reported    O
to    O
be    O
effective    O
against    O
the    O
bacteria    O
"    O
in    O
vitro    O
"    O
.    O

Salidroside    B-Glycoside114887305
,    O
common    O
in    O
rhodiola    O
spp    O
.    O
and    O
occurring    O
in    O
Rhodiola    O
rosea    O
is    O
not    O
a    O
cinnamyl    O
alcohol    O
glycoside    O
,    O
but    O
a    O
glycoside    O
of    O
tyrosol    O
.    O

Another    O
synthetic    O
drug    O
specific    O
to    O
the    O
adenosine    O
A2A    O
receptor    O
subtype    O
is    O
CGS-21680    B-Glycoside114887305
that    O
has    O
been    O
shown    O
to    O
cause    O
apneas    O
in    O
14-    O
to    O
21-day    O
-    O
old    O
rat    O
pups    O
"    O
in    O
vivo    O
"    O
.    O

In    O
large    O
quantities    O
,    O
jojoba    O
seed    O
meal    O
is    O
toxic    O
to    O
many    O
mammals    O
,    O
later    O
this    O
effect    O
was    O
found    O
to    O
be    O
due    O
to    O
simmondsin    B-Glycoside114887305
,    O
which    O
inhibits    O
hunger    O
.    O

Ziziphin    O
reduces    O
perceived    O
sweetness    O
of    O
most    O
of    O
the    O
carbohydrates    O
(    O
e.g.    O
glucose    O
,    O
fructose    O
)    O
,    O
bulk    O
sweeteners    O
,    O
intense    O
sweeteners    O
(    O
natural    O
:    O
steviol    B-Glycoside114887305
glycoside    I-Glycoside114887305
–    O
artificial    O
:    O
sodium    O
saccharin    O
and    O
aspartame    O
)    O
and    O
sweet    O
amino    O
acids    O
(    O
e.g.    O
glycine    O
)    O
.    O

Trop50    O
,    O
introduced    O
by    O
Tropicana    O
in    O
2009    O
,    O
is    O
orange    O
juice    O
with    O
50    O
percent    O
less    O
sugar    O
and    O
calories    O
,    O
and    O
no    O
artificial    O
sweeteners    O
(    O
Note    O
:    O
Has    O
Reb    B-Glycoside114887305
A    I-Glycoside114887305
or    O
PureVia    O
which    O
is    O
a    O
form    O
of    O
the    O
plant    O
Stevia    O
–    O
but    O
"    O
is    O
"    O
chemically    O
altered    O
and    O
changed    O
.    O
)    O
Trop50    O
is    O
available    O
in    O
several    O
varieties    O
including    O
Farmstand    O
Apple    O
,    O
Pomegranate    O
Blueberry    O
,    O
Pineapple    O
Mango    O
,    O
Orange    O
,    O
Lemonade    O
and    O
Raspberry    O
Lemonade    O
.    O

Unprocessed    O
aloe    O
that    O
contains    O
aloin    B-Glycoside114887305
is    O
generally    O
used    O
as    O
a    O
laxative    O
,    O
whereas    O
processed    O
juice    O
does    O
not    O
usually    O
contain    O
significant    O
aloin    O
.    O

According    O
to    O
W.    O
A.    O
Shenstone    O
,    O
two    O
classes    O
of    O
aloins    O
are    O
recognized    O
:    O
(    O
1    O
)    O
nataloins    O
,    O
which    O
yield    O
picric    O
and    O
oxalic    O
acids    O
with    O
nitric    O
acid    O
,    O
and    O
do    O
not    O
give    O
a    O
red    O
coloration    O
with    O
nitric    O
acid    O
;    O
and    O
(    O
2    O
)    O
barbaloin    B-Glycoside114887305
,    O
which    O
yield    O
aloetic    O
acid    O
(    O
C7H2N3O5    O
)    O
,    O
chrysammic    O
acid    O
(    O
C7H2N2O6    O
)    O
,    O
picric    O
and    O
oxalic    O
acids    O
with    O
nitric    O
acid    O
,    O
being    O
reddened    O
by    O
the    O
acid    O
.    O

A    O
momordicine    B-Glycoside114887305
is    O
any    O
of    O
several    O
compounds    O
found    O
the    O
bitter    O
melon    O
vine    O
,    O
"    O
Momordica    O
charantia    O
"    O
.    O

The    O
main    O
toxins    O
are    O
the    O
cardenolides    O
called    O
thevetin    B-Glycoside114887305
A    I-Glycoside114887305
and    O
thevetin    B-Glycoside114887305
B    I-Glycoside114887305
;    O
others    O
include    O
peruvoside    O
,    O
neriifolin    O
,    O
thevetoxin    O
and    O
ruvoside    O
.    O

It    O
is    O
an    O
enzyme    O
in    O
the    O
rutin    B-Glycoside114887305
catabolic    O
pathway    O
.    O

The    O
plant    O
also    O
contains    O
rutin    B-Glycoside114887305
,    O
a    O
source    O
of    O
the    O
bitter    O
taste    O
impression    O
.    O

The    O
dried    O
flower    O
buds    O
may    O
contain    O
as    O
much    O
as    O
20%    O
rutin    B-Glycoside114887305
with    O
some    O
quercetin    O
.    O
"    O
S.    O
japonicum    O
"    O
dried    O
fruit    O
contain    O
the    O
flavonoid    O
glycosides    O
sophoricoside    B-Glycoside114887305
,    O
genistin    B-Glycoside114887305
and    O
rutin    B-Glycoside114887305
and    O
the    O
flavonoid    O
aglycone    B-Glycoside114887305
genistein    O
,    O
quercetin    O
and    O
kaempferol    O
.    O

An    O
alcoholic    O
extract    O
of    O
the    O
plant    O
was    O
found    O
to    O
contain    O
daphnoretin    O
,    O
chrysophanol    O
,    O
myricitrime    O
and    O
rutin    B-Glycoside114887305
.    O

"    O
U.    O
guianensis    O
"    O
contains    O
many    O
phytochemicals    O
(    O
(    O
-)-epicatechin    O
,    O
alkaloid    O
,    O
beta    O
-    O
Sitosterol    O
,    O
campesterol    O
,    O
campherol    O
,    O
catechol    O
,    O
catechutannic    O
acid    O
,    O
chlorogenic    B-Glycoside114887305
acid    I-Glycoside114887305
,    O
ellagic    O
acid    O
,    O
gallic    O
acid    O
,    O
hyperin    B-Glycoside114887305
,    O
oleanolic    O
acid    O
,    O
rutin    B-Glycoside114887305
,    O
stigmasterol    O
,    O
ursolic    O
acid    O
)    O
and    O
proanthocyanidin    O
B1    O
and    O
proanthocyanidin    O
B2    O
,    O
B    O
type    O
proanthocyanidins    O
,    O
in    O
the    O
root    O
.    O

Major    O
chemical    O
constituents    O
are    O
hentriacontane    O
,    O
hentriacontanol    O
,    O
β-sitosterol    O
,    O
β-sitosterol    O
palmitate    O
,    O
β-sitosterol    O
-    O
D    O
-    O
glucoside    O
and    O
quercetin-3-rutinoside    B-Glycoside114887305

The    O
phenolic    O
compounds    O
methyl    O
(    O
S)-flavogallonate    O
,    O
gallic    O
acid    O
,    O
methyl    O
gallate    O
,    O
ethyl    O
gallate    O
,    O
[    O
[    O
2,3-di    O
-    O
O--(S)-4,5,6,4′,5′,6′-hexahydroxybiphenyl-2,2′-diyldicarbonyl-(α/β)-D    O
-    O
glucopyranose|2,3-di    O
-    O
O-[(S)-4,5,6,4′,5′,6′-hexahydroxybiphenyl-2,2′-diyldicarbonyl]-(α/β)-D    O
-    O
glucopyranose    O
]    O
]    O
,    O
vitexin    B-Glycoside114887305
,    O
isovitexin    B-Glycoside114887305
,    O
orientin    B-Glycoside114887305
,    O
iso-orientin    B-Glycoside114887305
,    O
kaempferol    O
3-O-β-D    O
-    O
rutinoside    O
,    O
rutin    B-Glycoside114887305
,    O
neosaponarin    O
,    O
ellagic    O
acid    O
,    O
flavogallonic    O
acid    O
and    O
(    O
α/β)-punicalagin    O
can    O
be    O
isolated    O
from    O
the    O
leaves    O
of    O
"    O
T.    O
myriocarpa    O
"    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
UDP    O
-    O
glucose    O
and    O
7,8-dihydroxycoumarin    O
,    O
whereas    O
its    O
two    O
products    O
are    O
UDP    O
and    O
daphnin    B-Glycoside114887305
.    O

Also    O
paeoniflorin    B-Glycoside114887305
seems    O
to    O
have    O
a    O
detoxifying    O
effect    O
on    O
the    O
acute    O
toxicity    O
of    O
aconitine    O
in    O
test    O
animals    O
.    O

8-Hydroxyguanosine    B-Glycoside114887305
is    O
a    O
nucleoside    O
which    O
is    O
an    O
oxidative    O
derivative    O
of    O
guanosine    O
.    O

Hidrosmin    B-Glycoside114887305
is    O
a    O
flavone    O
,    O
a    O
type    O
of    O
flavonoid    O
.    O

Bacoside    B-Glycoside114887305
A    I-Glycoside114887305
is    O
a    O
mixture    O
of    O
chemical    O
compounds    O
,    O
known    O
as    O
bacosides    O
,    O
isolated    O
from    O
"    O
Bacopa    O
monnieri    O
"    O
.    O

DEAD    O
box    O
proteins    O
were    O
first    O
brought    O
to    O
attention    O
in    O
the    O
late    O
1980s    O
in    O
a    O
study    O
that    O
looked    O
at    O
a    O
group    O
of    O
NTP    B-Glycoside114887305
binding    I-Glycoside114887305
site    I-Glycoside114887305
that    O
were    O
similar    O
in    O
sequence    O
to    O
the    O
eIF4A    O
RNA    O
helicase    O
sequence    O
.    O

Alkyl    B-Glycoside114887305
polyglycoside    I-Glycoside114887305

Brivudine    B-Glycoside114887305

Brivudine    B-Glycoside114887305
(    O
bromovinyldeoxyuridine    O
)    O
,    O
an    O
antiviral    O
drug    O

3-"O"-caffeoylshikimic    B-Glycoside114887305
acid    I-Glycoside114887305
(    O
dactylifric    B-Glycoside114887305
acid    I-Glycoside114887305
)    O
and    O
its    O
isomers    O
,    O
are    O
enzymic    O
browning    O
substrates    O
found    O
in    O
dates    O
(    O
"    O
Phoenix    O
dactylifera    O
"    O
fruits    O
)    O
.    O

CTN-986    B-Glycoside114887305
is    O
a    O
glycoside    O
of    O
quercetin    O
found    O
in    O
cottonseeds    O
and    O
cottonseed    O
oil    O
.    O

Dihydrouridine    B-Glycoside114887305
(    O
abbreviated    O
as    O
D    B-Glycoside114887305
,    O
DHU    B-Glycoside114887305
,    O
or    O
UH2    B-Glycoside114887305
)    O
is    O
a    O
pyrimidine    O
nucleoside    O
which    O
is    O
the    O
result    O
of    O
adding    O
two    O
hydrogen    O
atoms    O
to    O
a    O
uridine    B-Glycoside114887305
,    O
making    O
it    O
a    O
fully    O
saturated    O
pyrimidine    O
ring    O
with    O
no    O
remaining    O
double    O
bonds    O
.    O

The    O
"    O
RRM2B    O
"    O
gene    O
,    O
which    O
is    O
expressed    O
in    O
the    O
cell    O
nucleus    O
,    O
codes    O
for    O
one    O
of    O
two    O
versions    O
of    O
the    O
R2    O
subunit    O
of    O
ribonucleotide    O
reductase    O
,    O
which    O
generates    O
nucleotide    O
precursors    O
required    O
for    O
DNA    O
replication    O
by    O
reducing    O
ribonucleoside    B-Glycoside114887305
diphosphates    O
to    O
deoxyribonucloside    O
diphosphates    O
.    O

A    O
ribonucleoside    B-Glycoside114887305
is    O
a    O
type    O
of    O
nucleoside    O
including    O
ribose    O
as    O
a    O
component    O
.    O

The    O
method    O
relies    O
on    O
the    O
incorporation    O
of    O
ribonucleoside    B-Glycoside114887305
analogs    O
that    O
are    O
photoreactive    O
,    O
such    O
as    O
4-thiouridine    O
(    O
4-SU    O
)    O
and    O
6-thioguanosine    O
(    O
6-SG    O
)    O
,    O
into    O
nascent    O
RNA    O
transcripts    O
by    O
living    O
cells    O
.    O

Etopophos    B-Glycoside114887305
(    O
Bristol    O
-    O
Myers    O
Squibb    O
)    O

etoposide    B-Glycoside114887305
(    O
INN    O
)    O

Some    O
cancer    O
treatments    O
like    O
bexarotene    O
,    O
busulfan    O
,    O
chlorambucil    O
,    O
estramustine    O
,    O
etoposide    B-Glycoside114887305
,    O
flutamide    O
,    O
idarubicin    B-Glycoside114887305
,    O
ifosfamide    O
,    O
irinotecan    O
,    O
ixabepilone    O
,    O
letrozole    O
,    O
lomustine    O
,    O
megestrol    O
,    O
mitomycin    O
,    O
mitoxantrone    O
,    O
paclitaxel    O
,    O
procarbazine    O
,    O
tamoxifen    O
,    O
topotecan    O

Etopophos    O
(    O
etoposide    B-Glycoside114887305
)    O

Genistein    O
was    O
,    O
among    O
other    O
flavonoids    O
,    O
found    O
to    O
be    O
a    O
strong    O
topoisomerase    O
inhibitor    O
,    O
similarly    O
to    O
some    O
chemotherapeutic    O
anticancer    O
drugs    O
ex    O
.    O
etoposide    B-Glycoside114887305
and    O
doxorubicin    O
.    O

This    O
effect    O
has    O
been    O
observed    O
with    O
dexamethasone    O
,    O
the    O
anti    O
-    O
cancer    O
drugs    O
docetaxel    O
and    O
etoposide    B-Glycoside114887305
,    O
and    O
to    O
a    O
minor    O
(    O
not    O
clinically    O
significant    O
)    O
extent    O
with    O
levonorgestrel    O
,    O
erythromycin    O
and    O
midazolam    O
.    O

etoposide    B-Glycoside114887305

Etoposide    B-Glycoside114887305

Agents    O
commonly    O
used    O
in    O
induction    O
and    O
for    O
stem    O
cell    O
transplant    O
conditioning    O
are    O
platinum    O
compounds    O
(    O
cisplatin    O
,    O
carboplatin    O
)    O
,    O
alkylating    O
agents    O
(    O
cyclophosphamide    O
,    O
ifosfamide    O
,    O
melphalan    O
)    O
,    O
topoisomerase    O
II    O
inhibitor    O
(    O
etoposide    B-Glycoside114887305
)    O
,    O
anthracycline    O
antibiotics    O
(    O
doxorubicin    O
)    O
and    O
vinca    O
alkaloids    O
(    O
vincristine    O
)    O
.    O

The    O
study    O
screened    O
16,000    O
different    O
chemical    O
compounds    O
and    O
found    O
that    O
only    O
a    O
small    O
subset    O
,    O
including    O
salinomycin    O
and    O
etoposide    B-Glycoside114887305
,    O
targeted    O
cancer    O
stem    O
cells    O
responsible    O
for    O
metastasis    O
and    O
relapse    O
.    O

For    O
example    O
,    O
in    O
a    O
study    O
detecting    O
tumor    O
response    O
to    O
etoposide    B-Glycoside114887305
treatment    O
,    O
the    O
sample    O
was    O
dissolved    O
in    O
40    O
mM    O
HEPES    O
,    O
94    O
mM    O
NaOH    O
,    O
30    O
mM    O
NaCl    O
,    O
and    O
50    O
mg    O
/    O
L    O
EDTA    O
.    O

A    O
relatively    O
new    O
regimen    O
that    O
uses    O
old    O
drugs    O
is    O
PEP    O
-    O
C    O
,    O
which    O
includes    O
relatively    O
small    O
,    O
daily    O
doses    O
of    O
prednisone    O
,    O
etoposide    B-Glycoside114887305
,    O
procarbazine    O
,    O
and    O
cyclophosphamide    O
,    O
taken    O
orally    O
,    O
has    O
proven    O
effective    O
for    O
relapsed    O
patients    O
.    O

It    O
is    O
chemically    O
similar    O
to    O
the    O
anti    O
-    O
cancer    O
drug    O
etoposide    B-Glycoside114887305
,    O
being    O
distinguished    O
only    O
by    O
a    O
thienyl    O
rest    O
where    O
etoposide    O
has    O
a    O
methyl    O
.    O

Apigenin    O
,    O
apigenin    B-Glycoside114887305
7-O-glucoside    I-Glycoside114887305
,    O
and    O
a    O
new    O
acylflavone    O
glucoside    O
named    O
echitin    O
(    O
I    O
)    O
were    O
isolated    O
from    O
"    O
Echinops    O
echinatus    O
flowers    O
"    O
.    O

Resveratroloside    B-Glycoside114887305
(    O
3,5,4'-trihydroxystilbene-4'-O-β-D    O
-    O
glucopyranoside    O
)    O

The    O
enzyme    O
quercitrinase    B-Glycoside114887305
can    O
be    O
found    O
in    O
"    O
Aspergillus    O
flavus    O
"    O
.    O

Lauryl    B-Glycoside114887305
glucoside    I-Glycoside114887305

Avicularin    B-Glycoside114887305
is    O
a    O
bio    O
-    O
active    O
flavonol    O
isolated    O
from    O
a    O
number    O
of    O
plants    O
including    O
"    O
Polygonum    O
aviculare    O
"    O
,    O
"    O
Rhododendron    O
aureum    O
"    O
and    O
"    O
Taxillus    O
kaempferi    O
"    O
.    O

These    O
contain    O
an    O
iridoid    O
group    O
;    O
e.g.    O
aucubin    B-Glycoside114887305
,    O
Geniposidic    B-Glycoside114887305
acid    I-Glycoside114887305
,    O
theviridoside    O
,    O
Loganin    B-Glycoside114887305
,    O
Catalpol    B-Glycoside114887305
.    O

Aucubin    B-Glycoside114887305
is    O
an    O
iridoid    O
glycoside    O
.    O

Phlorizin    B-Glycoside114887305
is    O
a    O
compound    O
that    O
has    O
been    O
known    O
for    O
over    O
a    O
century    O
.    O

Phlorizin    B-Glycoside114887305
is    O
a    O
compound    O
that    O
has    O
been    O
known    O
for    O
over    O
a    O
century    O
.    O

It    O
is    O
the    O
"    O
O    O
"-    O
demethylated    O
derivative    O
of    O
bergenin    B-Glycoside114887305
.    O

Bergenin    B-Glycoside114887305
and    O
norbergenin    B-Glycoside114887305
are    O
chemical    O
compounds    O
that    O
can    O
be    O
isolated    O
from    O
rhizomes    O
of    O
"    O
B.    O
stracheyi    O
"    O
.    O

GD2    O
is    O
a    O
glycolipid    B-Glycoside114887305
that    O
is    O
expressed    O
on    O
the    O
surface    O
of    O
neuroblastoma    O
cells    O
.    O

Far    O
-    O
Eastern    O
blot    O
for    O
glycolipid    B-Glycoside114887305

He    O
is    O
known    O
for    O
discovery    O
of    O
the    O
"    O
Forssman    O
antigen    O
"    O
,    O
defined    O
as    O
a    O
glycolipid    B-Glycoside114887305
heterophile    O
antigen    O
found    O
on    O
tissue    O
cells    O
of    O
many    O
animal    O
species    O
.    O

Synthetic    O
"    O
Gylcolipids    O
"    O
–    O
one    O
family    O
of    O
the    O
FSL    O
constructs    O
are    O
synthetic    O
glycolipid    B-Glycoside114887305
with    O
well    O
-    O
defined    O
hydrophobic    O
tails    O
and    O
carbohydrate    O
head    O
groups    O

The    O
promastigote    O
can    O
do    O
this    O
using    O
its    O
glycolipid    B-Glycoside114887305
lipophosphoglycan    O
(    O
LPG    O
)    O
on    O
its    O
cell    O
membrane    O
.    O

Here    O
,    O
he    O
did    O
research    O
on    O
glycolipids    B-Glycoside114887305
,    O
glycosaminoglycans    O
and    O
glycoproteins    O
and    O
their    O
role    O
in    O
neural    O
development    O
and    O
neurological    O
disorders    O
.    O

This    O
discovery    O
assisted    O
other    O
scientists    O
in    O
the    O
elucidation    O
of    O
similar    O
glycolipid    B-Glycoside114887305
storage    O
diseases    O
such    O
as    O
Gaucher    O
's    O
disease    O
and    O
Tay    O
–    O
Sachs    O
disease    O
and    O
in    O
their    O
prenatal    O
diagnosis    O
.    O

Glycolipid    B-Glycoside114887305

Glycoproteins    O
,    O
proteoglycans    O
and    O
glycolipid    B-Glycoside114887305
are    O
the    O
most    O
abundant    O
glycoconjugates    O
found    O
in    O
mammalian    O
cells    O
.    O

The    O
Lec15    O
and    O
Lec35    O
mutations    O
are    O
characterized    O
by    O
inefficient    O
synthesis    O
and    O
utilization    O
,    O
respectively    O
,    O
of    O
mannose    O
-    O
P    O
-    O
dolichol    O
for    O
glycolipid    B-Glycoside114887305
biosynthesis    O
.    O

Analysis    O
of    O
the    O
lipid    O
and    O
fatty    O
acid    O
composition    O
revealed    O
that    O
"    O
D.    O
confragosa    O
"    O
contains    O
20.1%    O
total    O
lipids    O
(    O
mg    O
/    O
g    O
dry    O
weight    O
)    O
,    O
32.9%    O
neutral    O
lipids    O
,    O
53.8%    O
phospholipid    O
,    O
and    O
13.3%    O
glycolipid    B-Glycoside114887305
.    O

The    O
end    O
-    O
product    O
of    O
this    O
pathway    O
is    O
UDP    O
-    O
GlcNAc    O
,    O
which    O
is    O
then    O
used    O
for    O
making    O
glycosaminoglycans    O
,    O
proteoglycans    O
,    O
and    O
glycolipids    B-Glycoside114887305
.    O

Glycolipids    B-Glycoside114887305
are    O
lipids    O
with    O
a    O
carbohydrate    O
attached    O
by    O
a    O
glycosidic    B-Glycoside114887305
bond    I-Glycoside114887305
.    O

The    O
three    O
major    O
classes    O
of    O
membrane    O
lipids    O
are    O
phospholipids    O
,    O
glycolipid    B-Glycoside114887305
,    O
and    O
cholesterol    O
.    O

Scandenoside    B-Glycoside114887305
is    O
any    O
one    O
of    O
several    O
chemical    O
compounds    O
isolated    O
from    O
certain    O
plants    O
,    O
notably    O
"    O
Hemsleya    O
panacis    O
-    O
scandens    O
"    O
.    O

Cordycepin    B-Glycoside114887305
(    O
3'-deoxyadenosine    O
)    O

FC    O
(    O
fludarabine    B-Glycoside114887305
with    O
cyclophosphamide    O
)    O

FR    O
(    O
fludarabine    B-Glycoside114887305
with    O
rituximab    O
)    O

FCR    O
(    O
fludarabine    B-Glycoside114887305
,    O
cyclophosphamide    O
,    O
and    O
rituximab    O
)    O

Second    O
line    O
treatment    O
may    O
include    O
fludarabine    B-Glycoside114887305
,    O
combined    O
with    O
cyclophosphamide    O
and/or    O
mitoxantrone    O
,    O
usually    O
with    O
rituximab    O
.    O

It    O
was    O
approved    O
by    O
the    O
US    O
Food    O
and    O
Drug    O
Administration    O
for    O
CLL    O
patients    O
who    O
have    O
been    O
treated    O
with    O
alkylating    O
agents    O
and    O
who    O
have    O
failed    O
fludarabine    B-Glycoside114887305
therapy    O
.    O

Kaempferol    B-Glycoside114887305
7-O-glucoside    I-Glycoside114887305
,    O
a    O
flavonol    O
glucoside    O
,    O
can    O
be    O
found    O
in    O
"    O
S.    O
china    O
"    O
.    O

When    O
"    O
Ranunculus    O
"    O
plants    O
are    O
handled    O
,    O
naturally    O
occurring    O
ranunculin    B-Glycoside114887305
is    O
broken    O
down    O
to    O
form    O
protoanemonin    O
,    O
which    O
is    O
known    O
to    O
cause    O
contact    O
dermatitis    O
in    O
humans    O
;    O
care    O
should    O
therefore    O
be    O
exercised    O
in    O
extensive    O
handling    O
of    O
the    O
plants    O
.    O

There    O
are    O
six    O
treatment    O
options    O
approved    O
by    O
the    O
U.S.    O
Food    O
and    O
Drug    O
Administration    O
(    O
FDA    O
)    O
available    O
for    O
persons    O
with    O
a    O
chronic    O
hepatitis    O
B    O
infection    O
:    O
alpha    O
-    O
interferon    O
,    O
pegylated    O
interferon    O
,    O
adefovir    O
,    O
entecavir    B-Glycoside114887305
,    O
telbivudine    B-Glycoside114887305
,    O
and    O
lamivudine    O
.    O

LdT    O
,    O
Telbivudine    B-Glycoside114887305
(    O
Tyzeka    O
)    O
,    O
a    O
drug    O
for    O
the    O
treatment    O
of    O
chronic    O
hepatitis    O
B    O

sapacitabine    B-Glycoside114887305
(    O
INN    O
,    O
USAN    O
)    O

2-Chloro-"N"6-cyclopentyladenosine    B-Glycoside114887305
(    O
CCPA    B-Glycoside114887305
)    O
is    O
a    O
specific    O
receptor    O
agonist    O
for    O
the    O
Adenosine    O
A1    O
receptor    O
.    O

Broad    O
beans    O
,    O
e.g.    O
,    O
fava    O
beans    O
,    O
contain    O
high    O
levels    O
of    O
vicine    B-Glycoside114887305
,    O
divicine    O
,    O
convicine    O
and    O
isouramil    O
,    O
all    O
of    O
which    O
create    O
oxidants    O
.    O

Its    O
major    O
constituents    O
include    O
the    O
saponins    O
bacoside    O
A3    O
,    O
bacopaside    B-Glycoside114887305
II    I-Glycoside114887305
,    O
jujubogenin    O
isomer    O
of    O
bacopasaponin    O
C    O
,    O
and    O
bacopasaponin    O
C.    O
The    O
mixture    O
has    O
been    O
studied    O
in    O
"    O
in    O
vitro    O
"    O
experiments    O
and    O
animal    O
models    O
for    O
its    O
potential    O
neuroprotectivity    O
.    O

They    O
are    O
considered    O
to    O
have    O
more    O
variety    O
than    O
anthocyanins    B-Glycoside114887305
.    O

Primulin    O
is    O
an    O
anthocyanin    B-Glycoside114887305
.    O

Oenin    O
is    O
an    O
anthocyanin    B-Glycoside114887305
.    O

Antirrhinin    B-Glycoside114887305
is    O
an    O
anthocyanin    B-Glycoside114887305
.    O

Chrysanthemin    B-Glycoside114887305
is    O
an    O
anthocyanin    B-Glycoside114887305
.    O

Myrtillin    B-Glycoside114887305
is    O
an    O
anthocyanin    B-Glycoside114887305
.    O

The    O
enzyme    O
anthocyanin    O
3-O    O
-    O
glucoside    O
6"-O    O
-    O
hydroxycinnamoyltransferase    O
produces    O
delphinidin    O
3-(6-p    O
-    O
coumaroyl)glucoside    O
from    O
myrtillin    O
and    O
"    O
p    O
"-    O
coumaroyl    O
-    O
CoA    O
in    O
the    O
anthocyanin    B-Glycoside114887305
biosynthesis    I-Glycoside114887305
pathway    O
.    O

Tulipanin    O
is    O
an    O
anthocyanin    B-Glycoside114887305
.    O

The    O
fruit    O
is    O
high    O
in    O
anthocyanin    B-Glycoside114887305
pigment    O
,    O
and    O
can    O
be    O
used    O
to    O
make    O
a    O
natural    O
food    O
dye    O
.    O

In    O
fact    O
,    O
'    O
radicchio    O
'    O
contains    O
intybin    O
,    O
a    O
sedative    O
/    O
analgesic    O
,    O
as    O
well    O
as    O
a    O
type    O
of    O
flavonoid    O
called    O
anthocyanin    B-Glycoside114887305
which    O
is    O
used    O
for    O
making    O
dye    O
-    O
sensitized    O
solar    O
cells    O
.    O

The    O
primary    O
function    O
of    O
pigments    O
in    O
plants    O
is    O
photosynthesis    O
,    O
which    O
uses    O
the    O
green    O
pigment    O
chlorophyll    O
along    O
with    O
several    O
red    O
and    O
yellow    O
pigments    O
including    O
porphyrins    O
,    O
carotenoids    O
,    O
anthocyanin    B-Glycoside114887305
and    O
betalain    B-Glycoside114887305
.    O

Many    O
flowering    O
plants    O
of    O
the    O
alpine    O
tundra    O
have    O
dense    O
hairs    O
on    O
stems    O
and    O
leaves    O
to    O
provide    O
wind    O
protection    O
or    O
red-colored    B-Glycoside114887305
pigments    I-Glycoside114887305
capable    O
of    O
converting    O
the    O
sun    O
's    O
light    O
rays    O
into    O
heat    O
.    O

Occasionally    O
the    O
leaves    O
may    O
appear    O
purple    O
from    O
an    O
accumulation    O
of    O
anthocyanin    B-Glycoside114887305
.    O

Notable    O
for    O
deep    O
blue    O
-    O
purple    O
pigmentation    O
,    O
the    O
skin    O
of    O
Norton    O
grapes    O
has    O
a    O
higher    O
content    O
of    O
total    O
anthocyanin    B-Glycoside114887305
(    O
888    O
mg    O
per    O
100    O
g    O
)    O
than    O
other    O
purple    O
grape    O
cultivars    O
,    O
Concord    O
or    O
Marechal    O
Foch    O
grapes    O
.    O

After    O
moving    O
to    O
the    O
University    O
of    O
Oxford    O
,    O
Gertrude    O
Robinson    O
began    O
studying    O
plant    O
pigments    O
and    O
published    O
extensively    O
on    O
anthocyanin    B-Glycoside114887305
with    O
her    O
husband    O
.    O

The    O
metabolic    O
pathway    O
continues    O
through    O
a    O
series    O
of    O
enzymatic    O
modifications    O
to    O
yield    O
flavanones    O
→    O
dihydroflavonols    O
→    O
anthocyanin    B-Glycoside114887305
.    O

The    O
different    O
colors    O
on    O
the    O
lip    O
are    O
obtained    O
through    O
a    O
different    O
expression    O
of    O
both    O
anthocyanin    B-Glycoside114887305
and    O
carotenoids    O
.    O

Like    O
other    O
purple    O
basils    O
,    O
the    O
purple    O
color    O
is    O
from    O
anthocyanin    B-Glycoside114887305
,    O
especially    O
cyanidin-3-(di    O
-    O
p    O
-    O
coumarylglucoside)-5-glucoside    O
but    O
also    O
other    O
cyanidin    O
based    O
and    O
peonidin    O
based    O
compounds    O
.    O
'    O
Dark    O
opal    O
'    O
,    O
along    O
with    O
other    O
large    O
leaved    O
purple    O
cultivars    O
such    O
as    O
'    O
Purple    O
Ruffles    O
'    O
,    O
has    O
a    O
high    O
concentration    O
of    O
anthocyanins    O
and    O
is    O
considered    O
a    O
potential    O
source    O
of    O
red    O
pigments    O
for    O
the    O
food    O
industry    O
.    O

In    O
1835    O
Marquart    O
is    O
credited    O
for    O
coining    O
the    O
chemical    O
term    O
"    O
anthocyanin    B-Glycoside114887305
"    O
to    O
denote    O
the    O
blue    O
pigment    O
of    O
the    O
cornflower    O
.    O

Occasional    O
populations    O
of    O
yellow    O
-    O
flowered    O
"    O
Erythranthe    O
cardinalis    O
"    O
(    O
which    O
lack    O
anthocyanin    B-Glycoside114887305
pigments    O
in    O
their    O
corollas    O
)    O
are    O
found    O
in    O
the    O
wild    O
.    O

Anthocyanin    B-Glycoside114887305

Sulfur    O
dioxide    O
being    O
emitted    O
from    O
the    O
nearby    O
Mount    O
Io    O
(    O
硫黄山    O
"    O
iōzan    O
"    O
)    O
is    O
oxidized    O
to    O
form    O
diluted    O
sulfuric    O
acid    O
,    O
which    O
is    O
absorbed    O
through    O
the    O
soil    O
into    O
the    O
plant    O
and    O
used    O
as    O
anthocyanin    B-Glycoside114887305
.    O

Modifying    O
the    O
atmosphere    O
inside    O
fresh    O
produce    O
packaging    O
to    O
provide    O
lowered    O
levels    O
of    O
and    O
elevated    O
levels    O
of    O
is    O
beneficial    O
for    O
many    O
fresh    O
produce    O
items    O
and    O
“    O
can    O
reduce    O
respiration    O
,    O
decrease    O
ethylene    O
production    O
and    O
action    O
,    O
retard    O
tissue    O
ripening    O
and    O
softening    O
,    O
retard    O
chlorophyll    O
degradation    O
and    O
biosynthesis    O
of    O
carotenoids    O
and    O
anthocyanins    B-Glycoside114887305
,    O
reduce    O
enzymatic    O
browning    O
,    O
alleviate    O
physiological    O
disorders    O
and    O
chilling    O
injury    O
,    O
retard    O
development    O
of    O
decay    O
,    O
and    O
maintain    O
nutritional    O
quality    O
of    O
produce    O
.    O

Teinturier    O
,    O
a    O
French    O
language    O
term    O
meaning    O
to    O
dye    O
or    O
stain    O
,    O
is    O
a    O
wine    O
term    O
applied    O
to    O
grapes    O
whose    O
flesh    O
and    O
juice    O
is    O
red    O
in    O
colour    O
due    O
to    O
anthocyanin    B-Glycoside114887305
pigments    O
accumulating    O
within    O
the    O
pulp    O
of    O
the    O
grape    O
berry    O
itself    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
malonyl    O
-    O
CoA    O
and    O
anthocyanidin    B-Glycoside114887305
3-O-beta-D-glucoside    I-Glycoside114887305
,    O
whereas    O
its    O
two    O
products    O
are    O
CoA    O
and    O
anthocyanidin    O
3-O-(6-O    O
-    O
malonyl    O
-    O
beta    O
-    O
D    O
-    O
glucoside    O
)    O
.    O

Blueberries    O
are    O
commonly    O
branded    O
as    O
having    O
a    O
high    O
dose    O
of    O
antioxidants    O
,    O
particularly    O
anthocyanins    B-Glycoside114887305
for    O
which    O
antioxidant    O
properties    O
have    O
been    O
demonstrated    O
only    O
"    O
in    O
vitro    O
"    O
.    O

The    O
bran    O
hull    O
(    O
outermost    O
layer    O
)    O
of    O
black    O
rice    O
contains    O
one    O
of    O
the    O
highest    O
levels    O
of    O
anthocyanins    B-Glycoside114887305
found    O
in    O
food    O
.    O

The    O
main    O
targets    O
of    O
bleaches    O
are    O
oxidisible    O
organic    O
stains    O
;    O
which    O
are    O
usually    O
of    O
vegetable    O
origin    O
(    O
e.g.    O
chlorophyll    O
,    O
anthocyanin    B-Glycoside114887305
dyes    O
,    O
tannins    O
,    O
humic    O
acids    O
,    O
and    O

This    O
coloration    O
has    O
been    O
shown    O
to    O
be    O
an    O
example    O
of    O
copigmentation    O
,    O
a    O
result    O
of    O
the    O
presence    O
of    O
malvin    B-Glycoside114887305
(    O
an    O
anthocyanin    B-Glycoside114887305
)    O
and    O
saponarin    O
in    O
the    O
ratio    O
1:9    O
.    O

The    O
phenolic    O
compounds    O
such    O
as    O
anthocyanin    B-Glycoside114887305
and    O
tannins    O
help    O
give    O
the    O
wine    O
its    O
colour    O
,    O
bitterness    O
,    O
astringency    O
and    O
anti    O
-    O
oxidant    O
capacity    O
.    O

Additionally    O
,    O
red    O
wines    O
may    O
endure    O
a    O
loss    O
of    O
color    O
after    O
MLF    O
due    O
to    O
pH    O
changes    O
that    O
causes    O
a    O
shift    O
in    O
the    O
equilibrium    O
of    O
the    O
anthocyanins    B-Glycoside114887305
which    O
contribute    O
to    O
the    O
stability    O
of    O
color    O
in    O
wine    O
.    O

While    O
this    O
may    O
help    O
for    O
wines    O
with    O
excessive    O
levels    O
of    O
acetaldehyde    O
,    O
for    O
red    O
wines    O
,    O
it    O
can    O
also    O
destabilize    O
the    O
color    O
of    O
the    O
wine    O
by    O
interfering    O
with    O
acetaldehyde    O
's    O
reaction    O
with    O
anthocyanins    B-Glycoside114887305
to    O
create    O
polymeric    O
pigments    O
that    O
help    O
create    O
a    O
wine    O
's    O
color    O
.    O

Violdelphin    O
is    O
an    O
anthocyanin    B-Glycoside114887305
,    O
a    O
type    O
of    O
plant    O
pigment    O
,    O
found    O
in    O
the    O
purplish    O
blue    O
flower    O
of    O
"    O
A.    O
chinense    O
"    O
.    O

Ziziphin    B-Glycoside114887305
,    O
a    O
triterpene    O
glycoside    O
,    O
C51H80O18    O

Astringin    B-Glycoside114887305
in    O
the    O
bark    O
of    O
Norway    O
spruce    O

This    O
page    O
provides    O
supplementary    O
chemical    O
data    O
on    O
vitexin    B-Glycoside114887305
.    O

The    O
phenolic    O
compounds    O
methyl    O
(    O
S)-flavogallonate    O
,    O
gallic    O
acid    O
,    O
methyl    O
gallate    O
,    O
ethyl    O
gallate    O
,    O
[    O
[    O
2,3-di    O
-    O
O--(S)-4,5,6,4′,5′,6′-hexahydroxybiphenyl-2,2′-diyldicarbonyl-(α/β)-D    O
-    O
glucopyranose|2,3-di    O
-    O
O-[(S)-4,5,6,4′,5′,6′-hexahydroxybiphenyl-2,2′-diyldicarbonyl]-(α/β)-D    O
-    O
glucopyranose    O
]    O
]    O
,    O
vitexin    B-Glycoside114887305
,    O
isovitexin    B-Glycoside114887305
,    O
orientin    B-Glycoside114887305
,    O
iso-orientin    B-Glycoside114887305
,    O
kaempferol    O
3-O-β-D    O
-    O
rutinoside    O
,    O
rutin    B-Glycoside114887305
,    O
neosaponarin    O
,    O
ellagic    O
acid    O
,    O
flavogallonic    O
acid    O
and    O
(    O
α/β)-punicalagin    O
can    O
be    O
isolated    O
from    O
the    O
leaves    O
of    O
"    O
T.    O
myriocarpa    O
"    O
.    O

Benzoyl-beta-D-glucoside    B-Glycoside114887305
,    O
as    O
well    O
as    O
pterosin    O
sesquiterpenes    O
can    O
be    O
found    O
in    O
"    O
P.    O
ensiformis    O
"    O
.    O

File    O
:    O
Sorivudine    B-Glycoside114887305

In    O
the    O
small    O
intestine    O
,    O
kaempferol    O
is    O
metabolized    O
to    O
glucuronide    B-Glycoside114887305
and    O
sulfoconjugates    O
by    O
intestinal    O
enzymes    O
.    O

In    O
adult    O
patients    O
taking    O
valproate    O
alone    O
,    O
30–50%    O
of    O
an    O
administered    O
dose    O
is    O
excreted    O
in    O
urine    O
as    O
a    O
glucuronide    B-Glycoside114887305
conjugate    I-Glycoside114887305
.    O

Darexaban    O
is    O
rapidly    O
absorbed    O
and    O
extensively    O
metabolized    O
in    O
the    O
liver    O
to    O
its    O
active    O
metabolite    O
,    O
darexaban    O
glucuronide    B-Glycoside114887305
(    O
YM-222714    O
)    O
during    O
first    O
pass    O
metabolism    O
via    O
glucuronidation    O
.    O

Abacavir    O
is    O
metabolized    O
primarily    O
through    O
the    O
enzymes    O
alcohol    O
dehydrogenase    O
and    O
glucuronyl    O
transferase    O
to    O
an    O
inactive    O
carboxylate    O
and    O
glucuronide    B-Glycoside114887305
metabolites    O
.    O

Methylphenidate    O
,    O
on    O
the    O
other    O
hand    O
,    O
is    O
a    O
short    O
-    O
acting    O
compound    O
,    O
as    O
it    O
possesses    O
a    O
methyl    O
-    O
ester    O
moiety    O
that    O
is    O
easily    O
cleaved    O
,    O
forming    O
a    O
highly    O
polar    O
acid    O
group    O
,    O
while    O
pipradrol    O
is    O
intermediate    O
in    O
duration    O
,    O
possessing    O
a    O
hydroxyl    O
group    O
which    O
can    O
be    O
conjugated    O
(    O
e.g.    O
with    O
glucuronide    B-Glycoside114887305
)    O
to    O
increase    O
its    O
hydrophilicity    O
and    O
facilitate    O
excretion    O
,    O
but    O
no    O
easily    O
metabolized    O
groups    O
.    O

Catalog    O
products    O
include    O
Drugs    O
-    O
of    O
-    O
Abuse    O
,    O
Pharmaceuticals    O
,    O
Drug    O
Metabolites    O
and    O
Impurities    O
,    O
P450    O
metabolites    O
,    O
Glucuronides    B-Glycoside114887305
,    O
Benzodiazepines    O
,    O
Opiates    O
,    O
Steroids    O
,    O
Amphetamines    O
,    O
Drug    O
Mixes    O
,    O
Nitroglycerins/    O
Explosives    O
,    O
Chemical    O
Warfare    O
by    O
-    O
products    O
,    O
and    O
Phytochemicals    O
.    O

Aspirin    O
should    O
be    O
used    O
in    O
animals    O
only    O
under    O
the    O
direct    O
supervision    O
of    O
a    O
veterinarian    O
;    O
in    O
particular    O
,    O
cats    O
lack    O
the    O
glucuronide    B-Glycoside114887305
conjugates    O
that    O
aid    O
in    O
the    O
excretion    O
of    O
aspirin    O
,    O
making    O
it    O
potentially    O
toxic    O
.    O

Herbal    O
teas    O
made    O
from    O
"    O
Plectranthus    O
barbatus    O
"    O
contains    O
rosmarinic    O
acid    O
and    O
also    O
flavonoid    O
glucuronide    B-Glycoside114887305
and    O
diterpenoids    O
.    O

Estrogens    O
,    O
and    O
particularly    O
glucuronide    B-Glycoside114887305
such    O
as    O
estradiol-17β-D    O
-    O
glucuronide    O
,    O
have    O
been    O
shown    O
to    O
cause    O
cholestasis    O
in    O
animal    O
studies    O
,    O
by    O
reducing    O
bile    O
acid    O
uptake    O
by    O
hepatocytes    O
.    O

Charantoside    B-Glycoside114887305

One    O
of    O
them    O
,    O
the    O
saponin    O
QS21    B-Glycoside114887305
,    O
is    O
being    O
investigated    O
for    O
possible    O
beneficial    O
adjuvant    O
effects    O
on    O
the    O
human    O
immune    O
system    O
.    O

litoralis    O
"    O
contains    O
adenosine    O
,    O
coniferin    B-Glycoside114887305
,    O
the    O
two    O
dihydrofurocoumarin    O
glycosides    O
apterin    B-Glycoside114887305
and    O
1′-O-β-d    O
-    O
glycopyranosyl-(S)-marmesin    O
(    O
marmesinin    O
)    O
,    O
1′-O-β-d    O
-    O
glucopyranosyl-(2S    O
,    O
3R)-3-hydroxymarmesin    O
and    O
2′-β-d    O
-    O
glucopyranosyloxymarmesin    O
.    O

Saponarin    B-Glycoside114887305
is    O
a    O
flavone    O
glucoside    O
.    O

"    O
Senegalia    O
greggii    O
"    O
,    O
even    O
though    O
it    O
is    O
used    O
as    O
forage    O
for    O
livestock    O
,    O
contains    O
a    O
potentially    O
poisonous    O
cyanogenic    O
glycoside    O
called    O
prunasin    B-Glycoside114887305
.    O

Chemically    O
,    O
amygdalin    O
and    O
prunasin    B-Glycoside114887305
,    O
the    O
derivatives    O
of    O
which    O
produce    O
prussic    O
acid    O
as    O
well    O
as    O
Genistein    O
can    O
be    O
extracted    O
from    O
"    O
P.    O
maximowiczii    O
"    O
.    O

Regadenoson    B-Glycoside114887305
(    O
brand    O
name    O
"    O
Lexiscan    O
"    O
)    O
,    O
which    O
acts    O
specifically    O
at    O
the    O
adenosine    O
A2A    O
receptor    O
,    O
thus    O
affecting    O
the    O
heart    O
more    O
than    O
the    O
lung    O
.    O

Following    O
this    O
,    O
myocardial    O
stress    O
is    O
induced    O
,    O
either    O
by    O
exercise    O
or    O
pharmacologically    O
with    O
adenosine    O
,    O
dobutamine    O
or    O
dipyridamole(Persantine    O
)    O
,    O
which    O
increase    O
the    O
heart    O
rate    O
or    O
by    O
regadenoson    B-Glycoside114887305
)    O
,    O
a    O
vasodilator    O
.    O

TB11Cs2H1    O
is    O
a    O
member    O
of    O
the    O
H    O
/    O
ACA    O
-    O
like    O
class    O
of    O
non    O
-    O
coding    O
RNA    O
(    O
ncRNA    O
)    O
molecules    O
that    O
guide    O
the    O
sites    O
of    O
modification    O
of    O
uridine    B-Glycoside114887305
to    O
pseudouridine    B-Glycoside114887305
of    O
substrate    O
RNAs    O
.    O

tRNAs    O
with    O
anticodons    O
that    O
start    O
with    O
a    O
uridine    B-Glycoside114887305
and    O
carrying    O
an    O
already    O
-    O
prenylated    O
adenosine    O
adjacent    O
to    O
the    O
anticodon    O
release    O
on    O
degradation    O
the    O
adenosine    O
as    O
a    O
cytokinin    O
.    O

Originally    O
based    O
on    O
observed    O
nano    O
-    O
scale    O
structures    O
in    O
geological    O
formations    O
(    O
including    O
one    O
meteorite    O
)    O
,    O
the    O
status    O
of    O
nanobacteria    O
has    O
been    O
controversial    O
,    O
with    O
some    O
researchers    O
suggesting    O
they    O
are    O
a    O
new    O
class    O
of    O
living    O
organism    O
capable    O
of    O
incorporating    O
radiolabeled    O
uridine    B-Glycoside114887305
,    O
and    O
others    O
attributing    O
to    O
them    O
a    O
simpler    O
,    O
abiotic    O
nature    O
.    O

It    O
is    O
an    O
ester    O
of    O
pyrophosphoric    O
acid    O
with    O
the    O
nucleoside    O
uridine    B-Glycoside114887305
.    O

The    O
treatment    O
essentially    O
converts    O
a    O
cytosine    O
to    O
a    O
uridine    B-Glycoside114887305
,    O
but    O
methylated    O
cytosines    O
would    O
be    O
unchanged    O
by    O
the    O
treatment    O
.    O

TB10Cs1H1    O
is    O
a    O
member    O
of    O
the    O
H    O
/    O
ACA    O
-    O
like    O
class    O
of    O
non    O
-    O
coding    O
RNA    O
(    O
ncRNA    O
)    O
molecule    O
that    O
guide    O
the    O
sites    O
of    O
modification    O
of    O
uridine    B-Glycoside114887305
to    O
pseudouridine    B-Glycoside114887305
of    O
substrate    O
RNAs    O
.    O

psi-    O
Ψ    O
or    O
the    O
letter    O
Q    O
)    O
is    O
an    O
isomer    O
of    O
the    O
nucleoside    O
uridine    B-Glycoside114887305
in    O
which    O
the    O
uracil    O
is    O
attached    O
via    O
a    O
carbon    O
-    O
carbon    O
instead    O
of    O
a    O
nitrogen    O
-    O
carbon    O
glycosidic    B-Glycoside114887305
bond    I-Glycoside114887305
.    O

The    O
relevant    O
nature    O
of    O
dyskerin    O
throughout    O
most    O
species    O
is    O
to    O
catalyze    O
the    O
post    O
-    O
transcriptional    O
pseudouridylation    B-Glycoside114887305
of    O
specific    O
uridine    B-Glycoside114887305
found    O
in    O
non    O
-    O
coding    O
RNAs    O
,    O
such    O
as    O
ribosomal    O
RNA    O
(    O
rRNA    O
)    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
tRNA    O
containing    O
uridine    B-Glycoside114887305
at    O
position    O
54    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
tRNA    O
containing    O
ribothymidine    B-Glycoside114887305
at    O
position    O
54    O
.    O

Herein    O
lies    O
the    O
only    O
known    O
function    O
of    O
the    O
minicircles    O
-    O
producing    O
guide    O
RNA    O
(    O
gRNA    O
)    O
to    O
decode    O
this    O
encrypted    O
maxicircle    O
information    O
,    O
typically    O
through    O
the    O
insertion    O
or    O
deletion    O
of    O
uridine    B-Glycoside114887305
residues    O
.    O

Pyrimidine    O
analogues    O
of    O
uridine    B-Glycoside114887305
:    O
Idoxuridine    B-Glycoside114887305
,    O
Trifluridine    O

The    O
RNA    O
component    O
of    O
the    O
small    O
nuclear    O
ribonucleic    O
protein    O
or    O
snRNP    O
(    O
pronounced    O
"    O
snurp    O
"    O
)    O
is    O
rich    O
in    O
uridine    B-Glycoside114887305
(    O
the    O
nucleoside    O
analog    O
of    O
the    O
uracil    O
nucleotide    O
)    O
.    O

CMCT    O
like    O
DMS    O
serves    O
to    O
modify    O
the    O
exposed    O
bases    O
of    O
specific    O
nucleotides    O
,    O
which    O
are    O
uridine    B-Glycoside114887305
,    O
and    O
to    O
a    O
smaller    O
extent    O
guanine    O
.    O

Loss    O
of    O
ODCase    O
activity    O
leads    O
to    O
a    O
lack    O
of    O
cell    O
growth    O
unless    O
uracil    O
or    O
uridine    B-Glycoside114887305
is    O
added    O
to    O
the    O
media    O
.    O

#    O
The    O
T    O
arm    O
is    O
a    O
4-    O
to    O
5-    O
bp    O
stem    O
containing    O
the    O
sequence    O
TΨC    O
where    O
Ψ    O
is    O
pseudouridine    B-Glycoside114887305
,    O
a    O
modified    O
uridine    B-Glycoside114887305
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
ATP    O
and    O
uridine    B-Glycoside114887305
,    O
whereas    O
its    O
two    O
products    O
are    O
ADP    O
and    O
UMP    O
.    O

The    O
80    O
nucleotide    O
tRNA    O
was    O
sequenced    O
by    O
first    O
being    O
digested    O
with    O
Pancreatic    O
ribonuclease    O
(    O
producing    O
fragments    O
ending    O
in    O
Cytosine    O
or    O
Uridine    B-Glycoside114887305
)    O
and    O
then    O
with    O
takadiastase    O
ribonuclease    O
Tl    O
(    O
producing    O
fragments    O
which    O
finished    O
with    O
Guanosine    O
)    O
.    O
Chromatography    O
and    O
identification    O
of    O
the    O
5    O
'    O
and    O
3    O
'    O
ends    O
then    O
helped    O
arrange    O
the    O
fragments    O
to    O
establish    O
the    O
RNA    O
sequence    O
.    O

Dihydrouridine    B-Glycoside114887305
(    O
abbreviated    O
as    O
D    B-Glycoside114887305
,    O
DHU    B-Glycoside114887305
,    O
or    O
UH2    B-Glycoside114887305
)    O
is    O
a    O
pyrimidine    O
nucleoside    O
which    O
is    O
the    O
result    O
of    O
adding    O
two    O
hydrogen    O
atoms    O
to    O
a    O
uridine    B-Glycoside114887305
,    O
making    O
it    O
a    O
fully    O
saturated    O
pyrimidine    O
ring    O
with    O
no    O
remaining    O
double    O
bonds    O
.    O

They    O
are    O
named    O
'    O
FourU    O
'    O
due    O
to    O
the    O
four    O
highly    O
conserved    O
uridine    B-Glycoside114887305
nucleotides    O
found    O
directly    O
opposite    O
the    O
Shine    O
-    O
Dalgarno    O
sequence    O
on    O
hairpin    O
II    O
(    O
"    O
pictured    O
"    O
)    O
.    O

5-Bromouridine    B-Glycoside114887305
(    O
abbreviated    O
BrUrd    B-Glycoside114887305
,    O
5BrU    B-Glycoside114887305
,    O
br5Urd    B-Glycoside114887305
or    O
rarely    O
the    O
one    O
letter    O
code    O
B    O
)    O
is    O
a    O
uridine    B-Glycoside114887305
derivative    O
with    O
a    O
bromo    O
substituent    O
at    O
the    O
fifth    O
carbon    O
.    O

Certain    O
genera    O
including    O
the    O
sea    O
apples    O
in    O
the    O
genera    O
"    O
Paracucumaria    O
"    O
and    O
"    O
Pseudocolochirus    O
"    O
,    O
contain    O
toxic    O
holothurin    B-Glycoside114887305
and    O
holotoxin    O
and    O
release    O
it    O
into    O
the    O
water    O
when    O
damaged    O
or    O
killed    O
.    O
Spawning    O

p-Hydroxybenzoic    B-Glycoside114887305
acid    I-Glycoside114887305
glucoside    I-Glycoside114887305
,    O
picein    B-Glycoside114887305
,    O
piceatannol    O
and    O
its    O
glucoside    O
(    O
astringin    B-Glycoside114887305
)    O
,    O
isorhapontin    O
(    O
the    O
isorhapontigenin    O
glucoside    O
)    O
,    O
catechin    O
and    O
ferulic    O
acid    O
are    O
phenolic    O
compounds    O
found    O
in    O
mycorrhizal    O
and    O
non    O
-    O
mycorrhizal    O
roots    O
of    O
Norway    O
spruces    O
.    O

Recent    O
studies    O
have    O
found    O
that    O
great    O
mullein    O
contains    O
glycyrrhizin    B-Glycoside114887305
compounds    O
with    O
bactericide    O
and    O
potential    O
anti    O
-    O
tumoral    O
action    O
.    O

This    O
deficiency    O
—    O
known    O
as    O
apparent    O
mineralocorticoid    O
excess    O
syndrome    O
—    O
can    O
either    O
be    O
congenital    O
or    O
caused    O
by    O
consumption    O
of    O
glycyrrhizin    B-Glycoside114887305
,    O
which    O
is    O
contained    O
in    O
extract    O
of    O
licorice    O
,    O
sometimes    O
found    O
in    O
herbal    O
supplements    O
,    O
candies    O
,    O
and    O
chewing    O
tobacco    O
.    O

Glycyrrhizin    B-Glycoside114887305

Together    O
these    O
plants    O
are    O
used    O
to    O
create    O
a    O
drink    O
containing    O
puerarin    B-Glycoside114887305
,    O
daidzein    O
,    O
paenoflorin    O
,    O
cinnamic    O
acid    O
,    O
glycyrrhizin    B-Glycoside114887305
,    O
ephedrine    O
and    O
gingerol    O
.    O

It    O
contains    O
the    O
chemical    O
glycyrrhizin    B-Glycoside114887305
,    O
which    O
has    O
medicinal    O
uses    O
,    O
but    O
at    O
higher    O
levels    O
it    O
can    O
be    O
toxic    O
.    O

Nevertheless    O
,    O
other    O
plants    O
,    O
including    O
papaya    O
,    O
produce    O
glucosinolates    B-Glycoside114887305
in    O
unripened    O
fruit    O
,    O
skin    O
and    O
seeds    O
.    O

Along    O
with    O
"    O
Drypetes    O
"    O
(    O
of    O
the    O
same    O
family    O
)    O
,    O
it    O
contains    O
mustard    B-Glycoside114887305
oil    I-Glycoside114887305
as    O
a    O
chemical    O
defense    O
against    O
herbivores    O
.    O

Chemical    O
substances    O
in    O
this    O
species    O
include    O
saponins,[references    O
6    O
,    O
7    O
,    O
8)    O
]    O
flavonoids    O
,    O
and    O
glucosinolate    B-Glycoside114887305
.    O

A    O
chemotype    O
with    O
deviating    O
glucosinolate    O
content    O
has    O
been    O
described    O
from    O
Western    O
and    O
Central    O
Europe    O
and    O
named    O
the    O
"    O
NAS    O
-    O
type    O
"    O
(    O
because    O
it    O
is    O
dominated    O
by    O
the    O
glucosinolate    B-Glycoside114887305
glucoNASturtiin    O
.    O

Sinalbin    O
is    O
a    O
glucosinolate    B-Glycoside114887305
found    O
in    O
the    O
seeds    O
of    O
white    O
mustard    O
,    O
"    O
Sinapis    O
alba    O
"    O
,    O
and    O
in    O
many    O
wild    O
plant    O
species    O
.    O

Gluconasturtiin    B-Glycoside114887305
(    O
phenethylglucosinolate    B-Glycoside114887305
)    O
is    O
one    O
of    O
the    O
most    O
widely    O
distributed    O
glucosinolate    B-Glycoside114887305
in    O
the    O
cruciferous    O
vegetables    O
,    O
mainly    O
in    O
the    O
roots    O
,    O
and    O
is    O
probably    O
one    O
of    O
the    O
plant    O
compounds    O
responsible    O
for    O
the    O
natural    O
pest    O
-    O
inhibiting    O
properties    O
of    O
growing    O
crucifers    O
,    O
such    O
as    O
cabbage    O
,    O
mustard    O
or    O
rape    O
,    O
in    O
rotation    O
with    O
other    O
crops    O
.    O

In    O
1992    O
a    O
team    O
of    O
Johns    O
Hopkins    O
University    O
scientists    O
isolated    O
a    O
cancer    O
-    O
fighting    O
phytochemical    O
in    O
broccoli    O
called    O
glucoraphanin    O
,    O
which    O
is    O
the    O
glucosinolate    B-Glycoside114887305
precursor    O
of    O
sulforaphane    O
(    O
SGS    O
)    O
.    O

Broccoli    O
sprouts    O
contain    O
a    O
particular    O
glucosinolate    B-Glycoside114887305
compound    O
,    O
glucoraphanin    O
,    O
which    O
is    O
found    O
in    O
vacuoles    O
within    O
the    O
cytoplasm    O
of    O
the    O
plant    O
cell    O
.    O

The    O
glucosinolates    B-Glycoside114887305
are    O
natural    O
components    O
of    O
many    O
pungent    O
plants    O
such    O
as    O
mustard    O
,    O
cabbage    O
,    O
and    O
horseradish    O
.    O

Allyl    O
cyanide    O
is    O
produced    O
in    O
cruciferous    O
vegetables    O
by    O
myrosinase    O
,    O
an    O
enzyme    O
which    O
hydrolyses    O
glucosinolates    B-Glycoside114887305
to    O
form    O
nitriles    O
and    O
other    O
products    O
.    O

Diffutin    B-Glycoside114887305
is    O
a    O
flavan    O
,    O
a    O
type    O
of    O
flavonoid    O
,    O
found    O
in    O
"    O
H.    O
dichotoma    O
"    O
.    O

Abacavir    B-Glycoside114887305
(    O
ABC    B-Glycoside114887305
)    O
is    O
a    O
medication    O
used    O
to    O
prevent    O
and    O
treat    O
HIV    O
/    O
AIDS    O
.    O

This    O
class    O
of    O
medicinal    O
agents    O
included    O
the    O
drug    O
abacavir    B-Glycoside114887305
.    O

Abacavir    O
was    O
commercialized    O
by    O
GlaxoSmithKline    O
as    O
Ziagen    B-Glycoside114887305
for    O
the    O
treatment    O
of    O
AIDS    O
.    O

His    O
synthesis    O
of    O
abacavir    B-Glycoside114887305
made    O
use    O
of    O
a    O
bicyclic    O
γ-lactam    O
,    O
2-azabicyclo[2.2.1]hept-5-en-3-one    O
,    O
as    O
a    O
chemical    O
precursor    O
.    O

Abacavir    B-Glycoside114887305
,    O
an    O
antiretroviral    O
drug    O
used    O
to    O
treat    O
HIV    O
/    O
AIDS    O

Seven    O
flavonoids    O
named    O
diphylloside    O
A    O
,    O
epimedoside    O
A    O
,    O
epimedin    O
C    O
,    O
icariin    B-Glycoside114887305
,    O
epimedoside    B-Glycoside114887305
C    I-Glycoside114887305
,    O
icarisoside    O
A    O
,    O
desmethylanhydroicaritin    O
,    O
as    O
well    O
as    O
oleanolic    O
acid    O
can    O
be    O
isolated    O
from    O
the    O
roots    O
.    O

The    O
phenolic    O
compounds    O
methyl    O
(    O
S)-flavogallonate    O
,    O
gallic    O
acid    O
,    O
methyl    O
gallate    O
,    O
ethyl    O
gallate    O
,    O
[    O
[    O
2,3-di    O
-    O
O--(S)-4,5,6,4′,5′,6′-hexahydroxybiphenyl-2,2′-diyldicarbonyl-(α/β)-D    O
-    O
glucopyranose|2,3-di    O
-    O
O-[(S)-4,5,6,4′,5′,6′-hexahydroxybiphenyl-2,2′-diyldicarbonyl]-(α/β)-D    O
-    O
glucopyranose    O
]    O
]    O
,    O
vitexin    B-Glycoside114887305
,    O
isovitexin    B-Glycoside114887305
,    O
orientin    B-Glycoside114887305
,    O
iso-orientin    B-Glycoside114887305
,    O
kaempferol    O
3-O-β-D    O
-    O
rutinoside    O
,    O
rutin    B-Glycoside114887305
,    O
neosaponarin    O
,    O
ellagic    O
acid    O
,    O
flavogallonic    O
acid    O
and    O
(    O
α/β)-punicalagin    O
can    O
be    O
isolated    O
from    O
the    O
leaves    O
of    O
"    O
T.    O
myriocarpa    O
"    O
.    O

Eupatolin    B-Glycoside114887305
(    O
CAS    O
number    O
29725    O
-    O
50    O
-    O
6    O
)    O

The    O
same    O
SNPs    O
are    O
thought    O
to    O
be    O
responsible    O
for    O
resistance    O
against    O
josamycin    B-Glycoside114887305
which    O
is    O
prescribed    O
in    O
some    O
countries    O
.    O

glufosfamide    B-Glycoside114887305
(    O
INN    O
)    O

It    O
can    O
be    O
considered    O
a    O
syringin    B-Glycoside114887305
molecule    O
bound    O
to    O
meglutol    O
glucoside    O
.    O

1987    O
-    O
roxithromycin    B-Glycoside114887305

Roxithromycin    B-Glycoside114887305
is    O
a    O
semi    O
-    O
synthetic    O
macrolide    O
antibiotic    O
.    O

Empagliflozin    B-Glycoside114887305

Empagliflozin    B-Glycoside114887305

Empagliflozin    B-Glycoside114887305

Crocin    B-Glycoside114887305
(    O
analgesics    O
and    O
respiratory    O
tract    O
)    O

According    O
to    O
a    O
new    O
study    O
,    O
crocin    B-Glycoside114887305
has    O
demonstrated    O
the    O
properties    O
of    O
an    O
aphrodisiac    O
in    O
rats    O
.    O

Veronicastroside    B-Glycoside114887305
,    O
a    O
flavone    O
,    O
can    O
be    O
found    O
in    O
"    O
Veronicastrum    O
sibiricum    O
var    O
.    O

Additionally    O
,    O
other    O
wild    O
species    O
have    O
bitter    O
fruit    O
containing    O
cucurbitacin    B-Glycoside114887305
.    O

Important    O
sub    O
-    O
classes    O
include    O
sterols    O
and    O
cucurbitacin    B-Glycoside114887305
.    O

The    O
fruit    O
and    O
foliage    O
are    O
toxic    O
due    O
to    O
the    O
presence    O
of    O
cucurbitacin    B-Glycoside114887305
.    O

This    O
plant    O
,    O
and    O
especially    O
its    O
fruit    O
,    O
is    O
poisonous    O
,    O
containing    O
cucurbitacin    B-Glycoside114887305
.    O

Cucurbitacin    B-Glycoside114887305

The    O
rhizome    O
contains    O
iridin    B-Glycoside114887305
which    O
is    O
an    O
oleoresin    O
.    O

FV-100    B-Glycoside114887305

Curculigoside    B-Glycoside114887305
A    I-Glycoside114887305
is    O
a    O
curculigoside    B-Glycoside114887305
found    O
in    O
"    O
Curculigo    O
orchioides    O
"    O
.    O

Rosarin    B-Glycoside114887305
is    O
a    O
cinnamyl    O
alcohol    O
glycoside    O
isolated    O
from    O
"    O
Rhodiola    O
rosea    O
"    O
.    O

Another    O
analysis    O
found    O
genistein    O
and    O
genistein    O
glycosides    O
including    O
sophorabioside    O
,    O
sophoricoside    B-Glycoside114887305
,    O
genistein-7-diglucoside    O
,    O
genistein-7-diglucorhamnoside    O
,    O
and    O
kaempferol    O
and    O
the    O
kaempferol    O
glycosides    O
kaempferol-3-sophoroside    O
and    O
kaempferol-3-rhamnodiglucoside    O
.    O

"    O
Leucopaxillus    O
giganteus    O
"    O
contains    O
a    O
bioactive    O
compound    O
named    O
clitocine    B-Glycoside114887305
that    O
has    O
antibiotic    O
activity    O
against    O
a    O
number    O
of    O
bacteria    O
that    O
are    O
pathogenic    O
to    O
humans    O
,    O
such    O
as    O
"    O
Bacillus    O
cereus    O
"    O
and    O
"    O
Bacillus    O
subtilis    O
"    O
;    O
an    O
earlier    O
(    O
1945    O
)    O
study    O
showed    O
antibiotic    O
activity    O
against    O
"    O
Mycobacterium    O
tuberculosis    O
"    O
,    O
"    O
Salmonella    O
typhi    O
"    O
,    O
and    O
"    O
Brucea    O
abortus    O
"    O
.    O

Convallarin    B-Glycoside114887305
is    O
a    O
crystalline    O
glucoside    O
extracted    O
from    O
the    O
Lily    O
of    O
the    O
Valley    O
plant    O
(    O
"    O
Convallaria    O
majalis    O
"    O
)    O

Eriodictyol    O
was    O
also    O
found    O
in    O
the    O
twigs    O
of    O
"    O
Millettia    O
duchesnei    O
"    O
,    O
in    O
"    O
Eupatorium    O
arnottianum    O
"    O
,    O
and    O
its    O
glycosides    O
(    O
eriocitrin    B-Glycoside114887305
)    O
in    O
lemons    O
and    O
rose    O
hips    O
(    O
"    O
Rosa    O
canina    O
"    O
)    O
.    O

The    O
DNMT    O
inhibitors    O
5-azacytidine    B-Glycoside114887305
and    O
5-aza-20-deoxycytidine    B-Glycoside114887305
mentioned    O
above    O
have    O
both    O
been    O
approved    O
by    O
the    O
FDA    O
for    O
the    O
treatment    O
of    O
various    O
forms    O
of    O
cancer    O
.    O

Vidaza    B-Glycoside114887305
(    O
azacitidine    B-Glycoside114887305
)    O
in    O
phase    O
III    O
trials    O
for    O
Myelodysplastic    O
Syndromes    O
and    O
AML    O

Low    O
doses    O
of    O
azacitidine    B-Glycoside114887305
and    O
its    O
analog    O
decitabine    B-Glycoside114887305
have    O
shown    O
results    O
against    O
cancer    O
through    O
epigenetic    O
demethylation    O
.    O

The    O
basis    O
for    O
this    O
approach    O
was    O
that    O
5-azacytidine    B-Glycoside114887305
-    O
a    O
DNA    O
demethylation    O
reagent    O
-    O
can    O
cause    O
the    O
formation    O
of    O
myogenic    O
,    O
chondrogenic    O
and    O
adipogeni    O
clones    O
in    O
the    O
immortal    O
cell    O
line    O
of    O
mouse    O
embryonic    O
fibroblasts    O
and    O
that    O
the    O
activation    O
of    O
a    O
single    O
gene    O
,    O
later    O
named    O
MyoD1    O
,    O
is    O
sufficient    O
for    O
such    O
reprogramming    O
.    O

The    O
dried    O
flower    O
buds    O
may    O
contain    O
as    O
much    O
as    O
20%    O
rutin    B-Glycoside114887305
with    O
some    O
quercetin    O
.    O
"    O
S.    O
japonicum    O
"    O
dried    O
fruit    O
contain    O
the    O
flavonoid    O
glycosides    O
sophoricoside    B-Glycoside114887305
,    O
genistin    B-Glycoside114887305
and    O
rutin    B-Glycoside114887305
and    O
the    O
flavonoid    O
aglycone    B-Glycoside114887305
genistein    O
,    O
quercetin    O
and    O
kaempferol    O
.    O

Likewise    O
guaijaverin    O
is    O
the    O
3-"O    O
"-    O
arabinoside    O
,    O
hyperoside    B-Glycoside114887305
is    O
the    O
3-"O    O
"-    O
galactoside    B-Glycoside114887305
,    O
isoquercitin    B-Glycoside114887305
is    O
the    O
3-"O    O
"-    O
glucoside    O
and    O
spiraeoside    B-Glycoside114887305
is    O
the    O
4′-"O    O
"-    O
glucoside    O
.    O

"    O
U.    O
guianensis    O
"    O
contains    O
many    O
phytochemicals    O
(    O
(    O
-)-epicatechin    O
,    O
alkaloid    O
,    O
beta    O
-    O
Sitosterol    O
,    O
campesterol    O
,    O
campherol    O
,    O
catechol    O
,    O
catechutannic    O
acid    O
,    O
chlorogenic    B-Glycoside114887305
acid    I-Glycoside114887305
,    O
ellagic    O
acid    O
,    O
gallic    O
acid    O
,    O
hyperin    B-Glycoside114887305
,    O
oleanolic    O
acid    O
,    O
rutin    B-Glycoside114887305
,    O
stigmasterol    O
,    O
ursolic    O
acid    O
)    O
and    O
proanthocyanidin    O
B1    O
and    O
proanthocyanidin    O
B2    O
,    O
B    O
type    O
proanthocyanidins    O
,    O
in    O
the    O
root    O
.    O

In    O
enzymology    O
,    O
a    O
kaempferol    B-Glycoside114887305
3-O-galactosyltransferase    I-Glycoside114887305
is    O
an    O
enzyme    O
that    O
catalyzes    O
the    O
chemical    O
reaction    O

Ample    O
research    O
on    O
the    O
cycad    O
hypothesis    O
found    O
a    O
component    O
of    O
the    O
seeds    O
,    O
cycasin    B-Glycoside114887305
,    O
was    O
a    O
potent    O
toxin    O
;    O
it    O
was    O
discovered    O
in    O
the    O
1950s    O
.    O

Unlike    O
"    O
Metroxylon    O
"    O
palms    O
(    O
discussed    O
above    O
)    O
,    O
cycads    O
are    O
highly    O
poisonous    O
:    O
most    O
parts    O
of    O
the    O
plant    O
contain    O
the    O
neurotoxins    O
cycasin    B-Glycoside114887305
and    O
BMAA    O
.    O

"    O
cis"-"p    O
"-    O
Coumarate    O
glucosyltransferase    O
is    O
an    O
enzyme    O
that    O
uses    O
UDP    O
-    O
glucose    O
and    O
"    O
cis"-"p''-coumarate    O
to    O
produce    O
4′-"O"-β-D-glucosyl-"cis"-"p"-coumarate    B-Glycoside114887305
and    O
UDP    O
.    O

While    O
no    O
activators    O
are    O
required    O
,    O
"    O
lacUV5    O
"    O
promoter    O
expression    O
can    O
be    O
regulated    O
by    O
the    O
LacI    O
repressor    O
and    O
can    O
be    O
induced    O
with    O
IPTG    B-Glycoside114887305
,    O
which    O
is    O
an    O
effective    O
inducer    O
of    O
protein    O
expression    O
when    O
used    O
in    O
the    O
concentration    O
range    O
of    O
100μM    O
to    O
1.5mM.    O
Due    O
to    O
this    O
control    O
,    O
the    O
"    O
lacUV5    O
"    O
promoter    O
is    O
commonly    O
found    O
on    O
expression    O
plasmids    O
and    O
is    O
used    O
when    O
controllable    O
but    O
high    O
levels    O
of    O
a    O
product    O
are    O
desired    O
.    O

Furthermore    O
,    O
the    O
transformed    O
cells    O
containing    O
the    O
plasmid    O
with    O
the    O
gene    O
of    O
our    O
interest    O
can    O
be    O
distinguished    O
from    O
cells    O
with    O
the    O
plasmid    O
but    O
without    O
the    O
gene    O
of    O
interest    O
,    O
just    O
by    O
looking    O
at    O
the    O
color    O
of    O
the    O
colony    O
they    O
make    O
on    O
agar    O
media    O
supplemented    O
with    O
IPTG    B-Glycoside114887305
and    O
X-gal    B-Glycoside114887305
.    O

Therefore    O
,    O
the    O
media    O
used    O
should    O
contain    O
ampicillin    O
,    O
IPTG    B-Glycoside114887305
,    O
and    O
X-gal    B-Glycoside114887305
.    O

The    O
phenolic    O
compounds    O
2,4,6-trihydroxybenzoic    O
acid-4-O-2′,3′,4′,6′-tetraacetylglucoside    O
,    O
2,4,6-trihydroxybenzoic    O
acid-4-O-2′,3′,6′-triacetylglucoside    O
,    O
2,4,6-trihydroxybenzoic    O
acid-4-O-3′,4′,6′-triacetylglucoside    O
,    O
3-O    O
-    O
p    O
-    O
coumaroylshikimic    O
acid    O
,    O
2-(trans-1,4-dihydroxy-2-cyclohexenyl)-5-hydroxy-7-methoxychromone    O
,    O
kaempferol    O
and    O
kaempferol-3-O-β-d-glucoside    B-Glycoside114887305
can    O
be    O
isolated    O
from    O
the    O
methanolic    O
extract    O
of    O
fronds    O
of    O
"    O
Phegopteris    O
connectilis    O
"    O
.    O

"    O
Polygonum    O
aviculare    O
"    O
contains    O
the    O
flavonols    O
avicularin    B-Glycoside114887305
,    O
myricitrin    B-Glycoside114887305
,    O
juglanin    O
,    O
astragalin    B-Glycoside114887305
,    O
betmidin    O
and    O
the    O
lignan    O
aviculin    O
.    O

Three    O
natural    O
phenolic    O
glucosides    O
,    O
secoisolariciresinol    B-Glycoside114887305
diglucoside    I-Glycoside114887305
,    O
p-coumaric    B-Glycoside114887305
acid    I-Glycoside114887305
glucoside    I-Glycoside114887305
,    O
and    O
ferulic    O
acid    O
glucoside    O
,    O
can    O
be    O
found    O
in    O
commercial    O
breads    O
containing    O
flaxseed    O
.    O

From    O
in    O
-    O
person    O
interviews    O
and    O
physical    O
health    O
exams    O
after    O
about    O
two    O
years    O
of    O
coverage    O
,    O
researchers    O
examined    O
patient    O
health    O
issues    O
including    O
depression    O
,    O
high    O
blood    O
pressure    O
,    O
elevated    O
cholesterol    O
,    O
high    O
glycated    B-Glycoside114887305
hemoglobin    I-Glycoside114887305
levels    O
,    O
and    O
long    O
-    O
term    O
cardiovascular    O
risks    O
(    O
the    O
latter    O
using    O
the    O
Framingham    O
risk    O
score    O
)    O
.    O

The    O
HbA1c    B-Glycoside114887305
was    O
examined    O
after    O
SGLT-2    O
inhibitors    O
were    O
given    O
alone    O
(    O
as    O
monotherapy    O
)    O
or    O
as    O
an    O
add    O
-    O
on    O
therapy    O
to    O
the    O
other    O
diabetes    O
medicines    O
.    O

The    O
HbA1c    B-Glycoside114887305
was    O
examined    O
after    O
SGLT-2    O
inhibitors    O
were    O
given    O
alone    O
(    O
as    O
monotherapy    O
)    O
or    O
as    O
an    O
add    O
-    O
on    O
therapy    O
to    O
the    O
other    O
diabetes    O
medicines    O
.    O

The    O
HbA1c    B-Glycoside114887305
was    O
examined    O
after    O
SGLT-2    O
inhibitors    O
were    O
given    O
alone    O
(    O
as    O
monotherapy    O
)    O
or    O
as    O
an    O
add    O
-    O
on    O
therapy    O
to    O
the    O
other    O
diabetes    O
medicines    O
.    O

The    O
HbA1c    B-Glycoside114887305
was    O
examined    O
after    O
SGLT-2    O
inhibitors    O
were    O
given    O
alone    O
(    O
as    O
monotherapy    O
)    O
or    O
as    O
an    O
add    O
-    O
on    O
therapy    O
to    O
the    O
other    O
diabetes    O
medicines    O
.    O

The    O
HbA1c    B-Glycoside114887305
was    O
examined    O
after    O
SGLT-2    O
inhibitors    O
were    O
given    O
alone    O
(    O
as    O
monotherapy    O
)    O
or    O
as    O
an    O
add    O
-    O
on    O
therapy    O
to    O
the    O
other    O
diabetes    O
medicines    O
.    O

The    O
HbA1c    B-Glycoside114887305
was    O
examined    O
after    O
SGLT-2    O
inhibitors    O
were    O
given    O
alone    O
(    O
as    O
monotherapy    O
)    O
or    O
as    O
an    O
add    O
-    O
on    O
therapy    O
to    O
the    O
other    O
diabetes    O
medicines    O
.    O

The    O
HbA1c    B-Glycoside114887305
was    O
examined    O
after    O
SGLT-2    O
inhibitors    O
were    O
given    O
alone    O
(    O
as    O
monotherapy    O
)    O
or    O
as    O
an    O
add    O
-    O
on    O
therapy    O
to    O
the    O
other    O
diabetes    O
medicines    O
.    O

The    O
HbA1c    B-Glycoside114887305
was    O
examined    O
after    O
SGLT-2    O
inhibitors    O
were    O
given    O
alone    O
(    O
as    O
monotherapy    O
)    O
or    O
as    O
an    O
add    O
-    O
on    O
therapy    O
to    O
the    O
other    O
diabetes    O
medicines    O
.    O

HbA1c    B-Glycoside114887305
:    O
0.20(0.061    O
)    O

After    O
52    O
weeks    O
,    O
patients    O
treated    O
with    O
insulin    O
degludec    O
produced    O
a    O
similar    O
reduction    O
in    O
HbA1c    B-Glycoside114887305
(    O
0.40%    O
vs.    O
0.39%    O
)    O
meeting    O
the    O
criteria    O
for    O
noninferiority    O
.    O

Evidence    O
supporting    O
the    O
binding    O
of    O
Cr3    O
+    O
to    O
transferrin    O
comes    O
from    O
extensive    O
clinical    O
studies    O
that    O
showed    O
a    O
positive    O
correlation    O
between    O
levels    O
of    O
ferritin    O
and    O
of    O
fasting    O
glucose    O
,    O
insulin    O
,    O
and    O
glycosylated    B-Glycoside114887305
hemoglobin    I-Glycoside114887305
(    O
Hb1Ac    O
)    O
levels    O
.    O

Although    O
the    O
authors    O
of    O
this    O
review    O
mentioned    O
that    O
chromium(III    O
)    O
picolinate    O
decreases    O
HbA1c    B-Glycoside114887305
levels    O
(    O
measure    O
of    O
plasma    O
glucose    O
concentration    O
)    O
by    O
0.7%    O
(    O
95%    O
CI    O
)    O
in    O
type    O
2    O
diabetes    O
patients    O
,    O
they    O
noted    O
that    O
most    O
poor    O
quality    O
studies    O
produced    O
larger    O
positive    O
outcomes    O
than    O
higher    O
quality    O
studies    O
.    O

Compared    O
to    O
Cr(III    O
)    O
species    O
,    O
metformin    O
performs    O
both    O
more    O
consistently    O
and    O
effectively    O
,    O
lowering    O
HbA1c    B-Glycoside114887305
by    O
1.12%    O
,    O
compared    O
to    O
0.6%    O
with    O
chromium(III    O
)    O
picolinate    O
(    O
although    O
data    O
for    O
it    O
is    O
weak    O
)    O
.    O

Switching    O
people    O
with    O
diabetes    O
to    O
a    O
vegan    O
diet    O
lowered    O
hemoglobin    B-Glycoside114887305
A1C    I-Glycoside114887305
and    O
LDL    O
levels    O
in    O
one    O
study    O
.    O

Decyl    B-Glycoside114887305
glucoside    I-Glycoside114887305
is    O
a    O
mild    O
non    O
-    O
ionic    O
surfactant    O
used    O
in    O
cosmetic    O
formularies    O
including    O
baby    O
shampoo    O
and    O
in    O
products    O
for    O
individuals    O
with    O
a    O
sensitive    O
skin    O
.    O

Daucosterol    B-Glycoside114887305
(    O
eleutheroside    B-Glycoside114887305
A    O
)    O
is    O
a    O
natural    O
phytosterol    O
-    O
like    O
compound    O
.    O

The    O
three    O
cinnamyl    O
alcohol    O
-    O
vicianosides    O
of    O
rhodiola    O
rosea    O
commonly    O
referred    O
to    O
as    O
"    O
rosavins    O
"    O
are    O
rosin    O
and    O
the    O
structurally    O
related    O
disaccharide    O
Rosavin    B-Glycoside114887305
which    O
is    O
the    O
arabinose    O
ester    O
of    O
rosin    O
,    O
and    O
Rosarin    B-Glycoside114887305
,    O
the    O
arabinofuranose    O
ester    O
of    O
rosin    O
.    O

It    O
is    O
a    O
mixture    O
of    O
disodium    B-Glycoside114887305
inosinate    I-Glycoside114887305
(    O
IMP    O
)    O
and    O
disodium    B-Glycoside114887305
guanylate    I-Glycoside114887305
(    O
GMP    O
)    O
and    O
is    O
often    O
used    O
where    O
a    O
food    O
already    O
contains    O
natural    O
glutamates    O
(    O
as    O
in    O
meat    O
extract    O
)    O
or    O
added    O
monosodium    O
glutamate    O
(    O
MSG    O
)    O
.    O

Disodium    B-Glycoside114887305
inosinate    I-Glycoside114887305
.    O

Disodium    B-Glycoside114887305
inosinate    I-Glycoside114887305
(    O
E631    B-Glycoside114887305
)    O
is    O
the    O
disodium    O
salt    O
of    O
inosinic    O
acid    O
with    O
the    O
chemical    O
formula    O
C10H11N4Na2O8P.    O
It    O
is    O
used    O
as    O
a    O
food    O
additive    O
and    O
often    O
found    O
in    O
instant    O
noodles    O
,    O
potato    O
chips    O
,    O
and    O
a    O
variety    O
of    O
other    O
snacks    O
.    O

Deoxyuridine    B-Glycoside114887305
(    O
dU    B-Glycoside114887305
)    O
is    O
a    O
compound    O
and    O
a    O
nucleoside    O
.    O

Deoxyuridine    B-Glycoside114887305

teniposide    B-Glycoside114887305
(    O
chemotherapeutic    O
)    O

teniposide    B-Glycoside114887305
(    O
chemotherapeutic    O
)    O

Teniposide    B-Glycoside114887305
(    O
trade    O
name    O
Vumon    B-Glycoside114887305
)    O
is    O
a    O
chemotherapeutic    O
medication    O
used    O
in    O
the    O
treatment    O
of    O
childhood    O
acute    O
lymphocytic    O
leukemia    O
(    O
ALL    O
)    O
,    O
Hodgkin    O
's    O
lymphoma    O
,    O
certain    O
brain    O
tumours    O
,    O
and    O
other    O
types    O
of    O
cancer    O
.    O

The    O
dehydration    O
reaction    O
that    O
bonds    O
monosaccharides    O
into    O
disaccharides    O
(    O
and    O
also    O
bonds    O
monosaccharides    O
into    O
more    O
complex    O
polysaccharides    O
)    O
forms    O
what    O
are    O
called    O
glycosidic    B-Glycoside114887305
bond    I-Glycoside114887305
.    O

Because    O
of    O
the    O
configuration    O
of    O
their    O
glycosidic    B-Glycoside114887305
bond    I-Glycoside114887305
,    O
fructooligosaccharides    O
resist    O
hydrolysis    O
by    O
salivary    O
and    O
intestinal    O
digestive    O
enzymes    O
.    O

The    O
straight    O
chain    O
consists    O
of    O
α-1,6    O
glycosidic    B-Glycoside114887305
linkages    O
between    O
glucose    O
molecules    O
,    O
while    O
branches    O
begin    O
from    O
α-1,3    O
linkages    O
.    O

They    O
consist    O
of    O
a    O
hydrophobic    O
ceramide    O
part    O
and    O
a    O
glycosidically    B-Glycoside114887305
bound    I-Glycoside114887305
carbohydrate    O
part    O
.    O

Tn    O
antigen    O
refers    O
to    O
the    O
monosaccharide    O
structure    O
N    O
-    O
acetylgalactosamine    O
(    O
GalNAc    O
)    O
linked    O
to    O
serine    O
or    O
threonine    O
by    O
a    O
glycosidic    B-Glycoside114887305
bond    I-Glycoside114887305
.    O

Glycans    O
usually    O
consist    O
solely    O
of    O
O-glycosidic    B-Glycoside114887305
linkage    I-Glycoside114887305
of    O
monosaccharides    O
.    O

P22TSP    O
has    O
endorhamnosidase    O
activity    O
and    O
cleaves    O
the    O
glycosidic    B-Glycoside114887305
bond    I-Glycoside114887305
of    O
the    O
rhamnose    O
group    O
,    O
producing    O
an    O
octasaccharide    O
product    O
.    O

Sucrose    O
(    O
table    O
sugar    O
)    O
contains    O
two    O
sugars    O
(    O
fructose    O
and    O
glucose    O
)    O
joined    O
by    O
their    O
glycosidic    B-Glycoside114887305
bond    I-Glycoside114887305
in    O
such    O
a    O
way    O
as    O
to    O
prevent    O
the    O
glucose    O
isomerizing    O
to    O
aldehyde    O
,    O
or    O
the    O
fructose    O
to    O
alpha    O
-    O
hydroxy    O
-    O
ketone    O
form    O
.    O

The    O
acidic    O
conditions    O
and    O
heat    O
break    O
the    O
glycosidic    B-Glycoside114887305
bond    I-Glycoside114887305
in    O
sucrose    O
through    O
hydrolysis    O
.    O

Carbohydrates    O
are    O
typically    O
stored    O
as    O
long    O
polymers    O
of    O
glucose    O
molecules    O
with    O
glycosidic    B-Glycoside114887305
bond    I-Glycoside114887305
for    O
structural    O
support    O
(    O
e.g.    O
chitin    O
,    O
cellulose    O
)    O
or    O
for    O
energy    O
storage    O
(    O
e.g.    O
glycogen    O
,    O
starch    O
)    O
.    O

The    O
glucose    O
units    O
are    O
primarily    O
linked    O
with    O
α(1→4)    B-Glycoside114887305
glycosidic    I-Glycoside114887305
bonds    I-Glycoside114887305
.    O

The    O
glycosyl    O
group    O
and    O
amino    O
group    O
are    O
connected    O
with    O
a    O
β-N-glycosidic    B-Glycoside114887305
bond    I-Glycoside114887305
,    O
forming    O
a    O
cyclic    O
hemiaminal    O
ether    O
bond    O
(    O
α-aminoether    O
)    O
.    O

PNGase    O
F    O
catalyzes    O
the    O
cleavage    O
of    O
an    O
internal    O
glycoside    B-Glycoside114887305
bond    I-Glycoside114887305
in    O
an    O
oligosaccharide    O
.    O

Examples    O
:    O
The    O
most    O
common    O
natural    O
monomer    O
is    O
glucose    O
,    O
which    O
is    O
linked    O
by    O
glycosidic    B-Glycoside114887305
bonds    I-Glycoside114887305
into    O
polymers    O
such    O
as    O
cellulose    O
,    O
starch    O
,    O
and    O
glycogen    O
.    O

Under    O
physiological    O
conditions    O
the    O
glycosidic    B-Glycoside114887305
bond    I-Glycoside114887305
may    O
be    O
hydrolyzed    O
spontaneously    O
and    O
10,000    O
purine    O
sites    O
in    O
DNA    O
are    O
estimated    O
to    O
be    O
depurinated    O
each    O
day    O
in    O
a    O
cell    O
.    O

psi-    O
Ψ    O
or    O
the    O
letter    O
Q    O
)    O
is    O
an    O
isomer    O
of    O
the    O
nucleoside    O
uridine    B-Glycoside114887305
in    O
which    O
the    O
uracil    O
is    O
attached    O
via    O
a    O
carbon    O
-    O
carbon    O
instead    O
of    O
a    O
nitrogen    O
-    O
carbon    O
glycosidic    B-Glycoside114887305
bond    I-Glycoside114887305
.    O

Maltotriose    O
is    O
a    O
trisaccharide    O
(    O
three    O
-    O
part    O
sugar    O
)    O
consisting    O
of    O
three    O
glucose    O
molecules    O
linked    O
with    O
α-1,4    O
glycosidic    B-Glycoside114887305
bond    I-Glycoside114887305
.    O

The    O
creation    O
of    O
both    O
maltotriose    O
and    O
maltose    O
during    O
this    O
process    O
is    O
due    O
to    O
the    O
random    O
manner    O
in    O
which    O
alpha    O
amylase    O
hydrolyses    O
α-1,4    O
glycosidic    B-Glycoside114887305
bond    I-Glycoside114887305
.    O

RTA    O
has    O
rRNA    O
N    O
-    O
glycosylase    O
activity    O
that    O
is    O
responsible    O
for    O
the    O
cleavage    O
of    O
a    O
glycosidic    B-Glycoside114887305
bond    I-Glycoside114887305
within    O
the    O
large    O
rRNA    O
of    O
the    O
60S    O
subunit    O
of    O
eukaryotic    O
ribosomes    O
.    O

The    O
specific    O
reaction    O
involved    O
is    O
the    O
hydrolysis    O
of    O
the    O
1,4-beta    O
-    O
D    O
-    O
glycosidic    B-Glycoside114887305
linkage    I-Glycoside114887305
in    O
cellulose    O
,    O
hemicellulose    O
,    O
lichenin    O
,    O
and    O
cereal    O
beta    O
-    O
D    O
-    O
glucans    O
.    O

Fragmentation    O
generally    O
occurs    O
on    O
either    O
side    O
of    O
the    O
glycosidic    B-Glycoside114887305
bond    I-Glycoside114887305
(    O
b    O
,    O
c    O
,    O
y    O
and    O
z    O
ions    O
)    O
but    O
also    O
under    O
more    O
energetic    O
conditions    O
through    O
the    O
sugar    O
ring    O
structure    O
in    O
a    O
cross    O
-    O
ring    O
cleavage    O
(    O
x    O
ions    O
)    O
.    O

Although    O
the    O
sugar    O
residues    O
are    O
arranged    O
in    O
no    O
particular    O
/    O
discrete    O
order    O
,    O
and    O
thus    O
a    O
heteroglycan    O
,    O
the    O
residues    O
are    O
all    O
linked    O
by    O
α-1,4    O
glycosidic    B-Glycoside114887305
bonds    I-Glycoside114887305
.    O

The    O
repeating    O
unit    O
of    O
starch    O
is    O
derived    O
from    O
glucose    O
interconnected    O
with    O
glycosidic    B-Glycoside114887305
bond    I-Glycoside114887305
.    O

One    O
possible    O
reason    O
for    O
this    O
is    O
that    O
the    O
glycosidic    B-Glycoside114887305
linkage    I-Glycoside114887305
of    O
trehalose    O
,    O
when    O
acted    O
upon    O
by    O
an    O
insect    O
trehalase    O
,    O
releases    O
two    O
molecules    O
of    O
glucose    O
,    O
which    O
is    O
required    O
for    O
the    O
rapid    O
energy    O
requirements    O
of    O
flight    O
.    O

Parameters    O
taken    O
from    O
the    O
spectrum    O
,    O
mainly    O
NOESY    O
cross    O
-    O
peaks    O
and    O
coupling    O
constants    O
,    O
can    O
be    O
used    O
to    O
determine    O
local    O
structural    O
features    O
such    O
as    O
glycosidic    B-Glycoside114887305
bond    I-Glycoside114887305
angles    O
,    O
dihedral    O
angles    O
(    O
using    O
the    O
Karplus    O
equation    O
)    O
,    O
and    O
sugar    O
pucker    O
conformations    O
.    O

Maltose    O
:    O
a    O
disaccharide    O
formed    O
from    O
two    O
units    O
of    O
glucose    O
joined    O
with    O
an    O
α(1→4    O
)    O
bond    B-Glycoside114887305
,    O
formed    O
from    O
a    O
condensation    O
reaction    O

Glycolipids    B-Glycoside114887305
are    O
lipids    O
with    O
a    O
carbohydrate    O
attached    O
by    O
a    O
glycosidic    B-Glycoside114887305
bond    I-Glycoside114887305
.    O

The    O
two    O
molecular    O
groups    O
form    O
a    O
glycoconjugate    O
through    O
a    O
glycosidic    B-Glycoside114887305
bond    I-Glycoside114887305
,    O
a    O
type    O
of    O
covalent    O
bond    O
.    O

Arctiin    B-Glycoside114887305
from    O
"    O
C.    O
imperialis    O
"    O
kills    O
cancer    O
cells    O
in    O
culture    O
.    O

Hesperidin    B-Glycoside114887305

Hesperetin    O
(    O
metabolizes    O
to    O
hesperidin    B-Glycoside114887305
)    O

The    O
lignan    O
sesamin    O
,    O
the    O
N    O
-    O
isobutylamide    O
γ-sanshool    O
,    O
the    O
acridone    O
alkaloids    O
1-hydroxy-3-methoxy    O
-    O
N    O
-    O
methylacridone    O
,    O
arborinine    O
,    O
xanthoxoline    O
and    O
1-hydroxy-3-methoxyacridone    O
can    O
also    O
be    O
extracted    O
from    O
the    O
bark    O
as    O
well    O
as    O
the    O
alkaloids    O
oblongine    O
,    O
tembetarine    O
and    O
magnoflorine    O
and    O
the    O
flavonoid    O
hesperidin    B-Glycoside114887305
.    O

"    O
Co    O
-    O
V    O
"    O
is    O
a    O
trade    O
name    O
for    O
pentostatin    B-Glycoside114887305

Pentostatin    B-Glycoside114887305
(    O
or    O
deoxycoformycin    B-Glycoside114887305
,    O
trade    O
name    O
Nipent    B-Glycoside114887305
,    O
manufactured    O
by    O
SuperGen    O
)    O
is    O
an    O
anticancer    O
chemotherapeutic    O
drug    O
.    O

Tectoridin    B-Glycoside114887305
is    O
the    O
7-glucoside    O
of    O
tectorigenin    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
loganic    O
acid    O
(    O
also    O
called    O
loganate    O
)    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
loganin    B-Glycoside114887305
.    O

Ellence    B-Glycoside114887305

Ellence    B-Glycoside114887305
(    O
Pharmacia    O
&    O
Upjohn    O
Company    O
)    O

epirubicin    B-Glycoside114887305
(    O
INN    O
)    O

Doxorubicin    O
and    O
epirubicin    B-Glycoside114887305
are    O
two    O
epimers    O
that    O
are    O
used    O
as    O
drugs    O
.    O

The    O
new    O
drug    O
,    O
Alfaxan    O
,    O
used    O
a    O
cyclodextrin    B-Glycoside114887305
as    O
a    O
carrier    O
agent    O
to    O
make    O
alfaxalone    O
more    O
water    O
soluble    O
rather    O
than    O
Camphor    O
EL    O
.    O

Cyclodextrins    B-Glycoside114887305
are    O
cap    O
structures    O
with    O
a    O
hydrophilic    O
exterior    O
but    O
a    O
hydrophobic    O
interior    O
.    O

Crystal    O
structure    O
of    O
a    O
rotaxane    O
with    O
an    O
cyclodextrin    B-Glycoside114887305
macrocycle    O
..    O

He    O
also    O
showed    O
that    O
cyclodextrin    B-Glycoside114887305
can    O
be    O
used    O
to    O
investigate    O
catalysis    O
of    O
organic    O
reactions    O
within    O
the    O
scope    O
of    O
host    O
-    O
guest    O
chemistry    O
.    O

Chemical    O
-    O
based    O
transfection    O
can    O
be    O
divided    O
into    O
several    O
kinds    O
:    O
cyclodextrin    B-Glycoside114887305
,    O
polymers    O
,    O
liposomes    O
,    O
or    O
nanoparticles    O
(    O
with    O
or    O
without    O
chemical    O
or    O
viral    O
functionalization    O
.    O

More    O
recently    O
,    O
the    O
term    O
refers    O
to    O
many    O
molecular    O
hosts    O
,    O
including    O
calixarenes    O
and    O
cyclodextrin    B-Glycoside114887305
and    O
even    O
some    O
inorganic    O
polymers    O
such    O
as    O
zeolites    O
.    O

When    O
complexed    O
with    O
β-cyclodextrin    B-Glycoside114887305
,    O
it    O
has    O
on    O
average    O
a    O
1.5    O
hour    O
protection    O
duration    O
against    O
mosquitoes    O
.    O

An    O
oral    O
formulation    O
of    O
the    O
drug    O
with    O
cyclodextrin    B-Glycoside114887305
was    O
developed    O
and    O
Ivax    O
and    O
Serono    O
,    O
and    O
then    O
Merck    O
KGgA    O
conducted    O
several    O
clinical    O
studies    O
.    O

Cyclodextrin    B-Glycoside114887305
,    O
calixarenes    O
,    O
cucurbiturils    O
and    O
crown    O
ethers    O
are    O
readily    O
synthesized    O
in    O
large    O
quantities    O
,    O
and    O
are    O
therefore    O
convenient    O
for    O
use    O
in    O
supramolecular    O
systems    O
.    O

Dihydrochalcones    O
(    O
3′,5′-dihydroxy-2′,4′,6′-trimethoxydihydrochalcone    O
,    O
methyl    O
linderone    O
,    O
5-hydroxy-6,7,8-trimethoxyflavone    O
(    O
alnetin    O
)    O
and    O
2′-hydroxy-3′,4′,5′,6′-tetramethoxydihydrochalcone    B-Glycoside114887305
(    O
dihydrokanakugiol    B-Glycoside114887305
)    O
can    O
be    O
found    O
in    O
twigs    O
of    O
"    O
L.    O
lucida    O
"    O
.    O

Dapagliflozin    B-Glycoside114887305

Dapagliflozin    B-Glycoside114887305

On    O
December    O
12    O
,    O
2013    O
,    O
Zuckerman    O
testified    O
regarding    O
the    O
type-2    O
diabetes    O
drug    O
dapagliflozin    B-Glycoside114887305
(    O
Farxiga    O
)    O
,    O
saying    O
:    O
"    O
My    O
concern    O
about    O
this    O
drug    O
is    O
that    O
there    O
are    O
just    O
too    O
many    O
unanswered    O
questions    O
–    O
and    O
those    O
unanswered    O
questions    O
are    O
frightening    O
ones    O
.    O

Luteolin-7-O-glucuronide    B-Glycoside114887305
is    O
a    O
flavone    O
,    O
a    O
chemical    O
compound    O
.    O

The    O
aminocoumarin    B-Glycoside114887305
(    O
including    O
novobiocin    O
)    O
.    O

It    O
is    O
a    O
generic    O
sold    O
in    O
Europe    O
and    O
China    O
as    O
Glucobay    B-Glycoside114887305
(    O
Bayer    O
AG    O
)    O
,    O
in    O
North    O
America    O
as    O
Precose    B-Glycoside114887305
(    O
Bayer    O
Pharmaceuticals    O
)    O
,    O
and    O
in    O
Canada    O
as    O
Prandase    B-Glycoside114887305
(    O
Bayer    O
AG    O
)    O
.    O

Glucobay    B-Glycoside114887305
(    O
Bayer    O
AG    O
)    O
.    O

Redirects    O
to    O
"    O
acarbose    B-Glycoside114887305
"    O
.    O

Diabetes    O
:    O
Acarbose    B-Glycoside114887305
,    O
an    O
alpha    O
-    O
glucosidase    O
inhibitor    O
,    O
competitively    O
and    O
reversibly    O
inhibits    O
alpha    O
-    O
glucosidase    O
in    O
the    O
intestines    O
.    O

Scammonin    B-Glycoside114887305
,    O
Jalapin    B-Glycoside114887305
or    O
Scammonium    B-Glycoside114887305
is    O
a    O
glycoside    O
derived    O
naturally    O
from    O
the    O
stems    O
of    O
the    O
Jalap    O
plant    O
,    O
and    O
from    O
Scammony    O
.    O

Kuguaglycoside    B-Glycoside114887305

More    O
recently    O
,    O
mogroside    B-Glycoside114887305
(    O
typically    O
extracted    O
from    O
monk    O
fruit    O
)    O
have    O
been    O
used    O
in    O
commercial    O
products    O
after    O
the    O
FDA    O
granted    O
some    O
of    O
the    O
compounds    O
GRAS    O
status    O
in    O
2010    O
.    O

In    O
the    O
laboratory    O
,    O
it    O
is    O
used    O
to    O
detect    O
the    O
presence    O
of    O
alkaline    O
phosphatase    O
activity    O
by    O
hydrolysis    O
of    O
PNPP    O
and    O
β-galactosidase    O
activity    O
by    O
hydrolysis    O
of    O
ONPG    B-Glycoside114887305
.    O

diosmin    B-Glycoside114887305
(    O
INN    O
)    O

Coumarin    O
and    O
other    O
benzopyrones    O
,    O
such    O
as    O
5,6    O
benzopyrone    O
,    O
1,2    O
benzopyrone    O
,    O
diosmin    B-Glycoside114887305
and    O
others    O
are    O
known    O
to    O
stimulate    O
macrophages    O
to    O
degrade    O
extracellular    O
albumin    O
,    O
allowing    O
faster    O
resorption    O
of    O
edematous    O
fluids    O
.    O

Populin    B-Glycoside114887305
is    O
a    O
glucoside    O
occurring    O
in    O
the    O
bark    O
,    O
buds    O
and    O
leaves    O
of    O
certain    O
species    O
of    O
poplar    O
.    O

In    O
RNA    O
,    O
there    O
are    O
many    O
modified    O
bases    O
,    O
including    O
pseudouridine    O
(    O
Ψ    O
)    O
,    O
dihydrouridine    O
(    O
D    O
)    O
,    O
inosine    O
(    O
I    O
)    O
,    O
ribothymidine    O
(    O
rT    O
)    O
and    O
7-methylguanosine    B-Glycoside114887305
(    O
m7    O
G    O
)    O
.    O

7-Methylguanosine    B-Glycoside114887305

It    O
is    O
often    O
added    O
to    O
foods    O
in    O
conjunction    O
with    O
disodium    B-Glycoside114887305
guanylate    I-Glycoside114887305
;    O
the    O
combination    O
is    O
known    O
as    O
disodium    B-Glycoside114887305
5'-ribonucleotides    I-Glycoside114887305
.    O

fialuridine    B-Glycoside114887305
(    O
INN    O
)    O

Sakuranin    B-Glycoside114887305
is    O
a    O
flavanone    O
,    O
a    O
type    O
of    O
flavonoid    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
UDP    O
-    O
glucose    O
and    O
4-hydroxybenzoate    O
,    O
whereas    O
its    O
two    O
products    O
are    O
UDP    O
and    O
4-(beta-D-glucosyloxy)benzoate    B-Glycoside114887305
.    O

Gymnemic    B-Glycoside114887305
acids    I-Glycoside114887305
are    O
a    O
class    O
of    O
chemical    O
compounds    O
isolated    O
from    O
the    O
leaves    O
of    O
"    O
Gymnema    O
sylvestre    O
"    O
(    O
Asclepiadaceae    O
)    O
.    O

Xeractinol    B-Glycoside114887305
,    O
a    O
dihydroflavonol    O
C    O
-    O
glucoside    O
,    O
can    O
be    O
isolated    O
from    O
the    O
leaves    O
of    O
"    O
Paepalanthus    O
argenteus    O
var    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
tRNA    O
containing    O
uridine    B-Glycoside114887305
at    O
position    O
54    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
tRNA    O
containing    O
ribothymidine    B-Glycoside114887305
at    O
position    O
54    O
.    O

Vicianin    B-Glycoside114887305
is    O
a    O
cyanogenic    O
disaccharide    O
.    O

Arabinosyl    B-Glycoside114887305
nucleosides    I-Glycoside114887305
are    O
derivatives    O
of    O
the    O
nucleosides    O
.    O

Agnuside    B-Glycoside114887305
is    O
composed    O
of    O
aucubin    O
and    O
"    O
p    O
"-    O
hydroxybenzoic    O
acid    O
.    O

The    O
pigment    O
euxanthin    B-Glycoside114887305
,    O
known    O
as    O
Indian    B-Glycoside114887305
yellow    I-Glycoside114887305
,    O
is    O
often    O
thought    O
to    O
be    O
produced    O
from    O
the    O
urine    O
of    O
cattle    O
fed    O
mango    O
leaves    O
;    O
the    O
practice    O
is    O
described    O
as    O
having    O
been    O
outlawed    O
in    O
1908    O
because    O
of    O
malnutrition    O
of    O
the    O
cattle    O
and    O
possible    O
urushiol    O
poisoning    O
.    O

La    O
Florida    O
also    O
issued    O
'    O
Embajador    O
Lequerica    O
'    O
—    O
"    O
flowers    O
strawberry    O
-    O
pink    O
,    O
reverse    O
Indian    B-Glycoside114887305
yellow    I-Glycoside114887305
at    O
base    O
passing    O
to    O
brick    O
-    O
red    O
at    O
edge    O
"    O
–    O
in    O
1962    O
.    O

Betanin    B-Glycoside114887305
,    O
obtained    O
from    O
the    O
roots    O
,    O
are    O
used    O
industrially    O
as    O
red    O
food    O
colourants    O
,    O
e.g.    O
to    O
intensify    O
the    O
colour    O
of    O
tomato    O
paste    O
,    O
sauces    O
,    O
desserts    O
,    O
jams    O
and    O
jellies    O
,    O
ice    O
cream    O
,    O
sweets    O
,    O
and    O
breakfast    O
cereals    O
.    O

Betanin    B-Glycoside114887305
,    O
obtained    O
from    O
the    O
roots    O
,    O
is    O
used    O
industrially    O
as    O
red    O
food    O
colorant    O
,    O
to    O
improve    O
the    O
color    O
and    O
flavor    O
of    O
tomato    O
paste    O
,    O
sauces    O
,    O
desserts    O
,    O
jams    O
and    O
jellies    O
,    O
ice    O
cream    O
,    O
candy    O
,    O
and    O
breakfast    O
cereals    O
,    O
among    O
other    O
applications    O
.    O

The    O
red    O
colour    O
compound    O
betanin    B-Glycoside114887305
is    O
not    O
broken    O
down    O
in    O
the    O
body    O
,    O
and    O
in    O
higher    O
concentrations    O
may    O
temporarily    O
cause    O
urine    O
or    O
stools    O
to    O
assume    O
a    O
reddish    O
colour    O
,    O
in    O
the    O
case    O
of    O
urine    O
a    O
condition    O
called    O
beeturia    O
.    O

Catechin-7-O-glucoside    B-Glycoside114887305
can    O
be    O
found    O
in    O
the    O
stem    O
barks    O
of    O
"    O
C.    O
axillaris    O
"    O
.    O

Bergenin    B-Glycoside114887305
,    O
catechin    O
,    O
gallic    O
acid    O
,    O
gallicin    O
,    O
catechin-7-O-glucoside    B-Glycoside114887305
and    O
β-sitosterol    O
can    O
be    O
found    O
in    O
"    O
B.    O
ciliata    O
"    O
.    O

In    O
those    O
who    O
are    O
seriously    O
allergic    O
to    O
penicillin    O
,    O
erythromycin    O
or    O
clindamycin    B-Glycoside114887305
may    O
be    O
used    O
.    O

Depending    O
on    O
the    O
severity    O
,    O
treatment    O
involves    O
either    O
oral    O
or    O
intravenous    O
antibiotics    O
,    O
using    O
penicillins    O
,    O
clindamycin    B-Glycoside114887305
,    O
or    O
erythromycin    O
.    O

Treatment    O
with    O
ampicillin    O
/    O
sulbactam    O
,    O
amoxicillin    O
/    O
clavulanic    O
acid    O
,    O
or    O
clindamycin    B-Glycoside114887305
is    O
appropriate    O
if    O
deep    O
oropharyngeal    O
abscesses    O
are    O
present    O
,    O
in    O
conjunction    O
with    O
aspiration    O
or    O
drainage    O
.    O

It    O
is    O
resistant    O
to    O
lysozyme    O
(    O
minimum    O
inhibitory    O
concentration    O
(    O
MIC    O
)    O
>    O
1,000    O
kg    O
/    O
ml    O
)    O
and    O
susceptible    O
to    O
novobiocin    O
(    O
MIC    O
,    O
0.06    O
to    O
0.1    O
pg    O
/    O
ml    O
)    O
,    O
penicillin    O
(    O
MIC    O
,    O
0.01    O
to    O
0.06    O
pg    O
/    O
ml    O
)    O
,    O
oxacillin    O
(    O
MIC,0.2    O
pg    O
/    O
ml    O
)    O
,    O
ampicillin    O
(    O
MIC    O
,    O
0.06    O
to    O
1.0    O
pg    O
/    O
ml    O
)    O
,    O
cephaloridine(MIC    O
,    O
0.1    O
to    O
0.2    O
pg    O
/    O
ml    O
)    O
,    O
erythromycin    O
(    O
MIC    O
,    O
0.06    O
pg    O
/    O
ml    O
)    O
,    O
lincomycin    O
(    O
MIC    O
,    O
0.2    O
to    O
0.5    O
pg    O
/    O
ml    O
)    O
,    O
clindamycin    B-Glycoside114887305
(    O
MIC    O
,    O
0.1    O
pg    O
/    O
ml    O
)    O
,    O
chloramphenicol    O
(    O
MIC    O
,    O
2.0    O
pg    O
/    O
ml    O
)    O
,    O
tetracycline    O
(    O
MIC    O
,    O
0.1    O
to    O
0.2    O
pg    O
/    O
ml    O
)    O
,    O
gentamicin    O
(    O
MIC    O
,    O
0.2    O
pg    O
/    O
ml    O
)    O
and    O
vancomycin    O
(    O
MIC    O
,    O
1.0    O
pg    O
/    O
ml    O
)    O
.    O

Resistance    O
to    O
clindamycin    B-Glycoside114887305
is    O
common    O
and    O
has    O
been    O
seen    O
in    O
over    O
10%    O
of    O
isolates    O
in    O
the    O
US    O
.    O

Lincosamides    O
are    O
a    O
class    O
of    O
antibiotics    O
which    O
include    O
lincomycin    O
,    O
clindamycin    B-Glycoside114887305
,    O
and    O
pirlimycin    O
.    O

The    O
use    O
of    O
lincomycin    O
as    O
an    O
antibiotic    O
has    O
been    O
largely    O
superseded    O
by    O
clindamycin    B-Glycoside114887305
which    O
exhibits    O
improved    O
antibacterial    O
activity    O
.    O

Clindamycin    B-Glycoside114887305
.    O
(    O
Note    O
extra    O
chlorine    O
compared    O
to    O
lincomycin    O
,    O
but    O
disregard    O
inversion    O
of    O
image    O
.    O
)    O
.    O

Indeed    O
,    O
fosmidomycin    O
has    O
been    O
tested    O
in    O
combination    O
treatment    O
with    O
clindamycin    B-Glycoside114887305
for    O
treatment    O
of    O
malaria    O
with    O
favorable    O
results    O
.    O

Cephalosporins    O
,    O
and    O
particularly    O
quinolones    O
and    O
clindamycin    B-Glycoside114887305
,    O
are    O
more    O
likely    O
to    O
produce    O
colonisation    O
with    O
"    O
Clostridium    O
difficile    O
"    O
.    O

Six    O
strains    O
of    O
"    O
Clostridium    O
"    O
,    O
found    O
in    O
the    O
bowels    O
of    O
William    O
Braine    O
and    O
John    O
Hartnell    O
(    O
members    O
of    O
the    O
Franklin    O
Expedition    O
)    O
showed    O
resistance    O
to    O
cefoxitin    O
and    O
clindamycin    B-Glycoside114887305
.    O

"    O
C.    O
difficile    O
"    O
colitis    O
is    O
most    O
strongly    O
associated    O
with    O
fluoroquinolones    O
,    O
cephalosporins    O
,    O
carbapenems    O
,    O
and    O
clindamycin    B-Glycoside114887305
.    O

Pseudomembranous    O
colitis    O
can    O
follow    O
,    O
creating    O
generalized    O
inflammation    O
of    O
the    O
colon    O
and    O
the    O
development    O
of    O
"    O
pseudomembrane    O
"    O
,    O
a    O
viscous    O
collection    O
of    O
inflammatory    O
cells    O
,    O
fibrin    O
,    O
and    O
necrotic    O
cells.[4    O
]    O
Clindamycin    B-Glycoside114887305
-    O
resistant    O
"    O
C.    O
difficile    O
"    O
was    O
reported    O
as    O
the    O
causative    O
agent    O
of    O
large    O
outbreaks    O
of    O
diarrheal    O
disease    O
in    O
hospitals    O
in    O
New    O
York    O
,    O
Arizona    O
,    O
Florida    O
and    O
Massachusetts    O
between    O
1989    O
and    O
1992    O
.    O

If    O
infection    O
is    O
present    O
,    O
appropriate    O
cultures    O
should    O
be    O
obtained    O
,    O
followed    O
by    O
empirical    O
antibiotic    O
therapy    O
initially    O
,    O
for    O
example    O
amoxicillin    O
/    O
clavulanate    O
or    O
clindamycin    B-Glycoside114887305
which    O
cover    O
oral    O
flora    O
.    O

Maritimein    B-Glycoside114887305
is    O
an    O
aurone    O
,    O
a    O
type    O
of    O
natural    O
phenol    O
.    O

"    O
O    O
"-    O
Glycosylated    O
derivatives    O
such    O
as    O
skimmin    B-Glycoside114887305
(    O
7-"O"-β-D    O
-    O
glucopyranosylumbelliferone    O
)    O
occur    O
naturally    O
and    O
are    O
used    O
for    O
the    O
fluorimetric    O
determination    O
of    O
glycoside    O
hydrolase    O
enzymes    O
.    O

The    O
upper    O
part    O
of    O
the    O
trichome    O
cell    O
contains    O
flavonoids    O
,    O
"    O
e.g.    O
"    O
quercitrin    B-Glycoside114887305
and    O
myricitrin    B-Glycoside114887305
.    O

The    O
peptide    O
’s    O
effects    O
were    O
observed    O
through    O
BrdU    B-Glycoside114887305
labeling    O
and    O
cell    O
phenotyping    O
that    O
provided    O
evidence    O
for    O
the    O
migration    O
of    O
neuroblasts    O
through    O
the    O
rostral    O
migratory    O
stream    O
to    O
the    O
olfactory    O
bulb    O
(    O
confirming    O
previous    O
experiments    O
)    O
and    O
to    O
the    O
striatum    O
.    O

Indeed    O
,    O
levels    O
of    O
DCX    O
expression    O
increase    O
in    O
response    O
to    O
exercise    O
,    O
and    O
that    O
increase    O
occurs    O
in    O
parallel    O
with    O
increased    O
BrdU    B-Glycoside114887305
labelling    O
(    O
which    O
is    O
currently    O
a    O
"    O
gold    O
standard    O
"    O
in    O
measuring    O
neurogenesis    O
)    O
.    O

The    O
effects    O
of    O
bromodeoxyuridine    B-Glycoside114887305
on    O
cell    O
differentiation    O
(    O
conversion    O
of    O
a    O
primitive    O
cell    O
into    O
a    O
more    O
specialized    O
cell    O
)    O
were    O
also    O
analyzed    O
.    O

Base    O
analogs    O
(    O
e.g.    O
,    O
Bromodeoxyuridine    B-Glycoside114887305
(    O
BrdU    O
)    O
)    O

Bromodeoxyuridine    B-Glycoside114887305

Main    O
chemicals    O
of    O
sarsaparilla    O
are    O
acetyl    O
-    O
parigenin    O
,    O
astilbin    B-Glycoside114887305
,    O
beta    O
-    O
sitosterol    O
,    O
caffeoyl    O
-    O
shikimic    O
acids    O
,    O
dihydroquercetin    O
,    O
diosgenin    O
,    O
engeletin    O
,    O
essential    O
oils    O
,    O
epsilon    O
-    O
sitosterol    O
,    O
eucryphin    O
,    O
eurryphin    O
,    O
ferulic    O
acid    O
,    O
glucopyranosides    O
,    O
isoastilbin    B-Glycoside114887305
,    O
isoengetitin    O
,    O
kaempferol    O
,    O
parigenin    O
,    O
parillin    O
,    O
pollinastanol    O
,    O
resveratrol    O
,    O
rhamnose    O
,    O
saponin    O
,    O
sarasaponin    O
,    O
sarsaparilloside    O
,    O
sarsaponin    O
,    O
sarsasapogenin    O
,    O
shikimic    O
acid    O
,    O
sitosterol    O
-    O
d    O
-    O
glucoside    O
,    O
smilagenin    O
,    O
smilasaponin    O
,    O
smilax    O
saponins    O
A    O
-    O
C    O
,    O
smiglaside    O
A    O
-    O
E    O
,    O
smitilbin    B-Glycoside114887305
,    O
stigmasterol    O
,    O
taxifolin    O
,    O
and    O
titogenin    O
.    O

Afzelin    B-Glycoside114887305
is    O
a    O
flavonol    O
glycoside    O
.    O

This    O
class    O
includes    O
kanamycin    O
,    O
neomycin    O
,    O
gentamicin    O
,    O
apramycin    B-Glycoside114887305
,    O
hygromycin    O
.    O

A    O
variety    O
of    O
commercially    O
available    O
systemic    O
and    O
non    O
-    O
systemic    O
miticides    O
:    O
abamectin    B-Glycoside114887305
,    O
acequinocyl    O
,    O
bifenazate    O
,    O
bifenazate    O
,    O
chlorfenapyr    O
,    O
clofentezine    O
,    O
cyflumetofen    O
,    O
cypermethrin    O
,    O
dicofol    O
,    O
etoxazole    O
,    O
fenazaquin    O
,    O
fenpyroximate    O
,    O
hexythiazox    O
,    O
imidacloprid    O
,    O
propargite    O
,    O
pyridaben    O
,    O
spiromesifen    O
,    O
spirotetramat    O
.    O

To    O
secure    O
approval    O
,    O
ChemChina    O
agreed    O
to    O
divest    O
from    O
pesticide    O
production    O
of    O
paraquat    O
,    O
abamectin    B-Glycoside114887305
,    O
and    O
chlorothalonil    O
.    O

gemcitabine    B-Glycoside114887305
(    O
INN    O
)    O

Gemzar    B-Glycoside114887305
(    O
Eli    O
Lilly    O
)    O

On    O
the    O
other    O
hand    O
,    O
adding    O
infliximab    O
or    O
etanercept    O
to    O
gemcitabine    B-Glycoside114887305
for    O
treating    O
patients    O
with    O
advanced    O
pancreatic    O
cancer    O
was    O
not    O
associated    O
with    O
differences    O
in    O
efficacy    O
when    O
compared    O
with    O
placebo    O
.    O

After    O
surgery    O
,    O
adjuvant    O
chemotherapy    O
with    O
gemcitabine    B-Glycoside114887305
or    O
5-FU    O
can    O
be    O
offered    O
if    O
the    O
person    O
is    O
sufficiently    O
fit    O
,    O
after    O
a    O
recovery    O
period    O
of    O
one    O
to    O
two    O
months    O
.    O

He    O
is    O
the    O
principal    O
investigator    O
for    O
a    O
clinical    O
trial    O
of    O
neoadjuvant    O
gemcitabine    B-Glycoside114887305
and    O
cisplatin    O
followed    O
by    O
extrapleural    O
pneumonectomy    O
and    O
high    O
-    O
dose    O
radiation    O
.    O

Pharmaceuticals    O
,    O
including    O
the    O
chemotherapy    O
medication    O
gemcitabine    B-Glycoside114887305
,    O
as    O
well    O
as    O
certain    O
interleukins    O
and    O
monoclonal    O
antibodies    O
,    O
can    O
also    O
cause    O
capillary    O
leaks    O
.    O

In    O
a    O
preclinical    O
mouse    O
model    O
of    O
pancreatic    O
cancer    O
,    O
it    O
was    O
"    O
even    O
more    O
effective    O
than    O
gemcitabine    B-Glycoside114887305
"    O
.    O

Systemic    O
chemotherapies    O
such    O
as    O
gemcitabine    B-Glycoside114887305
and    O
cisplatin    O
are    O
sometimes    O
used    O
in    O
inoperable    O
cases    O
of    O
cholangiocarcinoma    O
.    O

Quercetin    O
forms    O
the    O
glycosides    O
quercitrin    B-Glycoside114887305
and    O
rutin    B-Glycoside114887305
together    O
with    O
rhamnose    O
and    O
rutinose    O
,    O
respectively    O
.    O

This    O
enzyme    O
hydrolyzes    O
the    O
glycoside    O
quercitrin    B-Glycoside114887305
to    O
release    O
quercetin    O
and    O
L    O
-    O
rhamnose    O
.    O

The    O
upper    O
part    O
of    O
the    O
trichome    O
cell    O
contains    O
flavonoids    O
,    O
"    O
e.g.    O
"    O
quercitrin    B-Glycoside114887305
and    O
myricitrin    B-Glycoside114887305
.    O

Rhoifolin    B-Glycoside114887305
or    O
apigenin    O
7-O    O
-    O
neohesperidoside    O

Rutin    B-Glycoside114887305
,    O
neohesperidin    B-Glycoside114887305
,    O
hyperoside    B-Glycoside114887305
,    O
catechin    O
and    O
ferulic    O
acid    O
can    O
be    O
found    O
in    O
"    O
C.    O
edulis    O
"    O
,    O
and    O
contribute    O
to    O
the    O
antibacterial    O
properties    O
of    O
the    O
plant    O
.    O

Entecavir    B-Glycoside114887305

Entecavir    B-Glycoside114887305
,    O
also    O
called    O
ETV    O
,    O
is    O
a    O
guanosine    O
analog    O
used    O
for    O
hepatitis    O
B    O
under    O
the    O
trade    O
name    O
Baraclude    O
.    O

Guanosine    O
analogues    O
:    O
abacavir    B-Glycoside114887305
(    O
ABC    O
)    O
and    O
entecavir    B-Glycoside114887305
(    O
ETV    O
)    O

It    O
is    O
often    O
added    O
to    O
foods    O
in    O
conjunction    O
with    O
disodium    B-Glycoside114887305
guanylate    I-Glycoside114887305
;    O
the    O
combination    O
is    O
known    O
as    O
disodium    B-Glycoside114887305
5'-ribonucleotides    I-Glycoside114887305
.    O

Disodium    B-Glycoside114887305
guanylate    I-Glycoside114887305

Chlorogenic    B-Glycoside114887305
acid    I-Glycoside114887305
–    O
echinacea    O
,    O
strawberries    O
,    O
pineapple    O
,    O
coffee    O
,    O
sunflower    O
,    O
blueberries    O

"    O
U.    O
guianensis    O
"    O
contains    O
many    O
phytochemicals    O
(    O
(    O
-)-epicatechin    O
,    O
alkaloid    O
,    O
beta    O
-    O
Sitosterol    O
,    O
campesterol    O
,    O
campherol    O
,    O
catechol    O
,    O
catechutannic    O
acid    O
,    O
chlorogenic    B-Glycoside114887305
acid    I-Glycoside114887305
,    O
ellagic    O
acid    O
,    O
gallic    O
acid    O
,    O
hyperin    B-Glycoside114887305
,    O
oleanolic    O
acid    O
,    O
rutin    B-Glycoside114887305
,    O
stigmasterol    O
,    O
ursolic    O
acid    O
)    O
and    O
proanthocyanidin    O
B1    O
and    O
proanthocyanidin    O
B2    O
,    O
B    O
type    O
proanthocyanidins    O
,    O
in    O
the    O
root    O
.    O

Apple    O
juice    O
has    O
a    O
significant    O
concentration    O
of    O
natural    O
phenols    O
of    O
low    O
molecular    O
weight    O
(    O
including    O
chlorogenic    B-Glycoside114887305
acid    I-Glycoside114887305
,    O
flavan-3-ols    O
,    O
and    O
flavonols    O
)    O
and    O
procyanidins    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
chlorogenate    B-Glycoside114887305
and    O
glucarate    O
,    O
whereas    O
its    O
two    O
products    O
are    O
quinate    O
and    O
2-O    O
-    O
caffeoylglucarate    O
.    O

Phenolics    O
found    O
in    O
flowering    O
heads    O
of    O
"    O
Scorzoneroides    O
"    O
taxa    O
include    O
luteolin    O
type    O
flavonoids    O
and    O
caffeoyl    O
quinic    O
acid    O
derivatives    O
such    O
as    O
chlorogenic    B-Glycoside114887305
acid    I-Glycoside114887305
and    O
dicaffeoylquinic    B-Glycoside114887305
acid    I-Glycoside114887305
.    O

Phenolics    O
found    O
in    O
"    O
Crepis    O
"    O
include    O
luteolin    O
-    O
type    O
flavonoids    O
and    O
caffeoyl    O
quinic    O
acid    O
derivatives    O
such    O
as    O
chlorogenic    B-Glycoside114887305
acid    I-Glycoside114887305
and    O
dicaffeoylquinic    B-Glycoside114887305
acid    I-Glycoside114887305
.    O

Some    O
investigators    O
report    O
slimming    O
actions    O
induced    O
by    O
chlorogenic    B-Glycoside114887305
acid    I-Glycoside114887305
from    O
green    O
coffee    O
,    O
but    O
further    O
investigations    O
need    O
to    O
be    O
performed    O
.    O

Momordin    B-Glycoside114887305
(saponin)    I-Glycoside114887305
,    O
a    O
derivative    O
of    O
the    O
triterpenoid    O
oleanic    O
acid    O

Lotaustralin    B-Glycoside114887305
is    O
a    O
cyanogenic    O
glucoside    O
found    O
in    O
small    O
amounts    O
in    O
Fabaceae    O
Austral    O
Trefoil    O
(    O
"    O
Lotus    O
australis    O
"    O
)    O
,    O
cassava    O
(    O
"    O
Manihot    O
esculenta    O
"    O
)    O
,    O
lima    O
bean    O
(    O
"    O
Phaseolus    O
lunatus    O
"    O
)    O
,    O
roseroot    O
(    O
"    O
Rhodiola    O
rosea    O
"    O
)    O
and    O
white    O
clover    O
(    O
"    O
Trifolium    O
repens    O
"    O
)    O
,    O
among    O
other    O
plants    O
.    O

Bryoamaride    B-Glycoside114887305
is    O
a    O
chemical    O
compound    O
isolated    O
from    O
certain    O
plants    O
,    O
notably    O
"    O
Bryonia    O
dioica    O
"    O
.    O

Mulberroside    B-Glycoside114887305
A    I-Glycoside114887305
is    O
a    O
stilbenoid    O
found    O
in    O
"    O
Morus    O
alba    O
"    O
,    O
the    O
white    O
mulberry    O
.    O

Bergenin    B-Glycoside114887305
and    O
norbergenin    B-Glycoside114887305
are    O
chemical    O
compounds    O
that    O
can    O
be    O
isolated    O
from    O
rhizomes    O
of    O
"    O
B.    O
stracheyi    O
"    O
.    O

Robinin    B-Glycoside114887305
is    O
a    O
chemical    O
compound    O
.    O

Acid    O
is    O
not    O
produced    O
from    O
arabinose    O
,    O
N    O
-    O
acetylglucosamine    O
,    O
D    O
-    O
cellobiose    O
,    O
D    O
-    O
galactose    O
,    O
or    O
methyl    O
alpha    O
-    O
D    O
-    O
glucoside    O
,    O
lactose    O
,    O
D    O
-    O
mannose    O
,    O
D    O
-    O
melibiose    O
,    O
melezitose    O
,    O
raffinose    O
,    O
ribose    O
,    O
D    O
-    O
salicin    B-Glycoside114887305
,    O
D    O
-    O
sorbitol    O
,    O
sucrose    O
,    O
turanose    O
,    O
xylitol    O
and    O
xylose    O
.    O

Like    O
other    O
willows    O
,    O
it    O
contains    O
salicin    B-Glycoside114887305
,    O
and    O
was    O
used    O
by    O
Native    O
Americans    O
as    O
a    O
painkiller    O
.    O

The    O
active    O
components    O
include    O
scopoletin    O
,    O
aesculetin    O
,    O
salicin    B-Glycoside114887305
,    O
1-methyl-2,3    O
clibutyl    O
hemimellitate    O
,    O
and    O
viburnin    O
.    O

Like    O
many    O
other    O
plants    O
,    O
including    O
many    O
food    O
plants    O
and    O
those    O
used    O
as    O
culinary    O
herbs    O
,    O
black    O
haw    O
contains    O
salicin    B-Glycoside114887305
,    O
a    O
chemical    O
relative    O
of    O
aspirin    O
.    O

Alder    O
bark    O
contains    O
the    O
anti    O
-    O
inflammatory    O
salicin    B-Glycoside114887305
,    O
which    O
is    O
metabolized    O
into    O
salicylic    O
acid    O
in    O
the    O
body    O
.    O

Stavudine    B-Glycoside114887305
,    O
also    O
called    O
d4    O
T    O
,    O
has    O
trade    O
names    O
Zerit    O
and    O
Zerit    O
XR    O
.    O

Thymidine    O
analogues    O
:    O
zidovudine    O
(    O
AZT    O
)    O
and    O
stavudine    B-Glycoside114887305
(    O
d4    O
T    O
)    O

Administration    O
with    O
drugs    O
with    O
overlapping    O
toxicity    O
,    O
such    O
as    O
zalcitabine    O
and    O
stavudine    B-Glycoside114887305
,    O
is    O
not    O
recommended    O
.    O

Additionally    O
,    O
zalcitabine    O
should    O
not    O
be    O
used    O
with    O
other    O
drugs    O
that    O
can    O
cause    O
peripheral    O
neuropathy    O
,    O
such    O
as    O
didanosine    O
and    O
stavudine    B-Glycoside114887305
.    O

Stavudine    B-Glycoside114887305
(    O
d4T    B-Glycoside114887305
)    O
,    O
sold    O
under    O
the    O
brand    O
name    O
Zerit    B-Glycoside114887305
among    O
others    O
,    O
is    O
an    O
antiretroviral    O
medication    O
used    O
to    O
prevent    O
and    O
treat    O
HIV    O
/    O
AIDS    O
.    O

#    O
The    O
carbonyl    O
group    O
of    O
the    O
sugar    O
reacts    O
with    O
the    O
amino    O
group    O
of    O
the    O
amino    O
acid    O
,    O
producing    O
N    O
-    O
substituted    O
glycosylamine    B-Glycoside114887305
and    O
water    O

Glycosylamines    B-Glycoside114887305
are    O
a    O
class    O
of    O
biochemical    O
compounds    O
consisting    O
of    O
a    O
glycosyl    O
group    O
attached    O
to    O
an    O
amino    O
group    O
,    O
-NR2    O
.    O

Chrysanthemin    B-Glycoside114887305
chloride    O
(    O
Cyanidin    O
3-O    O
-    O
glucoside    O
chloride    O
)    O

Chrysanthemin    B-Glycoside114887305
is    O
an    O
anthocyanin    B-Glycoside114887305
.    O

Chrysanthemin    B-Glycoside114887305
(    O
cyanidin-3-"O    O
"-    O
glucoside    O
)    O
,    O
found    O
in    O
blackcurrant    O
pomace    O

Quercetin    B-Glycoside114887305
3,4'-diglucoside    I-Glycoside114887305
,    O
a    O
flavonol    O
glycoside    O

The    O
pathogenicity    O
and    O
symptoms    O
are    O
generally    O
mild    O
in    O
human    O
and    O
it    O
can    O
be    O
treated    O
with    O
medicines    O
such    O
as    O
Doramectin    B-Glycoside114887305
,    O
Ivermectin    O
,    O
Febantel    O
.    O

Topical    O
treatment    O
of    O
livestock    O
,    O
dogs    O
and    O
cats    O
with    O
organophosphates    O
(    O
such    O
as    O
ecothiopate    O
iodide    O
or    O
isofluorophate    O
)    O
and    O
systemic    O
treatment    O
with    O
anthelmintics    O
(    O
such    O
as    O
ivermectin    O
,    O
levamisole    O
,    O
and    O
doramectin    B-Glycoside114887305
)    O
are    O
recommended    O
by    O
the    O
Merck    O
Veterinary    O
Manual    O
.    O

Charantin    B-Glycoside114887305
,    O
a    O
β-sitosteryl    O
glucoside    O
found    O
in    O
the    O
bitter    O
melon    O
plant    O
.    O

globoside    B-Glycoside114887305

Other    O
ketolides    O
in    O
development    O
include    O
cethromycin    B-Glycoside114887305
and    O
solithromycin    O
.    O

The    O
compound    O
that    O
is    O
believed    O
to    O
cause    O
its    O
beneficial    O
effects    O
is    O
Pseudopterosin    B-Glycoside114887305
A    I-Glycoside114887305
,    O
a    O
diterpene    O
glycoside    O
,    O
a    O
selective    O
analgesic    O
.    O
"    O

Khekadaengoside    B-Glycoside114887305
is    O
any    O
one    O
of    O
several    O
chemical    O
compounds    O
isolated    O
from    O
certain    O
plants    O
,    O
notably    O
"    O
Trichosanthes    O
tricuspidata    O
"    O
.    O

Gastrodin    B-Glycoside114887305
is    O
the    O
glucoside    O
of    O
gastrodigenin    O
.    O

It    O
is    O
similar    O
to    O
"N"6-cyclopentyladenosine    B-Glycoside114887305
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
O    O
-    O
demethylpuromycin    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
puromycin    B-Glycoside114887305
.    O

The    O
process    O
results    O
in    O
translated    O
peptides    O
or    O
proteins    O
that    O
are    O
associated    O
with    O
their    O
mRNA    O
progenitor    O
via    O
a    O
puromycin    B-Glycoside114887305
linkage    O
.    O

Puromycin    B-Glycoside114887305
is    O
an    O
analogue    O
of    O
the    O
3’    O
end    O
of    O
a    O
tyrosyl    O
-    O
tRNA    O
with    O
a    O
part    O
of    O
its    O
structure    O
mimics    O
a    O
molecule    O
of    O
adenosine    O
,    O
and    O
the    O
other    O
part    O
mimics    O
a    O
molecule    O
of    O
tyrosine    O
.    O

When    O
we    O
look    O
at    O
the    O
aglycones    B-Glycoside114887305
of    O
phlorizin    O
and    O
dapagliflozin    O
,    O
both    O
of    O
them    O
have    O
weak    O
inhibition    O
effects    O
on    O
SGLT-1    O
and    O
SGLT-2    O
.    O

These    O
prodrugs    O
go    O
through    O
changes    O
in    O
the    O
body    O
leading    O
to    O
carbon    O
-    O
carbon    O
bond    O
between    O
the    O
glucose    O
and    O
the    O
aglycone    B-Glycoside114887305
moiety    O
so    O
c    O
-    O
glucoside    O
are    O
formed    O
from    O
the    O
o    O
-    O
glucosides    O
.    O

When    O
we    O
look    O
at    O
the    O
aglycones    B-Glycoside114887305
of    O
phlorizin    O
and    O
dapagliflozin    O
,    O
both    O
of    O
them    O
have    O
weak    O
inhibition    O
effects    O
on    O
SGLT-1    O
and    O
SGLT-2    O
.    O

These    O
prodrugs    O
go    O
through    O
changes    O
in    O
the    O
body    O
leading    O
to    O
carbon    O
-    O
carbon    O
bond    O
between    O
the    O
glucose    O
and    O
the    O
aglycone    B-Glycoside114887305
moiety    O
so    O
c    O
-    O
glucoside    O
are    O
formed    O
from    O
the    O
o    O
-    O
glucosides    O
.    O

When    O
we    O
look    O
at    O
the    O
aglycones    B-Glycoside114887305
of    O
phlorizin    O
and    O
dapagliflozin    O
,    O
both    O
of    O
them    O
have    O
weak    O
inhibition    O
effects    O
on    O
SGLT-1    O
and    O
SGLT-2    O
.    O

These    O
prodrugs    O
go    O
through    O
changes    O
in    O
the    O
body    O
leading    O
to    O
carbon    O
-    O
carbon    O
bond    O
between    O
the    O
glucose    O
and    O
the    O
aglycone    B-Glycoside114887305
moiety    O
so    O
c    O
-    O
glucoside    O
are    O
formed    O
from    O
the    O
o    O
-    O
glucosides    O
.    O

When    O
we    O
look    O
at    O
the    O
aglycones    B-Glycoside114887305
of    O
phlorizin    O
and    O
dapagliflozin    O
,    O
both    O
of    O
them    O
have    O
weak    O
inhibition    O
effects    O
on    O
SGLT-1    O
and    O
SGLT-2    O
.    O

These    O
prodrugs    O
go    O
through    O
changes    O
in    O
the    O
body    O
leading    O
to    O
carbon    O
-    O
carbon    O
bond    O
between    O
the    O
glucose    O
and    O
the    O
aglycone    B-Glycoside114887305
moiety    O
so    O
c    O
-    O
glucoside    O
are    O
formed    O
from    O
the    O
o    O
-    O
glucosides    O
.    O

When    O
we    O
look    O
at    O
the    O
aglycones    B-Glycoside114887305
of    O
phlorizin    O
and    O
dapagliflozin    O
,    O
both    O
of    O
them    O
have    O
weak    O
inhibition    O
effects    O
on    O
SGLT-1    O
and    O
SGLT-2    O
.    O

This    O
distorted    O
structure    O
forms    O
a    O
sialosyl    O
cation    O
after    O
the    O
release    O
of    O
the    O
aglycon    B-Glycoside114887305
and    O
is    O
then    O
trapped    O
in    O
the    O
active    O
site    O
by    O
a    O
nucleophilic    O
attack    O
of    O
the    O
tyrosine    O
residue    O
.    O

Ouabain    B-Glycoside114887305

Within    O
the    O
last    O
decade    O
[    O
when    O
?    O
]    O
,    O
many    O
independent    O
labs    O
have    O
demonstrated    O
that    O
,    O
in    O
addition    O
to    O
the    O
classical    O
ion    O
transporting    O
,    O
this    O
membrane    O
protein    O
can    O
also    O
relay    O
extracellular    O
ouabain    B-Glycoside114887305
-    O
binding    O
signalling    O
into    O
the    O
cell    O
through    O
regulation    O
of    O
protein    O
tyrosine    O
phosphorylation    O
.    O

For    O
instance    O
,    O
--ATPase    O
found    O
in    O
the    O
membrane    O
of    O
heart    O
cells    O
is    O
an    O
important    O
target    O
of    O
cardiac    O
glycosides    O
(    O
for    O
example    O
digoxin    O
and    O
ouabain    B-Glycoside114887305
)    O
,    O
inotropic    O
drugs    O
used    O
to    O
improve    O
heart    O
performance    O
by    O
increasing    O
its    O
force    O
of    O
contraction    O
.    O

Post    O
had    O
recently    O
discovered    O
that    O
three    O
sodium    O
ions    O
were    O
pumped    O
out    O
of    O
the    O
cell    O
for    O
every    O
two    O
potassium    O
ions    O
pumped    O
in    O
,    O
and    O
in    O
his    O
research    O
he    O
had    O
made    O
use    O
of    O
a    O
substance    O
called    O
ouabain    B-Glycoside114887305
which    O
had    O
recently    O
been    O
shown    O
to    O
inhibit    O
the    O
pump    O
.    O

An    O
increase    O
in    O
extracellular    O
K+    O
has    O
been    O
shown    O
to    O
activate    O
an    O
ouabain    B-Glycoside114887305
-    O
sensitive    O
electrogenic    O
Na+–K+-ATPase    O
followed    O
by    O
hyperpolarization    O
and    O
smooth    O
muscle    O
cell    O
relaxation    O
.    O

Daucosterol    B-Glycoside114887305
(    O
eleutheroside    B-Glycoside114887305
A    O
)    O
is    O
a    O
natural    O
phytosterol    O
-    O
like    O
compound    O
.    O

5-Bromouridine    B-Glycoside114887305
(    O
abbreviated    O
BrUrd    B-Glycoside114887305
,    O
5BrU    B-Glycoside114887305
,    O
br5Urd    B-Glycoside114887305
or    O
rarely    O
the    O
one    O
letter    O
code    O
B    O
)    O
is    O
a    O
uridine    B-Glycoside114887305
derivative    O
with    O
a    O
bromo    O
substituent    O
at    O
the    O
fifth    O
carbon    O
.    O

Octyl    B-Glycoside114887305
glucoside    I-Glycoside114887305

Eriocitrin    O
is    O
an    O
antioxidant    O
reported    O
to    O
combat    O
lipid    O
peroxidation    O
and    O
like    O
neoeriocitrin    B-Glycoside114887305
is    O
said    O
to    O
block    O
the    O
formation    O
of    O
lipoxygenases    O
involved    O
in    O
allergies    O
and    O
atherosclerosis.。    O

In    O
medicine    O
several    O
nucleoside    B-Glycoside114887305
analogue    I-Glycoside114887305
are    O
used    O
as    O
antiviral    O
or    O
anticancer    O
agents    O
.    O

Deoxycytidine    O
kinase    O
(    O
dCK    O
)    O
phosphorylates    O
several    O
deoxyribonucleosides    O
and    O
their    O
nucleoside    B-Glycoside114887305
analogue    I-Glycoside114887305
(    O
a    O
nucleoside    O
with    O
a    O
sugar    O
and    O
a    O
different    O
nucleic    O
acid    O
base    O
substitute    O
or    O
analogue    O
that    O
has    O
unique    O
properties    O
when    O
modified    O
)    O
using    O
phosphate    O
groups    O
from    O
ATP    O
and    O
UTP    O
.    O

Major    O
areas    O
of    O
focus    O
for    O
his    O
research    O
include    O
1    O
)    O
the    O
mediation    O
of    O
cancer    O
cell    O
death    O
by    O
glucocorticoids    O
in    O
hematologic    O
malignancies    O
2    O
)    O
the    O
use    O
of    O
RNA    O
-    O
directed    O
nucleoside    B-Glycoside114887305
analogs    I-Glycoside114887305
in    O
cancer    O
therapy    O
and    O
3    O
)    O
the    O
role    O
of    O
proteins    O
in    O
cancer    O
metabolism    O
.    O

Nucleoside    B-Glycoside114887305
analogues    I-Glycoside114887305

Sofosbuvir    O
is    O
in    O
the    O
nucleotide    B-Glycoside114887305
analog    I-Glycoside114887305
family    O
of    O
medication    O
and    O
works    O
by    O
blocking    O
the    O
hepatitis    O
C    O
NS5B    O
protein    O
.    O

Red    O
beech    O
is    O
the    O
only    O
known    O
plant    O
source    O
,    O
apart    O
from    O
rooibos    O
(    O
"    O
Aspalathus    O
linearis    O
"    O
)    O
,    O
of    O
the    O
C    O
-    O
linked    O
dihydrochalcone    O
glycoside    O
nothofagin    B-Glycoside114887305
.    O

fludarabine    B-Glycoside114887305
,    O
cladribine    B-Glycoside114887305
,    O
gemcitabine    B-Glycoside114887305
,    O
tezacitabine    B-Glycoside114887305
,    O
and    O
triapine    O

Oleandrin    B-Glycoside114887305
,    O
one    O
of    O
the    O
toxins    O
present    O
in    O
oleander    O
.    O

Scilliroside    O
and    O
other    O
cardiac    O
glycosides    O
like    O
oleandrin    B-Glycoside114887305

It    O
does    O
not    O
hydrolyze    O
starch    O
or    O
esculin    B-Glycoside114887305
.    O

It    O
hydrolyses    O
casein    O
and    O
gelatin    O
but    O
not    O
Tween    O
80    O
,    O
starch    O
,    O
lecithin    O
,    O
aesculin    B-Glycoside114887305
or    O
tyrosine    O
.    O

They    O
do    O
not    O
hydrolyze    O
starch    O
or    O
aesculin    B-Glycoside114887305
.    O

M.    O
Nana    O
"    O
resembles    O
"    O
M.    O
dermatis    O
"    O
and    O
"    O
M.    O
sympodialis    O
"    O
,    O
but    O
is    O
distinguished    O
from    O
these    O
species    O
by    O
its    O
inability    O
to    O
use    O
Kolliphor    O
EL    O
(    O
Sigma    O
)    O
as    O
the    O
sole    O
lipid    O
source    O
and    O
to    O
hydrolyse    O
aesculin    B-Glycoside114887305
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
tRNA    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
tRNA    O
containing    O
N7-methylguanine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
tRNA    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
tRNA    O
containing    O
2'-O    O
-    O
methylguanosine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
tRNA    O
containing    O
uridine    B-Glycoside114887305
at    O
position    O
54    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
tRNA    O
containing    O
ribothymidine    B-Glycoside114887305
at    O
position    O
54    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
L    O
-    O
tryptophan    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
L-2-methyltryptophan    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
tyramine    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
N    O
-    O
methyltyramine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
vitexin    O
2"-O    O
-    O
beta    O
-    O
L    O
-    O
rhamnoside    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
7-O    O
-    O
methylvitexin    O
2"-O    O
-    O
beta    O
-    O
L    O
-    O
rhamnoside    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
xanthotoxol    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
O    O
-    O
methylxanthotoxol    O
.    O

A    O
SAM    B-Glycoside114887305
-    O
dependent    O
"    O
N    O
"-    O
methylation    O
of    O
putrescine    O
gives    O
the    O
"    O
N    O
"-    O
methylputrescine    O
product    O
,    O
which    O
then    O
undergoes    O
oxidative    O
deamination    O
by    O
the    O
action    O
of    O
diamine    O
oxidase    O
to    O
yield    O
the    O
aminoaldehyde    O
.    O

S-Adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
(    O
SAM    O
)    O
can    O
act    O
as    O
a    O
catalyst    O
for    O
the    O
transfer    O
of    O
methyl    O
group    O
from    O
the    O
sulfonium    O
compound    O
to    O
nucleophile    O
.    O

Vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
,    O
or    O
cobalamin    O
,    O
acts    O
as    O
a    O
cofactor    O
for    O
the    O
enzyme    O
methionine    O
synthase    O
(    O
which    O
forms    O
part    O
of    O
the    O
S-adenosylmethionine    B-Glycoside114887305
(    O
SAMe    O
)    O
biosynthesis    O
and    O
regeneration    O
cycle    O
)    O
.    O

S-Adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
(    O
SAMe    O
)    O
is    O
available    O
as    O
a    O
prescription    O
antidepressant    O
in    O
Europe    O
and    O
an    O
over    O
-    O
the    O
-    O
counter    O
dietary    O
supplement    O
in    O
the    O
US    O
.    O

One    O
review    O
claimed    O
benefit    O
for    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
in    O
disease    O
models    O
.    O

The    O
alkaloid    O
berberine    O
has    O
a    O
tetracyclic    O
skeleton    O
derived    O
from    O
a    O
benzyltetrahydroisoquinoline    O
system    O
with    O
the    O
incorporation    O
of    O
an    O
extra    O
carbon    O
atom    O
provided    O
by    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
(    O
SAM    O
)    O
via    O
an    O
"    O
N    O
"-    O
methyl    O
group    O
.    O

After    O
oxidation    O
and    O
methylation    O
by    O
SAM    B-Glycoside114887305
,    O
(    O
"    O
S")-reticuline    O
4    O
is    O
formed    O
.    O

Histamine    O
N    O
-    O
methyltransferase    O
catalyzes    O
the    O
methylation    O
of    O
histamine    O
in    O
the    O
presence    O
of    O
S-adenosylmethionine    B-Glycoside114887305
(    O
SAM    O
)    O
forming    O
N    O
-    O
methylhistamine    O
.    O

This    O
gene    O
encodes    O
the    O
first    O
enzyme    O
which    O
is    O
found    O
in    O
the    O
cytosol    O
and    O
uses    O
S-adenosyl-L-methionine    B-Glycoside114887305
as    O
the    O
methyl    O
donor    O
.    O

In    O
the    O
first    O
step    O
of    O
the    O
biosynthesis    O
these    O
two    O
amino    O
acids    O
are    O
combined    O
by    O
the    O
enzyme    O
arginine    O
:    O
glycine    O
amidinotransferase    O
(    O
AGAT    O
,    O
EC:2.1.4.1    O
)    O
to    O
form    O
guanidinoacetate    O
,    O
which    O
is    O
then    O
methylated    O
by    O
guanidinoacetate    O
N    O
-    O
methyltransferase    O
(    O
GAMT    O
,    O
EC:2.1.1.2    O
)    O
,    O
using    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
as    O
the    O
methyl    O
donor    O
.    O

The    O
pathway    O
for    O
the    O
synthesis    O
of    O
creatineArg    O
-    O
Arginine    O
;    O
GATM    O
-    O
Glycine    O
amidinotransferase    O
;    O
GAMT    O
-    O
Guanidinoacetate    O
N    O
-    O
methyltransferase    O
;    O
Gly    O
-    O
Glycine    O
;    O
Met    O
-    O
Methionine    O
;    O
SAH    O
-    O
S-adenosyl    B-Glycoside114887305
homocysteine    I-Glycoside114887305
;    O
SAM    O
-    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
.    O

Diphthamide    O
is    O
biosynthesized    O
from    O
histidine    O
and    O
"S"-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
.    O

Adequate    O
methionine    O
(    O
which    O
,    O
like    O
folate    O
,    O
must    O
otherwise    O
be    O
obtained    O
in    O
the    O
diet    O
,    O
if    O
it    O
is    O
not    O
regenerated    O
from    O
homocysteine    O
by    O
a    O
B12    O
dependent    O
reaction    O
)    O
is    O
needed    O
to    O
make    O
"S"-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
(    O
SAMe    O
)    O
,    O
which    O
is    O
in    O
turn    O
necessary    O
for    O
methylation    O
of    O
myelin    O
sheath    O
phospholipids    O
.    O

Vitamin    O
methylcobalamin    B-Glycoside114887305
and    O
5-methyltetrahydrofolate    O
are    O
needed    O
by    O
Methionine    O
synthase    O
in    O
the    O
Methionine    O
cycle    O
to    O
transfer    O
a    O
methyl    O
group    O
from    O
5-methyltetrahydrofolate    O
to    O
homocysteine    O
,    O
thereby    O
generating    O
tetrahydrofolate    O
(    O
THF    O
)    O
and    O
methionine    O
,    O
which    O
is    O
used    O
to    O
make    O
SAMe    B-Glycoside114887305
.    O

SAMe    B-Glycoside114887305
is    O
the    O
universal    O
methyl    O
donor    O
and    O
is    O
used    O
for    O
DNA    O
methylation    O
and    O
to    O
make    O
phospholipid    O
membranes    O
,    O
choline    O
,    O
sphingomyelin    O
and    O
acetylcholine    O
and    O
other    O
neurotransmitters    O
.    O

PFL    O
activase    O
is    O
part    O
of    O
the    O
radical    O
SAM    O
(    O
S-adenosylmethionine    B-Glycoside114887305
)    O
superfamily    O
.    O

The    O
5    O
substrates    O
of    O
this    O
enzyme    O
are    O
acetyl-CoA    B-Glycoside114887305
,    O
malonyl    O
-    O
CoA    O
,    O
NADPH    O
,    O
H+    O
,    O
and    O
S-adenosyl-L-methionine    B-Glycoside114887305
,    O
whereas    O
its    O
6    O
products    O
are    O
dihydromonacolin    O
L    O
,    O
CoA    O
,    O
CO2    O
,    O
NADP+    O
,    O
S-adenosyl-L-homocysteine    B-Glycoside114887305
,    O
and    O
H2O.    O

Hence    O
,    O
this    O
enzyme    O
has    O
one    O
substrate    O
,    O
S-adenosyl-L-methionine    B-Glycoside114887305
,    O
and    O
two    O
products    O
,    O
5'-methylthioadenosine    O
and    O
2-aminobutan-4-olide    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl-L-methionine    B-Glycoside114887305
and    O
N6-(Delta2-isopentenyl)-adenine    O
,    O
whereas    O
its    O
two    O
products    O
are    O
5'-methylthioadenosine    O
and    O
discadenine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl-L-methionine    B-Glycoside114887305
and    O
nocardicin    O
E    O
,    O
whereas    O
its    O
two    O
products    O
are    O
5'-methylthioadenosine    O
and    O
isonocardicin    O
A.    O

Hence    O
,    O
this    O
enzyme    O
has    O
one    O
substrate    O
,    O
S-adenosyl-L-methionine    B-Glycoside114887305
,    O
and    O
two    O
products    O
,    O
S    O
-    O
methyl-5'-thioadenosine    O
and    O
nicotianamine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl-L-methionine    B-Glycoside114887305
and    O
tRNA    O
uridine    O
,    O
whereas    O
its    O
two    O
products    O
are    O
5'-methylthioadenosine    O
and    O
tRNA    O
3-(3-amino-3-carboxypropyl)-uridine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl-L-methionine    B-Glycoside114887305
and    O
8-amino-7-oxononanoate    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S    O
-    O
adenosyl-4-methylthio-2-oxobutanoate    O
and    O
7,8-diaminononanoate    O
.    O

Although    O
the    O
mechanism    O
of    O
methylation    O
of    O
arsenic    O
in    O
humans    O
has    O
not    O
been    O
elucidated    O
,    O
the    O
source    O
of    O
methyl    O
is    O
methionine    O
,    O
which    O
suggests    O
a    O
role    O
of    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
.    O

S-Adenosylmethionine    B-Glycoside114887305
,    O
a    O
source    O
of    O
methyl    O
groups    O
in    O
many    O
biogenic    O
arsenic    O
compounds    O
.    O

"S"-Adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
can    O
subsequently    O
methylate    O
the    O
amine    O
of    O
phosphatidylethanolamines    O
to    O
yield    O
phosphatidylcholines    O
.    O

18-deoxy-25-demethyl    O
herboxitriene    O
is    O
then    O
epoxidized    O
by    O
enzyeme    O
HerE    O
on    O
the    O
carbon    O
carbon    O
double    O
bond    O
between    O
C14    O
and    O
C15    O
,    O
oxidized    O
by    O
enzyme    O
HerG    O
on    O
C-18    O
and    O
eventually    O
methylated    O
by    O
enzyme    O
HerF    O
on    O
C25    O
to    O
herboxidiene    O
with    O
the    O
help    O
of    O
cofactor    O
SAM    B-Glycoside114887305
.    O

The    O
backbone    O
is    O
synthesized    O
through    O
the    O
addition    O
of    O
two    O
carbon    O
units    O
via    O
addition    O
of    O
acetate    O
units    O
from    O
acetyl-CoA    B-Glycoside114887305
The    O
5    O
methyl    O
groups    O
are    O
added    O
via    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
(    O
SAM    O
)    O
methylation    O
,    O
as    O
opposed    O
to    O
incorporation    O
of    O
propionate    O
(    O
instead    O
of    O
acetate    O
)    O
to    O
the    O
growing    O
compound    O
during    O
biosynthesis    O
.    O

For    O
example    O
,    O
"S"-adenosylmethionine    B-Glycoside114887305
acts    O
as    O
a    O
methylating    O
agent    O
in    O
biological    O
SN2    O
reactions    O
.    O

The    O
methyl    O
groups    O
transferred    O
to    O
create    O
ADMA    O
are    O
derived    O
from    O
the    O
methyl    O
group    O
donor    O
"S"-adenosylmethionine    B-Glycoside114887305
,    O
an    O
intermediate    O
in    O
the    O
metabolism    O
of    O
homocysteine    O
.    O

Abbreviations    O
:    O
S-Adenosyl-L-homocysteine    B-Glycoside114887305
(    O
SAH    O
)    O
,    O
S-adenosyl-L-methionine    B-Glycoside114887305
(    O
SAM    O
)    O
,    O
DNA    O
methyltransferase    O
(    O
DNA    O
MTase    O
)    O
,    O
Uracil    O
-    O
DNA    O
glycosylase    O
(    O
UNG    O
)    O
.    O

CBS    O
uses    O
the    O
cofactor    O
pyridoxal    O
-    O
phosphate    O
(    O
PLP    O
)    O
and    O
can    O
be    O
allosterically    O
regulated    O
by    O
effectors    O
such    O
as    O
the    O
ubiquitous    O
cofactor    O
S-adenosyl-L-methionine    B-Glycoside114887305
(    O
adoMet    O
)    O
.    O

This    O
inhibition    O
is    O
alleviated    O
by    O
binding    O
of    O
the    O
allosteric    O
effector    O
,    O
adoMet    B-Glycoside114887305
,    O
or    O
by    O
deletion    O
of    O
the    O
regulatory    O
domain    O
;    O
however    O
,    O
the    O
magnitude    O
of    O
the    O
effects    O
differ    O
.    O

In    O
analogy    O
with    O
other    O
β-replacement    O
enzymes    O
,    O
the    O
reaction    O
catalyzed    O
by    O
CBS    O
is    O
predicted    O
to    O
involve    O
a    O
series    O
of    O
adoMet    B-Glycoside114887305
-    O
bound    O
intermediates    O
.    O

This    O
alternative    O
metabolic    O
pathway    O
is    O
also    O
dependent    O
on    O
adoMet    B-Glycoside114887305
.    O

Allosteric    O
activation    O
of    O
CBS    O
by    O
adoMet    B-Glycoside114887305
determines    O
the    O
metabolic    O
fate    O
of    O
homocysteine    O
.    O

Mammalian    O
CBS    O
is    O
activated    O
2.5    O
-    O
5-fold    O
by    O
AdoMet    O
with    O
a    O
dissociation    O
constant    O
of    O
15    O
µM.    O
AdoMet    B-Glycoside114887305
is    O
an    O
allosteric    O
activator    O
that    O
increases    O
the    O
Vmax    O
of    O
the    O
CBS    O
reaction    O
but    O
does    O
not    O
affect    O
the    O
Km    O
for    O
the    O
substrates    O
.    O

A    O
common    O
functional    O
feature    O
of    O
the    O
mutations    O
in    O
the    O
CBS    O
domains    O
is    O
that    O
the    O
mutations    O
abolish    O
or    O
strongly    O
reduce    O
activation    O
by    O
adoMet    B-Glycoside114887305
.    O

S-Adenosyl-L-methionine    B-Glycoside114887305

Puerarin    B-Glycoside114887305

Cleavage    O
of    O
a    O
bond    O
in    O
the    O
cyclopentane    O
ring    O
gives    O
rise    O
to    O
a    O
subclass    O
known    O
as    O
"    O
secoiridoids    O
"    O
,    O
such    O
as    O
oleuropein    B-Glycoside114887305
and    O
amarogentin    B-Glycoside114887305
.    O

Oleuropein    B-Glycoside114887305
,    O
a    O
chemical    O
compound    O
found    O
in    O
olive    O
leaf    O
from    O
the    O
olive    O
tree    O
,    O
together    O
with    O
other    O
closely    O
related    O
compounds    O
such    O
as    O
10-hydroxyoleuropein    B-Glycoside114887305
,    O
ligstroside    B-Glycoside114887305
and    O
10-hydroxyligstroside    B-Glycoside114887305
,    O
are    O
tyrosol    O
esters    O
of    O
elenolic    O
acid    O
.    O

A    O
deoxyribonucleoside    B-Glycoside114887305
is    O
a    O
type    O
of    O
nucleoside    O
including    O
deoxyribose    O
as    O
a    O
component    O
.    O

Nucleoside    O
diphosphate    O
(    O
NDP    O
)    O
kinase    O
catalyzes    O
in    O
vivo    O
ATP    O
-    O
dependent    O
synthesis    O
of    O
ribo-    O
and    O
deoxyribonucleoside    B-Glycoside114887305
triphosphates    O
.    O

idoxuridine    B-Glycoside114887305
(    O
INN    O
)    O

In    O
those    O
with    O
herpes    O
of    O
the    O
eye    O
,    O
aciclovir    O
may    O
be    O
more    O
effective    O
and    O
safer    O
than    O
idoxuridine    B-Glycoside114887305
.    O

Pyrimidine    O
analogues    O
of    O
uridine    B-Glycoside114887305
:    O
Idoxuridine    B-Glycoside114887305
,    O
Trifluridine    O

:    O
C05CA04    O
Troxerutin    B-Glycoside114887305

Main    O
chemicals    O
of    O
sarsaparilla    O
are    O
acetyl    O
-    O
parigenin    O
,    O
astilbin    B-Glycoside114887305
,    O
beta    O
-    O
sitosterol    O
,    O
caffeoyl    O
-    O
shikimic    O
acids    O
,    O
dihydroquercetin    O
,    O
diosgenin    O
,    O
engeletin    O
,    O
essential    O
oils    O
,    O
epsilon    O
-    O
sitosterol    O
,    O
eucryphin    O
,    O
eurryphin    O
,    O
ferulic    O
acid    O
,    O
glucopyranosides    O
,    O
isoastilbin    B-Glycoside114887305
,    O
isoengetitin    O
,    O
kaempferol    O
,    O
parigenin    O
,    O
parillin    O
,    O
pollinastanol    O
,    O
resveratrol    O
,    O
rhamnose    O
,    O
saponin    O
,    O
sarasaponin    O
,    O
sarsaparilloside    O
,    O
sarsaponin    O
,    O
sarsasapogenin    O
,    O
shikimic    O
acid    O
,    O
sitosterol    O
-    O
d    O
-    O
glucoside    O
,    O
smilagenin    O
,    O
smilasaponin    O
,    O
smilax    O
saponins    O
A    O
-    O
C    O
,    O
smiglaside    O
A    O
-    O
E    O
,    O
smitilbin    B-Glycoside114887305
,    O
stigmasterol    O
,    O
taxifolin    O
,    O
and    O
titogenin    O
.    O

Flavonoids    O
(    O
e.g.    O
epigallocatechin    O
,    O
rutin    B-Glycoside114887305
,    O
hyperoside    B-Glycoside114887305
,    O
isoquercetin    B-Glycoside114887305
,    O
quercitrin    B-Glycoside114887305
,    O
quercetin    O
,    O
amentoflavone    O
,    O
biapigenin    O
,    O
astilbin    B-Glycoside114887305
,    O
myricetin    O
,    O
miquelianin    B-Glycoside114887305
,    O
kaempferol    O
,    O
luteolin    O
)    O

Rebaudioside    O
A    O
,    O
in    O
particular    O
,    O
is    O
formed    O
from    O
stevioside    B-Glycoside114887305
.    O

Quercetin    B-Glycoside114887305
4'-O-glucoside    I-Glycoside114887305
or    O
spiraeoside    O
,    O
a    O
flavonol    O
glucoside    O

It    O
is    O
also    O
a    O
metabolite    O
of    O
capecitabine    B-Glycoside114887305
.    O

Benznidazole    O
and    O
other    O
nitroimidazoles    O
have    O
been    O
shown    O
to    O
decrease    O
the    O
rate    O
of    O
clearance    O
of    O
5-fluorouracil    O
(    O
including    O
5-fluorouracil    O
produced    O
from    O
its    O
prodrugs    O
capecitabine    B-Glycoside114887305
,    O
doxifluridine    O
,    O
and    O
tegafur    O
)    O
.    O

The    O
anti    O
-    O
cancer    O
medication    O
capecitabine    B-Glycoside114887305
may    O
cause    O
the    O
loss    O
of    O
fingerprints    O
.    O

Chemotherapy    O
commonly    O
used    O
is    O
similar    O
to    O
other    O
squamous    O
cell    O
epithelial    O
neoplasms    O
,    O
such    O
as    O
platinum    O
analogues    O
,    O
anthracyclines    O
such    O
as    O
doxorubicin    O
,    O
and    O
antimetabolites    O
such    O
as    O
5-FU    O
and    O
capecitabine    B-Glycoside114887305
.    O

Important    O
role    O
(    O
David    O
Cameron    O
as    O
joint    O
global    O
Chief    O
Investigator    O
)    O
in    O
the    O
pivotal    O
clinical    O
trial    O
that    O
tested    O
the    O
hypothesis    O
that    O
the    O
combination    O
of    O
lapatinib    O
and    O
the    O
cytotoxic    O
drug    O
capecitabine    B-Glycoside114887305
would    O
be    O
superior    O
to    O
capecitabine    O
alone    O
in    O
patients    O
with    O
HER2    O
+    O
metastatic    O
breast    O
cancer    O
that    O
had    O
progressed    O
despite    O
trastuzumab    O
treatment    O
.    O

Chemotherapy    O
is    O
usually    O
delivered    O
intravenously    O
,    O
although    O
a    O
number    O
of    O
agents    O
can    O
be    O
administered    O
orally    O
(    O
e.g.    O
specialty    O
drugs    O
,    O
melphalan    O
(    O
trade    O
name    O
Alkeran    O
)    O
,    O
busulfan    O
,    O
capecitabine    B-Glycoside114887305
)    O
.    O

The    O
most    O
advanced    O
of    O
these    O
compounds    O
is    O
miravirsen    O
,    O
a    O
locked    B-Glycoside114887305
nucleic    I-Glycoside114887305
acid    I-Glycoside114887305
-    O
DNA    O
mixmer    O

They    O
can    O
be    O
formed    O
of    O
DNA    O
,    O
RNA    O
,    O
LNA    B-Glycoside114887305
,    O
and    O
PNA    O
,    O
and    O
may    O
be    O
intramolecular    O
,    O
bimolecular    O
,    O
or    O
tetramolecular    O
.    O

Locked    B-Glycoside114887305
Nucleic    I-Glycoside114887305
Acid    I-Glycoside114887305

litoralis    O
"    O
contains    O
adenosine    O
,    O
coniferin    B-Glycoside114887305
,    O
the    O
two    O
dihydrofurocoumarin    O
glycosides    O
apterin    B-Glycoside114887305
and    O
1′-O-β-d    O
-    O
glycopyranosyl-(S)-marmesin    O
(    O
marmesinin    O
)    O
,    O
1′-O-β-d    O
-    O
glucopyranosyl-(2S    O
,    O
3R)-3-hydroxymarmesin    O
and    O
2′-β-d    O
-    O
glucopyranosyloxymarmesin    O
.    O

Coniferin    B-Glycoside114887305
is    O
a    O
glucoside    O
of    O
coniferyl    O
alcohol    O
.    O

Curculigoside    B-Glycoside114887305
A    I-Glycoside114887305

File    O
:    O
Amarogentin    B-Glycoside114887305
,    O
a    O
selected    O
constituent    O
of    O
"    O
Gentiana    O
"    O

Ononin    B-Glycoside114887305
is    O
an    O
isoflavone    O
glycoside    O
,    O
the    O
7    O
-    O
0-beta    O
-    O
D    O
-    O
glucopyranoside    O
of    O
formononetin    O
,    O
which    O
in    O
turn    O
is    O
the    O
4'-O    O
-    O
methoxy    O
derivative    O
of    O
the    O
parent    O
isoflavone    O
daidzein    O
.    O

The    O
major    O
metabolites    O
of    O
orally    O
absorbed    O
quercetin    O
are    O
quercetin-3-glucuronide    B-Glycoside114887305
,    O
3'-methylquercetin-3-glucuronide    O
,    O
and    O
quercetin-3'-sulfate    O
.    O

Solanine    B-Glycoside114887305

They    O
also    O
contain    O
small    O
amounts    O
of    O
solanine    B-Glycoside114887305
,    O
a    O
toxic    O
alkaloid    O
found    O
in    O
potato    O
leaves    O
and    O
other    O
plants    O
in    O
the    O
nightshade    O
family    O
.    O

Like    O
all    O
parts    O
of    O
the    O
plant    O
except    O
the    O
tubers    O
,    O
the    O
fruit    O
contain    O
the    O
toxic    O
alkaloid    O
solanine    B-Glycoside114887305
and    O
are    O
therefore    O
unsuitable    O
for    O
consumption    O
.    O

The    O
fruits    O
have    O
no    O
value    O
to    O
gardeners    O
as    O
the    O
fruits    O
are    O
inedible    O
as    O
they    O
are    O
filled    O
with    O
solanine    B-Glycoside114887305
,    O
which    O
causes    O
severe    O
illnesses    O
.    O

Remogliflozin    B-Glycoside114887305
etabonate    I-Glycoside114887305
(    O
INN    O
/    O
USAN    O
)    O
is    O
a    O
proposed    O
drug    O
of    O
the    O
gliflozin    O
class    O
for    O
the    O
treatment    O
of    O
non    O
-    O
alcoholic    O
steatohepatitis    O
(    O
"    O
NASH    O
"    O
)    O
and    O
type    O
2    O
diabetes    O
.    O

cellulose    O
powder    O
,    O
natural    O
flavors    O
as    O
well    O
as    O
the    O
stevia    O
extract    O
rebaudioside    B-Glycoside114887305
A    I-Glycoside114887305

The    O
same    O
,    O
or    O
a    O
closely    O
similar    O
substance    O
,    O
is    O
found    O
in    O
soapwort    O
(    O
"    O
Saponaria    O
officinalis    O
"    O
)    O
,    O
in    O
senega    O
root    O
(    O
"    O
Polygala    O
senega    O
"    O
)    O
and    O
in    O
sarsaparilla    O
;    O
it    O
appears    O
to    O
be    O
chemically    O
related    O
to    O
digitonin    B-Glycoside114887305
,    O
which    O
occurs    O
in    O
"    O
digitalis    O
"    O
.    O

File    O
:    O
Isoquercitrin    B-Glycoside114887305

Likewise    O
guaijaverin    O
is    O
the    O
3-"O    O
"-    O
arabinoside    O
,    O
hyperoside    B-Glycoside114887305
is    O
the    O
3-"O    O
"-    O
galactoside    B-Glycoside114887305
,    O
isoquercitin    B-Glycoside114887305
is    O
the    O
3-"O    O
"-    O
glucoside    O
and    O
spiraeoside    B-Glycoside114887305
is    O
the    O
4′-"O    O
"-    O
glucoside    O
.    O

Emtricitabine    B-Glycoside114887305
,    O
also    O
called    O
FTC    O
,    O
has    O
the    O
trade    O
name    O
Emtriva    O
(    O
formerly    O
Coviracil    O
)    O
.    O

Cytidine    O
analogues    O
:    O
zalcitabine    O
(    O
ddC    O
)    O
,    O
lamivudine    O
(    O
3TC    O
)    O
,    O
and    O
emtricitabine    B-Glycoside114887305
(    O
FTC    O
)    O

#    O
Do    O
not    O
prescribe    O
lamivudine    O
/    O
zidovudine    O
,    O
abacavir    O
/    O
lamivudine    O
,    O
or    O
abacavir    O
/    O
lamivudine    O
/    O
zidovudine    O
to    O
patients    O
taking    O
emtricitabine    B-Glycoside114887305
.    O

Emtricitabine    B-Glycoside114887305
,    O
an    O
antiretroviral    O
drug    O
used    O
to    O
treat    O
HIV    O
,    O
coded    O
FTC    O
in    O
medical    O
journals    O

Elvitegravir    O
,    O
emtricitabine    B-Glycoside114887305
and    O
tenofovir    O
directly    O
suppress    O
viral    O
reproduction    O
.    O

Tetuin    B-Glycoside114887305
is    O
the    O
6-glucoside    O
of    O
baicalein    O
.    O

5-Ethynyl-2´-deoxyuridine    B-Glycoside114887305
(    O
EdU    O
)    O
is    O
a    O
thymidine    O
analog    O
which    O
is    O
incorporated    O
into    O
the    O
DNA    O
of    O
dividing    O
cells    O
and    O
is    O
used    O
to    O
assay    O
DNA    O
synthesis    O
in    O
cell    O
culture    O
or    O
living    O
tissues    O
.    O

It    O
is    O
joined    O
to    O
the    O
anthracycline    O
aglycone    O
and    O
further    O
modifications    O
are    O
done    O
to    O
produce    O
first    O
daunorubicin    B-Glycoside114887305
then    O
DXR    O
.    O

Initially    O
,    O
two    O
successive    O
oxidations    O
are    O
done    O
at    O
C-13    O
,    O
followed    O
by    O
a    O
single    O
oxidation    O
of    O
C-14    O
that    O
converts    O
daunorubicin    B-Glycoside114887305
to    O
doxorubicin    O
.    O

Daunorubicin    B-Glycoside114887305
(    O
Bedford    O
Labs    O
)    O

daunorubicin    B-Glycoside114887305
(    O
INN    O
)    O

Daunorubicin    B-Glycoside114887305

Also    O
,    O
the    O
intercalation    O
into    O
DNA    O
of    O
anthracyclines    O
such    O
as    O
daunorubicin    B-Glycoside114887305
and    O
doxorubicin    O
interferes    O
with    O
the    O
functioning    O
of    O
the    O
enzyme    O
topoisomerase    O
II    O
,    O
blocking    O
replication    O
as    O
well    O
as    O
causing    O
mitotic    O
homologous    O
recombination    O
.    O

Scientists    O
named    O
the    O
drug    O
daunorubicin    B-Glycoside114887305
and    O
further    O
development    O
identified    O
a    O
related    O
compound    O
doxorubicin    O
that    O
finds    O
use    O
as    O
a    O
chemotherapeutic    O
agent    O
used    O
to    O
treat    O
cancer    O
.    O

The    O
plant    O
contains    O
the    O
anti    O
-    O
histamine    O
compound    O
koaburaside    B-Glycoside114887305
.    O

File    O
:    O
Clevudine    O
Clevudine    B-Glycoside114887305

Nonetheless    O
,    O
he    O
believed    O
it    O
was    O
poisonous    O
(    O
in    O
fact    O
,    O
the    O
plant    O
and    O
raw    O
fruit    O
do    O
have    O
low    O
levels    O
of    O
tomatine    B-Glycoside114887305
,    O
but    O
are    O
not    O
generally    O
dangerous    O
;    O
see    O
below    O
)    O
.    O

Leaves    O
,    O
stems    O
,    O
and    O
green    O
unripe    O
fruit    O
of    O
the    O
tomato    O
plant    O
contain    O
small    O
amounts    O
of    O
the    O
toxic    O
alkaloid    O
tomatine    B-Glycoside114887305
.    O

Catalpol    B-Glycoside114887305
and    O
a    O
combination    O
of    O
acetyl    O
-    O
carnitine    O
and    O
propionyl    O
-    O
carnitine    O
on    O
1:1    O
ratio    O
also    O
improves    O
endogenous    O
DHEA    O
production    O
and    O
release    O
due    O
to    O
direct    O
cholinergic    O
stimulation    O
of    O
CRH    O
release    O
and    O
an    O
increase    O
of    O
IGF-1    O
expression    O
respectively    O
.    O

Catalpol    B-Glycoside114887305
is    O
an    O
iridoid    O
glucoside    O
.    O

However    O
,    O
when    O
rats    O
were    O
treated    O
with    O
the    O
DNMT    O
inhibitors    O
zebularine    B-Glycoside114887305
or    O
5-aza-2′-deoxycytidine    B-Glycoside114887305
immediately    O
after    O
fear    O
-    O
conditioning    O
,    O
they    O
demonstrated    O
reduced    O
learning    O
(    O
freezing    O
behavior    O
)    O
.    O

Karaviloside    B-Glycoside114887305

Kaempferitrin    B-Glycoside114887305
is    O
a    O
chemical    O
compound    O
that    O
can    O
be    O
isolated    O
from    O
the    O
leaves    O
of    O
"    O
H    O
verticillata    O
"    O
.    O

Catechin-7-O-glucoside    B-Glycoside114887305
and    O
catechin-5-O-glucoside    B-Glycoside114887305
can    O
be    O
produced    O
by    O
biotransformation    O
of    O
(    O
+    O
)    O
-catechin    O
by    O
cultured    O
cells    O
of    O
"    O
E.    O
perriniana    O
"    O
.    O

The    O
powdered    O
preparation    O
was    O
also    O
reported    O
to    O
contain    O
twelve    O
flavonoid    O
-    O
like    O
compounds    O
,    O
including    O
homoorientin    B-Glycoside114887305
,    O
orientin    B-Glycoside114887305
,    O
taxifolin    O
deoxyhexose    O
,    O
isovitexin    B-Glycoside114887305
,    O
scoparin    O
,    O
as    O
well    O
as    O
proanthocyanidins    O
(    O
12.89    O
mg    O
/    O
g    O
)    O
,    O
and    O
low    O
levels    O
of    O
resveratrol    O
(    O
1.1    O
μg    O
/    O
g    O
)    O
.    O

The    O
phenolic    O
compounds    O
methyl    O
(    O
S)-flavogallonate    O
,    O
gallic    O
acid    O
,    O
methyl    O
gallate    O
,    O
ethyl    O
gallate    O
,    O
[    O
[    O
2,3-di    O
-    O
O--(S)-4,5,6,4′,5′,6′-hexahydroxybiphenyl-2,2′-diyldicarbonyl-(α/β)-D    O
-    O
glucopyranose|2,3-di    O
-    O
O-[(S)-4,5,6,4′,5′,6′-hexahydroxybiphenyl-2,2′-diyldicarbonyl]-(α/β)-D    O
-    O
glucopyranose    O
]    O
]    O
,    O
vitexin    B-Glycoside114887305
,    O
isovitexin    B-Glycoside114887305
,    O
orientin    B-Glycoside114887305
,    O
iso-orientin    B-Glycoside114887305
,    O
kaempferol    O
3-O-β-D    O
-    O
rutinoside    O
,    O
rutin    B-Glycoside114887305
,    O
neosaponarin    O
,    O
ellagic    O
acid    O
,    O
flavogallonic    O
acid    O
and    O
(    O
α/β)-punicalagin    O
can    O
be    O
isolated    O
from    O
the    O
leaves    O
of    O
"    O
T.    O
myriocarpa    O
"    O
.    O

Helicin    B-Glycoside114887305

Datiscoside    B-Glycoside114887305
is    O
any    O
one    O
of    O
several    O
chemical    O
compounds    O
isolated    O
from    O
certain    O
plants    O
,    O
notably    O
"    O
Datisca    O
glomerata    O
"    O
.    O

Neokuguaglucoside    B-Glycoside114887305
is    O
a    O
chemical    O
compound    O
with    O
formula    O
,    O
isolated    O
from    O
the    O
fruit    O
of    O
the    O
bitter    O
melon    O
vine    O
(    O
"    O
Momordica    O
charantia    O
"    O
,    O
called    O
"    O
kǔguā    O
"    O
in    O
Chinese    O
)    O
,    O
where    O
it    O
occurs    O
at    O
23    O
mg/35    O
kg    O
.    O

Hydroxocobalamin    B-Glycoside114887305
is    O
another    O
form    O
of    O
B12    O
commonly    O
encountered    O
in    O
pharmacology    O
,    O
but    O
which    O
is    O
not    O
normally    O
present    O
in    O
the    O
human    O
body    O
.    O

Hydroxocobalamin    B-Glycoside114887305

Historically    O
,    O
a    O
form    O
of    O
vitamin    O
called    O
hydroxocobalamin    B-Glycoside114887305
is    O
often    O
produced    O
by    O
bacteria    O
and    O
was    O
then    O
changed    O
to    O
cyanocobalamin    O
during    O
purification    O
in    O
activated    O
charcoal    O
columns    O
after    O
separation    O
from    O
the    O
bacterial    O
cultures    O
.    O

Hydroxocobalamin    B-Glycoside114887305

Theograndin    B-Glycoside114887305
I    I-Glycoside114887305
is    O
a    O
sulfated    O
glucuronide    O
of    O
isoscutellarein    O
.    O

A    O
related    O
glycoside    O
,    O
momordicoside    B-Glycoside114887305
,    O
occurs    O
in    O
the    O
unripe    O
fruit    O
.    O

Solauricine    O
,    O
solauricidine    O
,    O
and    O
solasodamine    B-Glycoside114887305
have    O
also    O
been    O
found    O
in    O
"    O
Solanum    O
mauritianum    O
"    O
.    O

Idamycin    B-Glycoside114887305
(    O
Adria    O
Laboratories    O
)    O

idarubicin    B-Glycoside114887305
(    O
INN    O
)    O

Some    O
cancer    O
treatments    O
like    O
bexarotene    O
,    O
busulfan    O
,    O
chlorambucil    O
,    O
estramustine    O
,    O
etoposide    B-Glycoside114887305
,    O
flutamide    O
,    O
idarubicin    B-Glycoside114887305
,    O
ifosfamide    O
,    O
irinotecan    O
,    O
ixabepilone    O
,    O
letrozole    O
,    O
lomustine    O
,    O
megestrol    O
,    O
mitomycin    O
,    O
mitoxantrone    O
,    O
paclitaxel    O
,    O
procarbazine    O
,    O
tamoxifen    O
,    O
topotecan    O

The    O
chemical    O
constituents    O
which    O
may    O
be    O
responsible    O
for    O
these    O
effects    O
include    O
acteoside    B-Glycoside114887305
,    O
echinacoside    B-Glycoside114887305
,    O
and    O
cistanosides    O
(    O
A    O
,    O
B    O
,    O
C    O
,    O
D    O
,    O
E    O
,    O
F    O
,    O
G    O
and    O
H    O
)    O
.    O

High    O
doses    O
of    O
the    O
chemical    O
compound    O
acteoside    B-Glycoside114887305
,    O
isolated    O
from    O
"    O
Cistanche    O
tubulosa    O
"    O
,    O
affected    O
biomarkers    O
related    O
to    O
aging    O
in    O
mice    O
.    O

Verbascoside    B-Glycoside114887305
can    O
also    O
be    O
produced    O
in    O
hairy    O
roots    O
cultures    O
of    O
"    O
P.    O
tomentosa    O
"    O
.    O

Daidzin    B-Glycoside114887305

Ginsenoside    B-Glycoside114887305
,    O
unique    O
phytochemicals    O
of    O
the    O
"    O
Panax    O
"    O
species    O
,    O
are    O
being    O
studied    O
for    O
their    O
potential    O
biological    O
properties    O
.    O

"    O
P.    O
notoginseng    O
"    O
contains    O
dammarane    O
-    O
type    O
ginsenosides    B-Glycoside114887305
as    O
major    O
constituents    O
.    O

"    O
Panax    O
"    O
species    O
are    O
characterized    O
by    O
the    O
presence    O
of    O
ginsenoside    B-Glycoside114887305
and    O
gintonin    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
acetyl-CoA    B-Glycoside114887305
and    O
monoterpenol    O
,    O
whereas    O
its    O
two    O
products    O
are    O
CoA    O
and    O
monoterpenol    O
acetate    O
ester    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
acetyl-CoA    B-Glycoside114887305
and    O
N6-hydroxy    O
-    O
L    O
-    O
lysine    O
,    O
whereas    O
its    O
two    O
products    O
are    O
CoA    O
and    O
N6-acetyl    O
-    O
N6-hydroxy    O
-    O
L    O
-    O
lysine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
acetyl-CoA    B-Glycoside114887305
and    O
N    O
-    O
acetylneuraminate    O
,    O
whereas    O
its    O
two    O
products    O
are    O
CoA    O
and    O
N    O
-    O
acetyl-4-O    O
-    O
acetylneuraminate    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
acetyl-CoA    B-Glycoside114887305
and    O
N    O
-    O
acetylneuraminate    O
,    O
whereas    O
its    O
3    O
products    O
are    O
CoA    O
,    O
N    O
-    O
acetyl-7-O    O
-    O
acetylneuraminate    O
,    O
and    O
N    O
-    O
acetyl-9-O    O
-    O
acetylneuraminate    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
acetyl-CoA    B-Glycoside114887305
and    O
N    O
-    O
hydroxyarylamine    O
,    O
whereas    O
its    O
two    O
products    O
are    O
CoA    O
and    O
N    O
-    O
acetoxyarylamine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
acetyl-CoA    B-Glycoside114887305
and    O
peptide    O
,    O
whereas    O
its    O
two    O
products    O
are    O
Nalpha    O
-    O
acetylpeptide    O
and    O
CoA.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
acetyl-CoA    B-Glycoside114887305
and    O
L    O
-    O
phenylalanine    O
,    O
whereas    O
its    O
two    O
products    O
are    O
CoA    O
and    O
N    O
-    O
acetyl    O
-    O
L    O
-    O
phenylalanine    O
.    O

The    O
substrates    O
of    O
this    O
enzyme    O
are    O
acetyl-CoA    B-Glycoside114887305
and    O
phosphate    O
,    O
whereas    O
its    O
two    O
products    O
are    O
CoA    O
and    O
acetyl    O
phosphate    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
acetyl-CoA    B-Glycoside114887305
and    O
alpha-2,8-linked    O
polymer    O
of    O
sialic    O
acid    O
,    O
whereas    O
its    O
3    O
products    O
are    O
CoA    O
,    O
polysialic    O
acid    O
acetylated    O
on    O
O-7    O
,    O
and    O
polysialic    O
acid    O
acetylated    O
on    O
O-9    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
acetyl-CoA    B-Glycoside114887305
and    O
ribosomal    O
-    O
protein    O
L    O
-    O
alanine    O
,    O
whereas    O
its    O
two    O
products    O
are    O
CoA    O
and    O
ribosomal    O
-    O
protein    O
N    O
-    O
acetyl    O
-    O
L    O
-    O
alanine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
acetyl-CoA    B-Glycoside114887305
and    O
salutaridinol    O
,    O
whereas    O
its    O
two    O
products    O
are    O
CoA    O
and    O
7-O    O
-    O
acetylsalutaridinol    O
.    O

:    O
acetyl-CoA    B-Glycoside114887305
+    O
L    O
-    O
serine    O
CoA    O
+    O
O    O
-    O
acetyl    O
-    O
L    O
-    O
serine    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
acetyl-CoA    B-Glycoside114887305
and    O
L    O
-    O
serine    O
,    O
whereas    O
its    O
two    O
products    O
are    O
CoA    O
and    O
O    O
-    O
acetyl    O
-    O
L    O
-    O
serine    O
.    O

More    O
specifically    O
,    O
its    O
role    O
is    O
to    O
catalyse    O
the    O
activation    O
of    O
L    O
-    O
serine    O
by    O
acetyl-CoA    B-Glycoside114887305
entry    O
refers    O
to    O
the    O
N    O
-    O
terminus    O
of    O
the    O
protein    O
which    O
has    O
a    O
sequence    O
that    O
is    O
conserved    O
in    O
plants    O
and    O
bacteria    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
acetyl-CoA    B-Glycoside114887305
and    O
taxa-4(20),11-dien-5alpha    O
-    O
ol    O
,    O
whereas    O
its    O
two    O
products    O
are    O
CoA    O
and    O
taxa-4(20),11-dien-5alpha    O
-    O
yl    O
acetate    O
.    O

The    O
3    O
substrates    O
of    O
this    O
enzyme    O
are    O
acetyl-CoA    B-Glycoside114887305
,    O
(    O
S)-2,3,4,5-tetrahydropyridine-2,6-dicarboxylate    O
,    O
and    O
H2O    O
,    O
whereas    O
its    O
two    O
products    O
are    O
CoA    O
and    O
L-2-acetamido-6-oxoheptanedioate    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
acetyl-CoA    B-Glycoside114887305
and    O
2-aminoethanethiol    O
,    O
whereas    O
its    O
two    O
products    O
are    O
CoA    O
and    O
S-(2-aminoethyl)thioacetate    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
acetyl-CoA    B-Glycoside114887305
and    O
16-epivellosimine    O
,    O
whereas    O
its    O
two    O
products    O
are    O
CoA    O
and    O
vinorine    O
.    O

Arsenic    O
interferes    O
with    O
cellular    O
longevity    O
by    O
allosteric    O
inhibition    O
of    O
an    O
essential    O
metabolic    O
enzyme    O
pyruvate    O
dehydrogenase    O
(    O
PDH    O
)    O
complex    O
,    O
which    O
catalyzes    O
the    O
oxidation    O
of    O
pyruvate    O
to    O
acetyl-CoA    B-Glycoside114887305
by    O
NAD+    O
.    O

PDH    O
is    O
a    O
precursor    O
of    O
acetyl-CoA    B-Glycoside114887305
,    O
thus    O
the    O
inhibition    O
of    O
PDH    O
eventually    O
limits    O
the    O
production    O
of    O
ATP    O
in    O
electron    O
transport    O
chain    O
,    O
as    O
well    O
as    O
the    O
production    O
of    O
gluconeogenesis    O
intermediates    O
.    O

However    O
,    O
an    O
understanding    O
of    O
the    O
physiology    O
of    O
the    O
organism    O
would    O
have    O
revealed    O
that    O
due    O
to    O
an    O
incomplete    O
tricarboxylic    O
acid    O
pathway    O
,    O
"    O
Lactobacillus    O
plantarum    O
"    O
does    O
not    O
actually    O
produce    O
succinyl    O
-    O
CoA    O
,    O
and    O
the    O
correct    O
reactant    O
for    O
that    O
part    O
of    O
the    O
reaction    O
was    O
acetyl-CoA    B-Glycoside114887305

In    O
contrast    O
the    O
"    O
Rhizobium    O
etli    O
"    O
,    O
tetramer    O
in    O
complex    O
with    O
ethyl    O
-    O
CoA    O
,    O
a    O
non    O
-    O
hydrolyzable    O
analog    O
of    O
acetyl-CoA    B-Glycoside114887305
,    O
possesses    O
only    O
one    O
line    O
of    O
symmetry    O
.    O

In    O
most    O
species    O
,    O
this    O
reaction    O
requires    O
acetyl-CoA    B-Glycoside114887305
as    O
an    O
allosteric    O
activator    O
binding    O
to    O
the    O
PT    O
domain    O
.    O

Next    O
,    O
a    O
series    O
of    O
condensation    O
reactions    O
of    O
three    O
acetate    O
units    O
from    O
malonyl    O
-    O
CoA    O
occurs    O
,    O
each    O
proceeding    O
through    O
an    O
acetyl-CoA    B-Glycoside114887305
carbanion    O
derived    O
from    O
malonyl    O
-    O
CoA    O
decarboxylation    O
.    O

In    O
this    O
pathway    O
,    O
two    O
molecules    O
of    O
acetyl-CoA    B-Glycoside114887305
undergo    O
a    O
condensation    O
reaction    O
to    O
give    O
acetoacetyl    O
-    O
CoA.    O
This    O
product    O
then    O
condenses    O
with    O
third    O
molecule    O
of    O
acetyl    O
-    O
CoA    O
in    O
a    O
stereospecific    O
fashion    O
to    O
form    O
3-hydroxy-3-methylglutaryl    O
-    O
CoA    O
(    O
HMG    O
-    O
CoA    O
)    O
which    O
then    O
is    O
reduced    O
to    O
mevalonic    O
acid    O
(    O
MVA    O
)    O
.    O

The    O
backbone    O
is    O
synthesized    O
through    O
the    O
addition    O
of    O
two    O
carbon    O
units    O
via    O
addition    O
of    O
acetate    O
units    O
from    O
acetyl-CoA    B-Glycoside114887305
The    O
5    O
methyl    O
groups    O
are    O
added    O
via    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
(    O
SAM    O
)    O
methylation    O
,    O
as    O
opposed    O
to    O
incorporation    O
of    O
propionate    O
(    O
instead    O
of    O
acetate    O
)    O
to    O
the    O
growing    O
compound    O
during    O
biosynthesis    O
.    O

IPP    O
is    O
formed    O
from    O
acetyl-CoA    B-Glycoside114887305
via    O
the    O
intermediacy    O
of    O
mevalonic    O
acid    O
in    O
the    O
HMG    O
-    O
CoA    O
reductase    O
pathway    O
.    O

The    O
pyruvate    O
is    O
then    O
converted    O
into    O
acetyl-CoA    B-Glycoside114887305
so    O
that    O
it    O
can    O
enter    O
the    O
TCA    O
cycle    O
and    O
convert    O
the    O
original    O
pyruvate    O
molecules    O
into    O
ATP    O
,    O
or    O
usable    O
energy    O
for    O
the    O
organism    O
.    O

Each    O
pyruvate    O
goes    O
through    O
a    O
series    O
of    O
reactions    O
that    O
converts    O
it    O
to    O
acetyl    B-Glycoside114887305
coenzyme    I-Glycoside114887305
A    I-Glycoside114887305

In    O
the    O
presence    O
of    O
air    O
and    O
various    O
cofactors    O
and    O
enzymes    O
,    O
fatty    O
acids    O
are    O
degraded    O
to    O
acetyl-CoA    B-Glycoside114887305
The    O
pathway    O
is    O
called    O
beta    O
-    O
oxidation    O
.    O

Enoyl    O
-    O
CoA    O
hydratase    O
is    O
an    O
enzyme    O
that    O
hydrates    O
the    O
double    O
bond    O
between    O
the    O
second    O
and    O
third    O
carbons    O
on    O
acyl    O
-    O
CoA.    O
This    O
enzyme    O
,    O
also    O
known    O
as    O
crotonase    O
,    O
is    O
essential    O
to    O
metabolizing    O
fatty    O
acids    O
to    O
produce    O
both    O
acetyl    B-Glycoside114887305
CoA    I-Glycoside114887305
and    O
energy    O
.    O

ATP    O
citrate    O
lyase    O
is    O
the    O
primary    O
enzyme    O
responsible    O
for    O
the    O
synthesis    O
of    O
cytosolic    O
acetyl-CoA    B-Glycoside114887305
in    O
many    O
tissues    O
.    O

ATP    O
-    O
citrate    O
lyase    O
is    O
responsible    O
for    O
catalyzing    O
the    O
conversion    O
of    O
citrate    O
and    O
CoA    O
into    O
acetyl-CoA    B-Glycoside114887305
and    O
oxaloacetate    O
,    O
along    O
with    O
the    O
hydrolysis    O
of    O
ATP    O
.    O

In    O
the    O
presence    O
of    O
ATP    O
and    O
Coenzyme    O
A    O
,    O
citrate    O
lyase    O
catalyzes    O
the    O
cleavage    O
of    O
citrate    O
to    O
yield    O
acetyl    B-Glycoside114887305
CoA    I-Glycoside114887305
,    O
oxaloacetate    O
,    O
ADP    O
,    O
and    O
orthophosphate    O
:    O

:    O
citrate    O
+    O
ATP    O
+    O
CoA    O
+    O
H2O    O
→    O
oxaloacetate    O
+    O
Acetyl-CoA    B-Glycoside114887305
+    O
ADP    O
+    O
Pi    O

The    O
first    O
three    O
steps    O
of    O
the    O
reaction    O
pathways    O
lead    O
from    O
ethanol    O
to    O
acetaldehyde    O
to    O
acetic    O
acid    O
to    O
acetyl-CoA    B-Glycoside114887305
Once    O
acetyl    O
-    O
CoA    O
is    O
formed    O
,    O
it    O
is    O
free    O
to    O
enter    O
directly    O
into    O
the    O
citric    O
acid    O
cycle    O
.    O

Two    O
enzymes    O
are    O
associated    O
with    O
the    O
conversion    O
of    O
acetic    O
acid    O
to    O
acetyl-CoA    B-Glycoside114887305
The    O
first    O
is    O
acyl    O
-    O
CoA    O
synthetase    O
short    O
-    O
chain    O
family    O
member    O
2    O
ACSS2    O
(    O
EC    O
6.2.1.1    O
)    O
.    O

It    O
is    O
created    O
from    O
acetyl-CoA    B-Glycoside114887305
,    O
a    O
thioester    O
,    O
which    O
reacts    O
with    O
the    O
enolate    O
of    O
a    O
second    O
molecule    O
of    O
acetyl    O
-    O
CoA    O
in    O
a    O
Claisen    O
condensation    O
reaction    O
,    O
and    O
it    O
is    O
acted    O
upon    O
by    O
HMG    O
-    O
CoA    O
synthase    O
to    O
form    O
HMG    O
-    O
CoA.    O
During    O
the    O
metabolism    O
of    O
leucine    O
,    O
this    O
last    O
reaction    O
is    O
reversed    O
.    O

Thiolases    O
,    O
also    O
known    O
as    O
acetyl    O
-    O
coenzyme    O
A    O
acetyltransferases    O
(    O
ACAT    O
)    O
,    O
are    O
enzymes    O
which    O
convert    O
two    O
units    O
of    O
acetyl-CoA    B-Glycoside114887305
to    O
acetoacetyl    O
CoA    O
in    O
the    O
mevalonate    O
pathway    O
.    O

This    O
gene    O
encodes    O
a    O
mitochondrially    O
localized    O
enzyme    O
that    O
catalyzes    O
the    O
reversible    O
formation    O
of    O
acetoacetyl    O
-    O
CoA    O
from    O
two    O
molecules    O
of    O
acetyl-CoA    B-Glycoside114887305
The    O
ACAT1    O
enzyme    O
has    O
a    O
few    O
unique    O
properties    O
.    O

The    O
compound    O
undergoes    O
beta    O
oxidation    O
,    O
forming    O
one    O
or    O
more    O
molecules    O
of    O
acetyl-CoA    B-Glycoside114887305
This    O
,    O
in    O
turn    O
,    O
enters    O
the    O
citric    O
acid    O
cycle    O
,    O
eventually    O
forming    O
several    O
molecules    O
of    O
ATP    O
.    O

Acetyl-CoA    B-Glycoside114887305

The    O
complex    O
acts    O
to    O
convert    O
pyruvate    O
(    O
a    O
product    O
of    O
glycolysis    O
in    O
the    O
cytosol    O
)    O
to    O
acetyl-coA    B-Glycoside114887305
,    O
which    O
is    O
then    O
oxidized    O
in    O
the    O
mitochondria    O
to    O
produce    O
energy    O
,    O
in    O
the    O
citric    O
acid    O
cycle    O
.    O

Pyruvate    O
dehydrogenase    O
kinase    O
is    O
activated    O
by    O
ATP    O
,    O
NADH    O
and    O
acetyl-CoA    B-Glycoside114887305
It    O
is    O
inhibited    O
by    O
ADP    O
,    O
NAD+    O
,    O
CoA    O
-    O
SH    O
and    O
pyruvate    O
.    O

The    O
first    O
anticodon    O
base    O
,    O
or    O
wobble    O
-    O
position    O
,    O
is    O
sometimes    O
modified    O
to    O
inosine    O
(    O
derived    O
from    O
adenine    O
)    O
,    O
pseudouridine    B-Glycoside114887305
or    O
lysidine    B-Glycoside114887305
(    O
derived    O
from    O
cytosine    O
)    O
.    O

Azalein    B-Glycoside114887305
,    O
a    O
flavonol    O

Geneticin    B-Glycoside114887305
,    O
or    O
G418    O
,    O
neutralized    O
by    O
the    O
product    O
of    O
the    O
neomycin    O
resistance    O
gene    O

Certain    O
medications    O
,    O
e.g.    O
amiodarone    O
,    O
bleomycin    B-Glycoside114887305
(    O
pingyangmycin    B-Glycoside114887305
)    O
,    O
busulfan    O
,    O
methotrexate    O
,    O
apomorphine    O
,    O
and    O
nitrofurantoin    O

Trans-resveratrol-3-O-glucuronide    B-Glycoside114887305
,    O
a    O
stilbenoid    O

Her    O
research    O
has    O
suggested    O
that    O
drinking    O
rooibos    O
may    O
lower    O
stress    O
through    O
the    O
effects    O
of    O
two    O
compounds    O
in    O
it    O
,    O
aspalathin    B-Glycoside114887305
and    O
nothofagin    B-Glycoside114887305
,    O
which    O
(    O
in    O
laboratory    O
conditions    O
)    O
block    O
the    O
production    O
of    O
stress    O
hormone    O
cortisol    O
.    O

Chromomycin    B-Glycoside114887305
A3    I-Glycoside114887305

Hodulcine    B-Glycoside114887305
,    O
a    O
dammarane    O
-    O
type    O
triterpene    O
glycoside    O
from    O
the    O
leaves    O
of    O
"    O
Hovenia    O
dulcis    O
"    O

Liquiritin    B-Glycoside114887305
is    O
the    O
4'-"O    O
"-    O
glucoside    O
of    O
the    O
flavanone    O
liquiritigenin    O
.    O

Methylcobalamin    B-Glycoside114887305

Cobalamin    O
analogs    O
prepared    O
by    O
this    O
method    O
include    O
the    O
naturally    O
occurring    O
coenzymes    O
methylcobalamin    B-Glycoside114887305
and    O
cobamamide    O
,    O
and    O
other    O
cobalamins    O
that    O
do    O
not    O
occur    O
naturally    O
,    O
such    O
as    O
vinylcobalamin    O
,    O
carboxymethylcobalamin    O
and    O
cyclohexylcobalamin    O
.    O

The    O
two    O
bioactive    O
forms    O
of    O
vitamin    O
are    O
methylcobalamin    B-Glycoside114887305
in    O
cytosol    O
and    O
adenosylcobalamin    O
in    O
mitochondria    O
.    O

Vitamin    O
methylcobalamin    B-Glycoside114887305
and    O
5-methyltetrahydrofolate    O
are    O
needed    O
by    O
Methionine    O
synthase    O
in    O
the    O
Methionine    O
cycle    O
to    O
transfer    O
a    O
methyl    O
group    O
from    O
5-methyltetrahydrofolate    O
to    O
homocysteine    O
,    O
thereby    O
generating    O
tetrahydrofolate    O
(    O
THF    O
)    O
and    O
methionine    O
,    O
which    O
is    O
used    O
to    O
make    O
SAMe    B-Glycoside114887305
.    O

Methylcobalamin    B-Glycoside114887305

It    O
also    O
contains    O
the    O
hydroxystilbenes    O
rhaponticin    B-Glycoside114887305
and    O
desoxyrhaponticin    O
.    O

Antirrhinin    B-Glycoside114887305

Antirrhinin    B-Glycoside114887305
(    O
cyanidin-3-rutinoside    O
or    O
3-C    O
-    O
R    O
)    O
,    O
found    O
in    O
black    O
raspberry    O

Glucobrassicin    B-Glycoside114887305

The    O
chemical    O
constituents    O
which    O
may    O
be    O
responsible    O
for    O
these    O
effects    O
include    O
acteoside    B-Glycoside114887305
,    O
echinacoside    B-Glycoside114887305
,    O
and    O
cistanosides    O
(    O
A    O
,    O
B    O
,    O
C    O
,    O
D    O
,    O
E    O
,    O
F    O
,    O
G    O
and    O
H    O
)    O
.    O

Chemically    O
,    O
phytoecdysteroids    O
are    O
classed    O
as    O
triterpenoids    O
,    O
the    O
group    O
of    O
compounds    O
that    O
includes    O
triterpene    B-Glycoside114887305
saponin    I-Glycoside114887305
,    O
phytosterols    O
,    O
and    O
phytoecdysteroids    O
.    O

α-Hederin    O
(    O
"    O
alpha    O
"-    O
hederin    O
)    O
is    O
a    O
water    O
-    O
soluble    O
pentacyclic    O
triterpenoid    B-Glycoside114887305
saponin    I-Glycoside114887305
found    O
in    O
the    O
seeds    O
of    O
"    O
Nigella    O
sativa    O
"    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
isoorientin    B-Glycoside114887305
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
isoscoparin    O
.    O

The    O
phenolic    O
compounds    O
methyl    O
(    O
S)-flavogallonate    O
,    O
gallic    O
acid    O
,    O
methyl    O
gallate    O
,    O
ethyl    O
gallate    O
,    O
[    O
[    O
2,3-di    O
-    O
O--(S)-4,5,6,4′,5′,6′-hexahydroxybiphenyl-2,2′-diyldicarbonyl-(α/β)-D    O
-    O
glucopyranose|2,3-di    O
-    O
O-[(S)-4,5,6,4′,5′,6′-hexahydroxybiphenyl-2,2′-diyldicarbonyl]-(α/β)-D    O
-    O
glucopyranose    O
]    O
]    O
,    O
vitexin    B-Glycoside114887305
,    O
isovitexin    B-Glycoside114887305
,    O
orientin    B-Glycoside114887305
,    O
iso-orientin    B-Glycoside114887305
,    O
kaempferol    O
3-O-β-D    O
-    O
rutinoside    O
,    O
rutin    B-Glycoside114887305
,    O
neosaponarin    O
,    O
ellagic    O
acid    O
,    O
flavogallonic    O
acid    O
and    O
(    O
α/β)-punicalagin    O
can    O
be    O
isolated    O
from    O
the    O
leaves    O
of    O
"    O
T.    O
myriocarpa    O
"    O
.    O

A    O
licence    O
was    O
granted    O
to    O
Phytopharm    O
,    O
for    O
development    O
of    O
the    O
active    O
ingredient    O
in    O
the    O
"    O
Hoodia    O
"    O
plant    O
,    O
p57    B-Glycoside114887305
(glycoside)    I-Glycoside114887305
,    O
to    O
be    O
used    O
as    O
a    O
pharmaceutical    O
drug    O
for    O
dieting    O
.    O

Picrocrocin    B-Glycoside114887305
is    O
a    O
monoterpene    O
glycoside    O
precursor    O
of    O
safranal    O
.    O

monoxerutin    B-Glycoside114887305
(    O
INN    O
)    O

Sergliflozin    B-Glycoside114887305
etabonate    I-Glycoside114887305
(    O
INN    O
/    O
USAN    O
,    O
codenamed    O
GW869682X    B-Glycoside114887305
)    O
is    O
an    O
investigational    O
anti    O
-    O
diabetic    O
drug    O
being    O
developed    O
by    O
GlaxoSmithKline    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
16-hydroxytabersonine    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
16-methoxytabersonine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
5,8,13,13a    O
-    O
tetrahydrocolumbamine    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
tetrahydropalmatine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
7-methylxanthine    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
3,7-dimethylxanthine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
dimethyl    O
sulfide    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
trimethylsulfonium    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
thiol    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
thioether    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
gamma    O
-    O
tocopherol    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
alpha    O
-    O
tocopherol    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
trans    O
-    O
aconitate    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
(    O
E)-3-(methoxycarbonyl)pent-2-enedioate    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
trans    O
-    O
aconitate    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
(    O
E)-2-(methoxycarbonylmethyl)butenedioate    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
tRNA    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
tRNA    O
containing    O
5-methylaminomethyl-2-thiouridylic    O
acid    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
tRNA    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
tRNA    O
containing    O
N1-methyladenine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
tRNA    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
tRNA    O
containing    O
N6-methyladenine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
tRNA    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
tRNA    O
containing    O
5-methylcytosine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
tRNA    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
tRNA    O
containing    O
N1-methylguanine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
tRNA    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
tRNA    O
containing    O
N2-Methylguanine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
tRNA    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
tRNA    O
containing    O
N7-methylguanine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
tRNA    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
tRNA    O
containing    O
2'-O    O
-    O
methylguanosine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
tRNA    O
containing    O
uridine    B-Glycoside114887305
at    O
position    O
54    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
tRNA    O
containing    O
ribothymidine    B-Glycoside114887305
at    O
position    O
54    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
L    O
-    O
tryptophan    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
L-2-methyltryptophan    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
tyramine    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
N    O
-    O
methyltyramine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
vitexin    O
2"-O    O
-    O
beta    O
-    O
L    O
-    O
rhamnoside    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
7-O    O
-    O
methylvitexin    O
2"-O    O
-    O
beta    O
-    O
L    O
-    O
rhamnoside    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
xanthotoxol    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
O    O
-    O
methylxanthotoxol    O
.    O

DPD    O
is    O
produced    O
by    O
degradation    O
of    O
"S"-adenosylhomocysteine    B-Glycoside114887305
by    O
the    O
action    O
of    O
the    O
enzyme    O
"    O
S    O
"-    O
ribosylhomocysteinase    O
.    O

The    O
pathway    O
for    O
the    O
synthesis    O
of    O
creatineArg    O
-    O
Arginine    O
;    O
GATM    O
-    O
Glycine    O
amidinotransferase    O
;    O
GAMT    O
-    O
Guanidinoacetate    O
N    O
-    O
methyltransferase    O
;    O
Gly    O
-    O
Glycine    O
;    O
Met    O
-    O
Methionine    O
;    O
SAH    O
-    O
S-adenosyl    B-Glycoside114887305
homocysteine    I-Glycoside114887305
;    O
SAM    O
-    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
.    O

According    O
to    O
the    O
official    O
blog    O
of    O
Autism    O
Speaks    O
,    O
James    O
found    O
that    O
autistic    O
children    O
exhibit    O
abnormal    O
folate    O
metabolism    O
that    O
is    O
detectable    O
by    O
higher    O
levels    O
of    O
plasma    O
homocysteine    O
,    O
adenosine    O
,    O
and    O
S-adenosyl-L-homocysteine    B-Glycoside114887305
in    O
the    O
mothers    O
of    O
these    O
children    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl-L-homocysteine    B-Glycoside114887305
and    O
H2O    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S    O
-    O
inosyl    O
-    O
L    O
-    O
homocysteine    O
and    O
NH3    O
.    O

The    O
5    O
substrates    O
of    O
this    O
enzyme    O
are    O
acetyl-CoA    B-Glycoside114887305
,    O
malonyl    O
-    O
CoA    O
,    O
NADPH    O
,    O
H+    O
,    O
and    O
S-adenosyl-L-methionine    B-Glycoside114887305
,    O
whereas    O
its    O
6    O
products    O
are    O
dihydromonacolin    O
L    O
,    O
CoA    O
,    O
CO2    O
,    O
NADP+    O
,    O
S-adenosyl-L-homocysteine    B-Glycoside114887305
,    O
and    O
H2O.    O

Abbreviations    O
:    O
S-Adenosyl-L-homocysteine    B-Glycoside114887305
(    O
SAH    O
)    O
,    O
S-adenosyl-L-methionine    B-Glycoside114887305
(    O
SAM    O
)    O
,    O
DNA    O
methyltransferase    O
(    O
DNA    O
MTase    O
)    O
,    O
Uracil    O
-    O
DNA    O
glycosylase    O
(    O
UNG    O
)    O
.    O

Oroxindin    B-Glycoside114887305
is    O
a    O
flavone    O
,    O
a    O
type    O
of    O
phenolic    O
chemical    O
compound    O
.    O

Taxillusin    B-Glycoside114887305
is    O
a    O
flavonol    O
found    O
in    O
the    O
parasitic    O
plant    O
"    O
Taxillus    O
kaempferi    O
"    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosyl    B-Glycoside114887305
methionine    I-Glycoside114887305
and    O
macrocin    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S-adenosylhomocysteine    B-Glycoside114887305
and    O
tylosin    B-Glycoside114887305
.    O

Different    O
strains    O
of    O
"    O
S.    O
fradiae    O
"    O
are    O
known    O
to    O
produce    O
the    O
antibiotics    O
neomycin    O
,    O
tylosin    B-Glycoside114887305
,    O
and    O
fosfomycin    O
.    O

Following    O
this    O
,    O
Chopra    O
,    O
Haydon    O
,    O
Lambert    O
and    O
colleague    O
Chris    O
Bassude    O
complained    O
to    O
the    O
Public    O
Service    O
Integrity    O
Officer    O
(    O
PSIO    O
)    O
office    O
,    O
a    O
federal    O
investigative    O
body    O
under    O
the    O
jurisdiction    O
of    O
the    O
Treasury    O
Board    O
of    O
Canada    O
,    O
indicating    O
again    O
that    O
they    O
were    O
pressured    O
by    O
their    O
seniors    O
to    O
pass    O
a    O
number    O
of    O
veterinary    O
drugs    O
,    O
including    O
Tylosin    B-Glycoside114887305
,    O
Revalor    O
H    O
,    O
Synergistin    O
Injectable    O
Suspension    O
,    O
Baytril    O
,    O
rBST    O
,    O
Carbodex    O
and    O
Eugenol    O
,    O
without    O
proof    O
of    O
human    O
safety    O
.    O

In    O
"    O
Gardenia    O
jasminoides    O
"    O
,    O
the    O
cyclized    O
lactone    O
intermediate    O
is    O
glycosylated    O
to    O
form    O
boschnaloside    O
that    O
is    O
then    O
hydroxylated    O
on    O
C10    O
;    O
boschnaloside    O
is    O
oxidized    O
to    O
geniposidic    B-Glycoside114887305
acid    I-Glycoside114887305
;    O
geniposidic    O
acid    O
is    O
then    O
decarboxylated    O
to    O
form    O
bartisioside    O
;    O
bartisioside    O
is    O
then    O
hydroxylated    O
to    O
form    O
aucubin    O
.    O

Methylation    O
of    O
adenosine    O
does    O
not    O
affect    O
its    O
ability    O
to    O
base    O
-    O
pair    O
with    O
thymidine    O
or    O
uracil    O
,    O
so    O
N6-methyladenosine    B-Glycoside114887305
(    O
m6A    O
)    O
can    O
not    O
be    O
detected    O
using    O
standard    O
sequencing    O
or    O
hybridization    O
methods    O
.    O

N6-Methyladenosine    B-Glycoside114887305

It    O
is    O
the    O
most    O
common    O
ingredient    O
of    O
traditional    O
herbal    O
drinks    O
in    O
Taiwan    O
containing    O
different    O
phenolic    O
compounds    O
:    O
kaempferol    O
3-O-α-l    O
-    O
rhamnopyranoside-7-O-[α-d    O
-    O
apiofuranosyl-(1    O
-    O
2)-β-d    O
-    O
glucopyranoside    O
]    O
,    O
7-O    O
-    O
caffeoylhydroxymaltol    O
3-O-β-d    O
-    O
glucopyranoside    O
,    O
hispidin    O
4-O-β-d    O
-    O
glucopyranoside    O
,    O
kaempferol    O
3-O-α-l    O
-    O
rhamnopyranoside-7-O-β-d    O
-    O
glucopyranoside    O
,    O
caffeic    O
acid    O
,    O
5-O-caffeoylquinic    B-Glycoside114887305
acid    I-Glycoside114887305
,    O
3,5-di    O
-    O
O    O
-    O
caffeoylquinic    O
acid    O
and    O
4,5-di    O
-    O
O    O
-    O
caffeoylquinic    O
acid    O
.    O

Castavinol    B-Glycoside114887305
C3    I-Glycoside114887305
,    O
a    O
natural    O
phenolic    O
compound    O
found    O
in    O
red    O
wines    O

Goyaglycoside    B-Glycoside114887305

The    O
ripe    O
fruit    O
also    O
contains    O
0.3–0.45%    O
solasonine    B-Glycoside114887305
,    O
and    O
acetylcholine    O
,    O
and    O
has    O
a    O
cholinesterase    O
-    O
inhibiting    O
effect    O
on    O
human    O
plasma    O
.    O

The    O
flavones    O
diosmin    B-Glycoside114887305
,    O
cirsimaritin    O
,    O
salvigenin    O
,    O
cirsilineol    O
,    O
cirsiliol    O
,    O
luteolin    O
,    O
apigenin    O
and    O
the    O
flavanone    O
naringenin    O
,    O
as    O
well    O
as    O
the    O
flavone    O
glycosides    O
luteolin-7-O-β-D-glucoside    B-Glycoside114887305
and    O
apigenin-7-O-β-D-glucoside    B-Glycoside114887305
,    O
and    O
the    O
diglycosides    O
luteolin-7-O-β-D    O
-    O
rutinoside    O
,    O
luteolin-7-O-β-D    O
-    O
neohesperidoside    O
(    O
veronicastroside    B-Glycoside114887305
)    O
and    O
luteolin-7-O-β-D    O
-    O
sambubioside    O
can    O
be    O
found    O
in    O
"    O
T.    O
gnaphalodes    O
"    O
.    O

Astragalosides    B-Glycoside114887305
are    O
bio    O
-    O
active    O
isolates    O
of    O
"    O
Astragalus    O
membranaceus    O
"    O
.    O

CP-532,903    B-Glycoside114887305

The    O
angucyclines    O
include    O
for    O
example    O
aquayamycin    B-Glycoside114887305
,    O
the    O
landomycins    O
,    O
moromycins    O
,    O
saquayamycins    O
,    O
urdamycins    O
and    O
vineomycins    O
.    O

Corilagin    B-Glycoside114887305
,    O
an    O
ellagitannin    O

Eleutherobin    B-Glycoside114887305
is    O
a    O
marine    O
diterpene    O
glycoside    O
with    O
anticancer    O
activity    O
.    O

Tribenoside    B-Glycoside114887305
(    O
Glyvenol    B-Glycoside114887305
)    O
is    O
a    O
vasoprotective    O
and    O
a    O
mixture    O
of    O
the    O
α-    O
und    O
β-anomers    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
UDP    O
-    O
galactose    O
and    O
kaempferol    O
,    O
whereas    O
its    O
two    O
products    O
are    O
UDP    O
and    O
trifolin    B-Glycoside114887305
.    O

Linamarin    B-Glycoside114887305
is    O
a    O
cyanogenic    O
glucoside    O
found    O
in    O
the    O
leaves    O
and    O
roots    O
of    O
plants    O
such    O
as    O
cassava    O
,    O
lima    O
beans    O
,    O
and    O
flax    O
.    O

Lotaustralin    O
is    O
the    O
glucoside    O
of    O
methyl    O
ethyl    O
ketone    O
cyanohydrin    O
and    O
is    O
structurally    O
related    O
to    O
linamarin    B-Glycoside114887305
,    O
the    O
acetone    O
cyanohydrin    O
glucoside    O
also    O
found    O
in    O
these    O
plants    O
.    O

decitabine    B-Glycoside114887305
(    O
INN    O
)    O

In    O
a    O
methotrexate    O
resistant    O
breast    O
cancer    O
cell    O
line    O
lacking    O
drug    O
uptake    O
and    O
folate    O
carrier    O
expression    O
,    O
administration    O
of    O
DAC    B-Glycoside114887305
,    O
a    O
DNA    O
methylation    O
inhibitor    O
,    O
effectively    O
improved    O
drug    O
uptake    O
and    O
folate    O
carrier    O
expression    O
.    O

However    O
,    O
when    O
rats    O
were    O
treated    O
with    O
the    O
DNMT    O
inhibitors    O
zebularine    B-Glycoside114887305
or    O
5-aza-2′-deoxycytidine    B-Glycoside114887305
immediately    O
after    O
fear    O
-    O
conditioning    O
,    O
they    O
demonstrated    O
reduced    O
learning    O
(    O
freezing    O
behavior    O
)    O
.    O

5-Aza-2'-deoxycytidine    O
(    O
decitabine    B-Glycoside114887305
)    O
is    O
a    O
nucleoside    O
analog    O
that    O
inhibits    O
DNMTs    O
by    O
trapping    O
them    O
in    O
a    O
covalent    O
complex    O
on    O
DNA    O
by    O
preventing    O
the    O
β-elimination    O
step    O
of    O
catalysis    O
,    O
thus    O
resulting    O
in    O
the    O
enzymes    O
'    O
degradation    O
.    O

Pulmonary    O
toxicity    O
,    O
or    O
lung    O
damage    O
,    O
can    O
occur    O
with    O
the    O
use    O
of    O
bleomycin    B-Glycoside114887305
in    O
ABVD    O
,    O
especially    O
when    O
radiation    O
therapy    O
to    O
the    O
chest    O
is    O
also    O
given    O
as    O
part    O
of    O
the    O
treatment    O
for    O
Hodgkin    O
's    O
lymphoma    O
.    O

Streptomyces    O
mobaraensis    O
"    O
produces    O
bleomycin    B-Glycoside114887305
,    O
detoxin    O
,    O
piericidin    O
A    O
,    O
piericidin    O
B    O
,    O
reticulol    O
and    O
transglutaminase    O
.    O

Exposure    O
to    O
certain    O
chemicals    O
such    O
as    O
salicylic    O
acid    O
,    O
bleomycin    B-Glycoside114887305
,    O
and    O
cisplatin    O
.    O

Chemicals    O
such    O
as    O
bleomycin    B-Glycoside114887305
,    O
tetracycline    O
(    O
e.g.    O
,    O
minocycline    O
)    O
,    O
povidone    O
-    O
iodine    O
,    O
or    O
a    O
slurry    O
of    O
talc    O
can    O
be    O
introduced    O
into    O
the    O
pleural    O
space    O
through    O
a    O
chest    O
drain    O
.    O

For    O
example    O
,    O
glyoxalase    O
I    O
resembles    O
several    O
proteins    O
that    O
allow    O
bacteria    O
to    O
resist    O
antibiotics    O
such    O
as    O
fosfomycin    O
,    O
bleomycin    B-Glycoside114887305
and    O
mitomycin    O
.    O

Phleomycins    O
are    O
a    O
group    O
of    O
glycopeptide    O
antibiotics    O
found    O
in    O
"    O
Streptomycin    O
"    O
which    O
are    O
closely    O
related    O
to    O
bleomycin    B-Glycoside114887305
.    O

EP2    O
expression    O
in    O
fibroblasts    O
from    O
the    O
lungs    O
of    O
mice    O
with    O
Bleomycin    B-Glycoside114887305
-    O
induced    O
pulmonary    O
fibrosis    O
and    O
humans    O
with    O
Idiopathic    O
pulmonary    O
fibrosis    O
is    O
greatly    O
reduced    O
.    O

"    O
PTGFR    O
"    O
knockout    O
mice    O
also    O
show    O
a    O
reduction    O
in    O
the    O
development    O
of    O
pulmonary    O
fibrosis    O
normally    O
caused    O
by    O
microbial    O
invasion    O
or    O
bleomycin    B-Glycoside114887305
treatment    O
.    O

On    O
the    O
other    O
hand    O
,    O
IP    O
receptors    O
may    O
serve    O
to    O
promote    O
non    O
-    O
allergic    O
inflammatory    O
responses    O
:    O
IP    O
receptor    O
-    O
deficient    O
mice    O
exhibited    O
increased    O
lung    O
inflammation    O
in    O
a    O
model    O
of    O
bleomycin    B-Glycoside114887305
-    O
induced    O
pulmonary    O
fibrosis    O
while    O
mice    O
made    O
to    O
over    O
-    O
express    O
the    O
PGI2-forming    O
enzyme    O
,    O
Prostacyclin    O
synthase    O
,    O
in    O
their    O
airway    O
epithelial    O
cells    O
were    O
protected    O
against    O
lung    O
injury    O
in    O
this    O
model    O
.    O

Certain    O
drugs    O
such    O
as    O
amiodarone    O
,    O
bleomycin    B-Glycoside114887305
and    O
methotrexate    O
.    O

Exposure    O
of    O
"    O
Sulfolobus    O
solfataricus    O
"    O
to    O
the    O
DNA    O
damaging    O
agents    O
UV    O
-    O
irradiation    O
,    O
bleomycin    B-Glycoside114887305
or    O
mitomycin    O
C    O
induces    O
cellular    O
aggregation    O
.    O

5-methylcytidine    B-Glycoside114887305
,    O
m5C    O
,    O
is    O
abundantly    O
found    O
in    O
mRNA    O
and    O
ncRNAs    O
,    O
especially    O
tRNA    O
and    O
rRNAs    O
.    O

In    O
DNA    O
,    O
the    O
most    O
common    O
modified    O
base    O
is    O
5-methylcytidine    B-Glycoside114887305
(    O
m5C    O
)    O
.    O

Neomogroside    B-Glycoside114887305
is    O
a    O
cucurbitane    O
glycoside    O
isolated    O
from    O
the    O
fruit    O
of    O
"    O
Siraitia    O
grosvenorii    O
"    O
.    O

Examples    O
include    O
amygdalin    O
and    O
prunasin    B-Glycoside114887305
which    O
are    O
made    O
by    O
the    O
bitter    O
almond    O
tree    O
;    O
other    O
species    O
that    O
produce    O
cyanogenic    O
glycosides    O
are    O
sorghum    O
(    O
from    O
which    O
dhurrin    B-Glycoside114887305
,    O
the    O
first    O
cyanogenic    O
glycoside    O
to    O
be    O
identified    O
,    O
was    O
first    O
isolated    O
)    O
,    O
barley    O
,    O
flax    O
,    O
white    O
clover    O
,    O
and    O
cassava    O
,    O
which    O
produces    O
linamarin    B-Glycoside114887305
and    O
lotaustralin    B-Glycoside114887305
.    O

Thiocolchicoside    B-Glycoside114887305

The    O
plant    O
family    O
contains    O
some    O
interesting    O
alkaloids    O
,    O
coumarins    O
,    O
furano    O
coumarins    O
,    O
and    O
pryanocoumarins    O
,    O
ancetophenones    O
such    O
as    O
Zantholoxylin    O
,    O
flavanoids    O
like    O
amurensin    B-Glycoside114887305
,    O
and    O
polyhydroxol    O
flavainoids    O
,    O
and    O
Amides    O
.    O

Fraxin    B-Glycoside114887305
is    O
a    O
glucoside    O
of    O
fraxetin    O
.    O

The    O
fluid    O
also    O
contains    O
alkaloids    O
,    O
such    O
as    O
arbutin    B-Glycoside114887305
.    O

According    O
to    O
Lewis    O
and    O
Elvin    O
-    O
Lewis    O
,    O
the    O
active    O
compounds    O
within    O
"    O
Kalmia    O
polifolia    O
"    O
include    O
andromedotoxin    O
and    O
arbutin    B-Glycoside114887305
.    O

No    O
acid    O
is    O
produced    O
from    O
adonitol    O
,    O
arabinose    O
,    O
arbutin    B-Glycoside114887305
,    O
cellobiose    O
,    O
dulcitol    O
,    O
fucose    O
,    O
galactose    O
,    O
inositol    O
,    O
inulin    O
,    O
lactose    O
,    O
maltose    O
,    O
mannitol    O
,    O
mannose    O
,    O
melezitose    O
,    O
melibiose    O
,    O
raffinose    O
,    O
rhamnose    O
,    O
ribose    O
,    O
salicin    B-Glycoside114887305
,    O
sorbose    O
,    O
or    O
tagatose    O
.    O

The    O
defect    O
in    O
red    O
cell    O
DNA    O
synthesis    O
is    O
most    O
often    O
due    O
to    O
hypovitaminosis    O
,    O
specifically    O
a    O
deficiency    O
of    O
vitamin    B-Glycoside114887305
B    I-Glycoside114887305
and/or    O
folic    O
acid    O
.    O

Selective    O
vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
malabsorption    O
(    O
congenital    O
—    O
juvenile    O
megaloblastic    O
anemia    O
1—and    O
drug    O
-    O
induced    O
)    O

A    O
,    O
D3    O
,    O
E    O
,    O
B6    O
,    O
B12    B-Glycoside114887305
,    O
folic    O
acid    O
(    O
B9    O
)    O
,    O
ascorbic    O
acid    O
(    O
vitamin    O
C    O
)    O
,    O
along    O
with    O
a    O
vitamin    O
K    O
derivative    O
,    O
menadione    O
sodium    O
bisulfite    O
DVL    O
adds    O
these    O
vitamins    O
to    O
an    O
electrolyte    O
premix    O
that    O
has    O
7    O
mineral    O
salts    O
:    O
magnesium    O
acetate    O
,    O
sodium    O
acetate    O
,    O
calcium    O
acetate    O
,    O
potassium    O
chloride    O
,    O
calcium    O
chloride    O
,    O
sodium    O
chloride    O
and    O
sodium    O
diacetate    O
.    O

vitamins    O
(    O
folic    O
acid    O
,    O
nicotinamide    O
,    O
riboflavin    O
,    O
B12    B-Glycoside114887305
)    O

Patients    O
should    O
take    O
folic    O
acid    O
and    O
vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
supplement    O
even    O
if    O
levels    O
are    O
normal    O
when    O
they    O
are    O
on    O
pemetrexed    O
therapy    O
.    O

Vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
,    O
folic    O
acid    O
and    O
other    O
anti    O
-    O
megaloblastic    O
-    O
anaemia    O
preparations    O

Vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
deficiency    O
anaemia    O

Vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
deficiency    O
anaemia    O
due    O
to    O
intrinsic    O
factor    O
deficiency    O

Vitamin    B-Glycoside114887305
B    I-Glycoside114887305
12    I-Glycoside114887305
deficiency    O
anaemia    O
due    O
to    O
selective    O
vitamin    B-Glycoside114887305
B    I-Glycoside114887305
12    I-Glycoside114887305
malabsorption    O
with    O
proteinuria    O

Other    O
dietary    O
vitamin    B-Glycoside114887305
B    I-Glycoside114887305
12    I-Glycoside114887305
deficiency    O
anaemia    O

Other    O
vitamin    B-Glycoside114887305
B    I-Glycoside114887305
12    I-Glycoside114887305
deficiency    O
anaemias    O

Vitamin    B-Glycoside114887305
B    I-Glycoside114887305
12    I-Glycoside114887305
deficiency    O
anaemia    O
,    O
unspecified    O

It    O
has    O
3    O
cofactors    O
:    O
pyridoxal    O
phosphate    O
,    O
Cobamide    B-Glycoside114887305
coenzyme    I-Glycoside114887305
,    O
and    O
Dithiothreitol    O
.    O

Vitamin    B-Glycoside114887305
B12    I-Glycoside114887305

Vitamin    B-Glycoside114887305
B12    I-Glycoside114887305

One    O
study    O
in    O
2014    O
pointed    O
to    O
certain    O
species    O
of    O
seaweed    O
as    O
being    O
a    O
possible    O
vegan    O
source    O
of    O
biologically    O
-    O
active    O
Vitamin    B-Glycoside114887305
B-12    I-Glycoside114887305
.    O

Diseases    O
that    O
may    O
present    O
similar    O
to    O
an    O
anxiety    O
disorder    O
,    O
including    O
certain    O
endocrine    O
diseases    O
(    O
hypo-    O
and    O
hyperthyroidism    O
,    O
hyperprolactinemia    O
)    O
,    O
metabolic    O
disorders    O
(    O
diabetes    O
)    O
,    O
deficiency    O
states    O
(    O
low    O
levels    O
of    O
vitamin    O
D    O
,    O
B2    O
,    O
B12    B-Glycoside114887305
,    O
folic    O
acid    O
)    O
,    O
gastrointestinal    O
diseases    O
(    O
celiac    O
disease    O
,    O
non    O
-    O
celiac    O
gluten    O
sensitivity    O
,    O
inflammatory    O
bowel    O
disease    O
)    O
,    O
heart    O
diseases    O
,    O
blood    O
diseases    O
(    O
anemia    O
)    O
,    O
and    O
brain    O
degenerative    O
diseases    O
(    O
Parkinson    O
's    O
disease    O
,    O
dementia    O
,    O
multiple    O
sclerosis    O
,    O
Huntington    O
's    O
disease    O
)    O
.    O

Vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
,    O
or    O
cobalamin    O
,    O
acts    O
as    O
a    O
cofactor    O
for    O
the    O
enzyme    O
methionine    O
synthase    O
(    O
which    O
forms    O
part    O
of    O
the    O
S-adenosylmethionine    B-Glycoside114887305
(    O
SAMe    O
)    O
biosynthesis    O
and    O
regeneration    O
cycle    O
)    O
.    O

The    O
"    O
FIGLU    O
"    O
test    O
is    O
used    O
to    O
identify    O
deficiency    O
of    O
vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
or    O
folate    O
deficiency    O
or    O
liver    O
disease    O
.    O

Indomie    O
is    O
made    O
from    O
flour    O
supplied    O
by    O
Bogasari    O
flour    O
mills    O
,    O
and    O
fortified    O
with    O
vitamin    O
A    O
,    O
B1    O
,    O
B6    O
,    O
B12    B-Glycoside114887305
,    O
niacin    O
,    O
folic    O
acid    O
and    O
iron    O
.    O

He    O
is    O
best    O
known    O
for    O
his    O
development    O
of    O
rapid    O
-    O
reaction    O
techniques    O
,    O
including    O
stopped    O
flow    O
and    O
rapid    O
freeze    O
-    O
quench    O
EPR    O
methods    O
,    O
as    O
tools    O
to    O
study    O
the    O
mechanisms    O
of    O
enzymes    O
containing    O
flavin    O
,    O
iron    O
,    O
cobalamin    B-Glycoside114887305
,    O
or    O
pyridoxal    O
phosphate    O
cofactors    O
.    O

Vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
,    O
vitamin    O
C    O
and    O
thiamin    O

Vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
deficiency    O
can    O
cause    O
demyelination    O
.    O

Hyperhomocysteine    O
,    O
a    O
condition    O
known    O
to    O
promote    O
clots    O
,    O
can    O
be    O
caused    O
by    O
a    O
combination    O
of    O
genetic    O
factors    O
and    O
vitamin    O
B6    O
,    O
vitamin    B-Glycoside114887305
b12    I-Glycoside114887305
and    O
folic    O
acid    O
deficiency    O
.    O

This    O
vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
enzyme    O
catalyzes    O
the    O
isomerization    O
of    O
methylmalonyl    O
-    O
CoA    O
to    O
succinyl    O
-    O
CoA    O
in    O
humans    O
.    O

Regarding    O
autism    O
,    O
James    O
'    O
view    O
is    O
that    O
the    O
transsulfuration    O
pathway    O
is    O
disrupted    O
in    O
autistic    O
children    O
,    O
resulting    O
in    O
these    O
children    O
being    O
deficient    O
in    O
glutathione    O
,    O
as    O
well    O
as    O
vitamins    O
such    O
as    O
vitamin    O
B6    O
and    O
vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
,    O
and    O
that    O
maternal    O
glutathione    O
deficiency    O
may    O
also    O
be    O
a    O
risk    O
factor    O
for    O
autism    O
.    O

Nitrous    O
oxide    O
is    O
thought    O
to    O
be    O
particularly    O
non    O
-    O
toxic    O
,    O
though    O
heavy    O
long    O
-    O
term    O
use    O
can    O
lead    O
to    O
a    O
variety    O
of    O
serious    O
health    O
problems    O
linked    O
to    O
destruction    O
of    O
vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
and    O
folic    O
acid    O
.    O

Vitamin    B-Glycoside114887305
B12    I-Glycoside114887305

The    O
rings    O
of    O
porphyrin    O
are    O
components    O
of    O
hemoglobin    O
,    O
myoglobin    O
,    O
vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
,    O
chlorophyll    O
,    O
and    O
cytochromes    O
.    O

H.    O
Boyd    O
Woodruff    O
(    O
1917    O
-    O
2017    O
)    O
,    O
soil    O
microbiologist    O
who    O
discovered    O
actinomycin    O
and    O
developed    O
industrial    O
production    O
by    O
fermentation    O
of    O
many    O
natural    O
products    O
,    O
including    O
cyanocobalamin    O
(    O
a    O
synthetic    O
form    O
of    O
Vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
)    O
,    O
the    O
avermectins    O
and    O
other    O
important    O
antibiotics    O
.    O

In    O
nature    O
,    O
vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
and    O
its    O
many    O
derivatives    O
contain    O
reactive    O
Co    O
-    O
alkyl    O
bonds    O
.    O

|rowspan=2|    O
Vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
(    O
Cobalamin    O
)    O

Vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
,    O
also    O
called    O
cobalamin    O
,    O
is    O
a    O
water    O
-    O
soluble    O
vitamin    O
that    O
has    O
a    O
key    O
role    O
in    O
the    O
normal    O
functioning    O
of    O
the    O
brain    O
and    O
nervous    O
system    O
via    O
the    O
synthesis    O
of    O
myelin    O
(    O
myelinogenesis    O
)    O
,    O
and    O
the    O
formation    O
of    O
red    O
blood    O
cells    O
.    O

Cyanocobalamin    O
is    O
a    O
synthetic    O
form    O
of    O
vitamin    B-Glycoside114887305
.    O
Vitamin    O
is    O
the    O
"    O
generic    O
descriptor    O
"    O
name    O
for    O
any    O
vitamers    O
of    O
vitamin    O
.    O

Vitamin    B-Glycoside114887305
B12    I-Glycoside114887305

A    O
corrole    O
is    O
an    O
aromatic    O
organic    O
chemical    O
tetrapyrrole    O
,    O
the    O
structure    O
of    O
which    O
is    O
similar    O
to    O
the    O
corrin    O
ring    O
,    O
which    O
is    O
also    O
present    O
in    O
cobalamin    O
(    O
vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
)    O
.    O

Insects    O
such    O
as    O
crickets    O
and    O
meal    O
worms    O
have    O
high    O
concentrations    O
of    O
amino    O
acids    O
,    O
vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
,    O
riboflavin    O
and    O
vitamin    O
A.    O
Insect    O
farming    O
is    O
cheaper    O
than    O
other    O
livestock    O
farming    O
and    O
requires    O
much    O
less    O
energy    O
and    O
space    O
.    O

Mary    O
Shaw    O
Shorb    O
,    O
research    O
scientist    O
,    O
invented    O
first    O
method    O
to    O
assay    O
Vitamin    B-Glycoside114887305
B-12    I-Glycoside114887305

A    O
small    O
serving    O
of    O
sardines    O
once    O
a    O
day    O
can    O
provide    O
up    O
to    O
13%    O
of    O
the    O
RDA    O
(    O
recommended    O
daily    O
allowance    O
)    O
value    O
of    O
vitamin    O
B2    O
;    O
roughly    O
one    O
-    O
quarter    O
of    O
the    O
RDA    O
of    O
niacin    O
,    O
and    O
about    O
150%    O
of    O
the    O
RDA    O
of    O
vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
.    O

Before    O
this    O
procedure    O
is    O
undertaken    O
,    O
a    O
patient    O
will    O
generally    O
have    O
had    O
other    O
blood    O
tests    O
to    O
find    O
diagnostic    O
clues    O
,    O
including    O
a    O
complete    O
blood    O
count    O
,    O
renal    O
function    O
and    O
electrolytes    O
,    O
liver    O
enzymes    O
,    O
thyroid    O
function    O
tests    O
,    O
vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
and    O
folic    O
acid    O
levels    O
.    O

He    O
made    O
significant    O
contributions    O
to    O
developing    O
a    O
therapy    O
for    O
vitamin    B-Glycoside114887305
B-12    I-Glycoside114887305
deficiency    O
.    O

Individual    O
fruits    O
weigh    O
between    O
270    O
and    O
480    O
mg    O
and    O
contain    O
high    O
amounts    O
of    O
vitamin    O
C    O
,    O
vitamin    O
E    O
,    O
carotenoids    O
,    O
flavonoids    O
and    O
health    O
-    O
beneficial    O
fatty    O
acids    O
,    O
as    O
well    O
as    O
higher    O
amounts    O
of    O
vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
than    O
other    O
fruits    O
.    O

He    O
would    O
later    O
claim    O
to    O
have    O
received    O
a    O
tainted    O
Vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
shot    O
from    O
teammate    O
Miguel    O
Tejada    O
.    O

The    O
failure    O
of    O
the    O
electrical    O
insulation    O
surrounding    O
nerves    O
,    O
the    O
myelin    O
,    O
is    O
seen    O
in    O
certain    O
deficiency    O
diseases    O
,    O
such    O
as    O
the    O
failure    O
of    O
the    O
body    O
's    O
system    O
for    O
absorbing    O
vitamin    B-Glycoside114887305
B-12    I-Glycoside114887305

Vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
is    O
depleted    O
by    O
recreational    O
use    O
of    O
nitrous    O
oxide    O
,    O
and    O
is    O
thereby    O
useful    O
.    O

Haptocorrin    O
(    O
also    O
known    O
as    O
R    O
-    O
factor    O
)    O
:    O
Helps    O
with    O
the    O
absorption    O
of    O
vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
.    O

Congenital    O
disorders    O
of    O
the    O
stomach    O
include    O
pernicious    O
anaemia    O
,    O
in    O
which    O
a    O
targeted    O
immune    O
response    O
against    O
parietal    O
cells    O
results    O
in    O
an    O
inability    O
to    O
absorb    O
vitamin    O
B12    B-Glycoside114887305
.    O

The    O
claims    O
of    O
Metabolite    O
's    O
patent    O
include    O
the    O
correlation    O
between    O
levels    O
of    O
homocysteine    O
and    O
vitamins    O
B6    O
and    O
B12    B-Glycoside114887305
.    O

Carbohydrates    O
,    O
fat    O
,    O
protein    O
,    O
niacin    O
,    O
pantothenic    O
acid    O
,    O
vitamin    O
B2    O
,    O
vitamin    O
B6    O
,    O
vitamin    B-Glycoside114887305
B12    I-Glycoside114887305
,    O
caffeine    O
,    O
taurine    O
.    O

It    O
contains    O
no    O
lactose    O
or    O
cholesterol    O
,    O
and    O
is    O
usually    O
sold    O
with    O
added    O
calcium    O
and    O
vitamins    O
,    O
especially    O
B12    B-Glycoside114887305
.    O

Fischer    O
glycosidation    O
of    O
glucose    O
to    O
produce    O
methyl    B-Glycoside114887305
glucoside    I-Glycoside114887305
using    O
trimethylsilylchloride    O
as    O
catalyst    O
..    O

Methyl    B-Glycoside114887305
alpha-D-glucopyranoside    I-Glycoside114887305
(    O
C7H14O6    O
)    O

The    O
primary    O
function    O
of    O
pigments    O
in    O
plants    O
is    O
photosynthesis    O
,    O
which    O
uses    O
the    O
green    O
pigment    O
chlorophyll    O
along    O
with    O
several    O
red    O
and    O
yellow    O
pigments    O
including    O
porphyrins    O
,    O
carotenoids    O
,    O
anthocyanin    B-Glycoside114887305
and    O
betalain    B-Glycoside114887305
.    O

The    O
flowers    O
are    O
funnel    O
-    O
shaped    O
and    O
range    O
from    O
7    O
mm    O
to    O
40    O
mm    O
and    O
more    O
in    O
length    O
and    O
in    O
diameter    O
,    O
from    O
white    O
and    O
greenish    O
to    O
yellow    O
,    O
pink    O
and    O
red    O
in    O
colour    O
,    O
often    O
with    O
a    O
darker    O
mid    O
-    O
stripe    O
;    O
the    O
reddish    O
hues    O
are    O
due    O
to    O
betalain    B-Glycoside114887305
pigments    O
as    O
usual    O
for    O
Caryophyllales    O
.    O

This    O
fruit    O
is    O
one    O
of    O
the    O
few    O
to    O
have    O
indicaxanthin    O
,    O
a    O
betalain    B-Glycoside114887305
,    O
a    O
type    O
of    O
plant    O
pigment    O
antioxidant    O
.    O

Eight    O
betaxanthin    B-Glycoside114887305
(    O
indicaxanthin    O
,    O
vulgaxanthin    O
-    O
I    O
,    O
miraxanthin    O
-    O
I    O
,    O
-II    O
,    O
-III    O
,    O
-IV    O
,    O
-V    O
and    O
-VI    O
)    O
can    O
be    O
isolated    O
from    O
"    O
M.    O
jalapa    O
"    O
flowers    O
.    O

Also    O
a    O
synthetic    O
dye    O
was    O
named    O
"    O
amaranth    O
"    O
for    O
its    O
similarity    O
in    O
color    O
to    O
the    O
natural    O
amaranth    O
pigments    O
known    O
as    O
betalain    B-Glycoside114887305
.    O

It    O
catalyses    O
the    O
condensation    O
of    O
tryptamine    O
with    O
secologanin    B-Glycoside114887305
to    O
form    O
strictosidine    O
:    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
tryptamine    O
and    O
secologanin    B-Glycoside114887305
,    O
whereas    O
its    O
two    O
products    O
are    O
3-alpha(S)-strictosidine    O
and    O
H2O.    O

Acid    O
is    O
not    O
formed    O
aerobically    O
from    O
D    O
-    O
raffinose    O
,    O
ribose    O
,    O
D    O
-    O
cellobiose    O
,    O
D    O
-    O
arabinose    O
,    O
L    O
-    O
xylose    O
,    O
adonitol    O
,    O
methyl    O
-    O
D    O
-    O
xyloside    B-Glycoside114887305
,    O
rhamnose    O
,    O
L    O
-    O
sorbose    O
,    O
dulcitol    O
,    O
starch    O
,    O
inositol    O
,    O
methyl    O
-    O
D    O
-    O
mannoside    O
,    O
methyl    O
-    O
D    O
-    O
glucoside    O
,    O
amygdalin    O
,    O
melibiose    O
,    O
melezitose    O
,    O
gentiobiose    O
,    O
glycogen    O
,    O
inulin    O
,    O
D    O
-    O
tagatose    O
,    O
D    O
-    O
lyxose    O
,    O
cellobiose    O
,    O
D    O
-    O
fucose    O
,    O
L    O
-    O
fucose    O
,    O
L    O
-    O
arabitol    O
,    O
gluconate    O
,    O
2-ketogluconate    O
or    O
5-ketogluconate    O
.    O

Major    O
anthocyanins    B-Glycoside114887305
in    O
blackcurrant    O
pomace    O
are    O
delphinidin-3-O-glucoside    B-Glycoside114887305
,    O
delphinidin-3-O    O
-    O
rutinoside    O
,    O
cyanidin-3-O-glucoside    B-Glycoside114887305
,    O
and    O
cyanidin-3-O-rutinoside    B-Glycoside114887305
which    O
are    O
retained    O
in    O
the    O
juice    O
concentrate    O
among    O
other    O
yet    O
unidentified    O
polyphenols    O
.    O

Myrtillin    B-Glycoside114887305
is    O
an    O
anthocyanin    B-Glycoside114887305
.    O

For    O
example    O
,    O
its    O
leaves    O
have    O
been    O
analyzed    O
to    O
have    O
triterpenes    O
(    O
friedelin    O
,    O
friedelinol    O
and    O
β-amyrin    O
)    O
,    O
flavonol    O
glycosides    O
(    O
hibifolin    B-Glycoside114887305
,    O
triflin    O
and    O
melocorin    O
)    O
,    O
aliphatic    O
compounds    O
,    O
flavonoids    O
(    O
vitexin    B-Glycoside114887305
and    O
robunin    O
)    O
,    O
β-D    O
-    O
sitosterol    O
β-D    O
-    O
glucoside    O
and    O
alkaloids    O
.    O

Neohesperidin    B-Glycoside114887305
dihydrochalcone    I-Glycoside114887305
,    O
an    O
artificial    O
sweetener    O
derived    O
from    O
citrus    O

Strictinin    B-Glycoside114887305
,    O
an    O
ellagitannin    O

Scutellarin    B-Glycoside114887305
is    O
transformed    O
by    O
hydrolysis    O
into    O
scutellarein    O
.    O

Also    O
,    O
the    O
flavonoid    O
narirutin    B-Glycoside114887305
is    O
said    O
to    O
be    O
the    O
active    O
chemical    O
in    O
the    O
Wakayama    O
Prefecture    O
specialty    O
"    O
citrus    O
jabara    O
"    O
juice    O
(    O
ja:ジャバラ    O
)    O
that    O
is    O
said    O
to    O
diminish    O
the    O
effects    O
of    O
pollen    O
allergies    O
.    O

Solamargine    B-Glycoside114887305

Phillyrin    B-Glycoside114887305
is    O
an    O
endophytic    O
fungal    O
isolate    O
with    O
anti    O
-    O
obesity    O
activity    O
.    O

First    O
rhamnosidase    O
breaks    O
naringin    O
into    O
prunin    B-Glycoside114887305
and    O
rhamnose    O
.    O

Chemical    O
compounds    O
isolated    O
from    O
"    O
E.    O
alsinoides    O
"    O
include    O
scopoletin    O
,    O
umbelliferone    O
,    O
scopolin    B-Glycoside114887305
and    O
2-methyl-1,2,3,4-butanetetrol    O
.    O

Hydroxyethylrutoside    B-Glycoside114887305
,    O
synthetic    O
hydroxyethyl    O
acetylations    O
of    O
rutin    O
,    O
are    O
used    O
in    O
the    O
treatment    O
of    O
chronic    O
venous    O
insufficiency    O
.    O

Okanin    B-Glycoside114887305
4'-O-glucoside    I-Glycoside114887305
or    O
marein    O
,    O
a    O
chalconoid    O
glucoside    O

Xanthorhamnin    B-Glycoside114887305
is    O
a    O
chemical    O
compound    O
.    O

File    O
:    O
Eleutheroside    O
Eleutheroside    B-Glycoside114887305
D    I-Glycoside114887305

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
UDP    O
-    O
glucose    O
and    O
indoxyl    O
,    O
whereas    O
its    O
two    O
products    O
are    O
UDP    O
and    O
indican    B-Glycoside114887305
.    O

They    O
are    O
soaked    O
in    O
water    O
and    O
fermented    O
in    O
order    O
to    O
convert    O
the    O
glycoside    O
indican    B-Glycoside114887305
naturally    O
present    O
in    O
the    O
plant    O
to    O
the    O
blue    O
dye    O
indigotin    O
.    O

PreQ1-III    O
riboswitches    O
are    O
a    O
class    O
of    O
riboswitches    O
that    O
bind    O
pre    O
-    O
queuosine1    O
(    O
PreQ1    O
)    O
,    O
a    O
precursor    O
to    O
the    O
modified    O
nucleoside    O
queuosine    B-Glycoside114887305
.    O

cytarabine    B-Glycoside114887305

Cytarabine    B-Glycoside114887305

These    O
compounds    O
led    O
to    O
the    O
synthesis    O
of    O
a    O
new    O
generation    O
,    O
sugar    O
modified    O
nucleoside    O
analog    O
vidarabine    O
,    O
and    O
the    O
related    O
compound    O
cytarabine    B-Glycoside114887305
.    O

Pyrimidine    O
antagonists    O
(    O
cytarabine    B-Glycoside114887305
)    O

File    O
:    O
Cytarabine    B-Glycoside114887305

Additionally    O
,    O
omigapil    O
can    O
prevent    O
NMDA    O
and    O
kainate    O
receptor    O
excitotoxicity    O
in    O
rat    O
cortical    O
neurons    O
as    O
well    O
as    O
toxicity    O
from    O
cytosine    B-Glycoside114887305
arabinoside    I-Glycoside114887305
(    O
ara    O
C    O
)    O
in    O
cerebellar    O
granule    O
cells    O
.    O

The    O
patient    O
was    O
prescribed    O
six    O
oral    O
drugs    O
,    O
intrathecal    O
cytarabine    B-Glycoside114887305
and    O
intravenous    O
vincristine    O
by    O
another    O
doctor    O
,    O
and    O
was    O
injected    O
by    O
the    O
trainee    O
later    O
the    O
day    O
.    O

Cytarabine    B-Glycoside114887305
,    O
a    O
DNA    O
-    O
synthesis    O
inhibitor    O
also    O
known    O
as    O
ara    O
-    O
C    O
,    O
is    O
cited    O
as    O
the    O
classic    O
cell    O
cycle    O
phase    O
-    O
specific    O
agent    O
.    O

Phleomycin    B-Glycoside114887305
D1    I-Glycoside114887305
(    O
zeocin    O
)    O

Siamenoside    B-Glycoside114887305

This    O
is    O
one    O
of    O
several    O
"    O
Solanum    O
"    O
species    O
that    O
contain    O
solasodine    B-Glycoside114887305
.    O

Solasodine    B-Glycoside114887305

Malvin    B-Glycoside114887305
is    O
a    O
naturally    O
occurring    O
chemical    O
of    O
the    O
anthocyanin    B-Glycoside114887305
family    O
.    O

This    O
coloration    O
has    O
been    O
shown    O
to    O
be    O
an    O
example    O
of    O
copigmentation    O
,    O
a    O
result    O
of    O
the    O
presence    O
of    O
malvin    B-Glycoside114887305
(    O
an    O
anthocyanin    B-Glycoside114887305
)    O
and    O
saponarin    O
in    O
the    O
ratio    O
1:9    O
.    O

dexelvucitabine    B-Glycoside114887305
(    O
USAN    O
,    O
INN    O
)    O

Lactitol    O
,    O
erythritol    O
,    O
sorbitol    O
,    O
xylitol    O
,    O
mannitol    O
,    O
and    O
maltitol    B-Glycoside114887305
are    O
all    O
sugar    O
alcohols    O
.    O

Sugar    O
free    O
marzipan    O
can    O
be    O
made    O
by    O
replacing    O
sugar    O
with    O
polyols    O
such    O
as    O
maltitol    B-Glycoside114887305
.    O

They    O
include    O
short    O
chain    O
oligo    O
-    O
saccharide    O
polymers    O
of    O
fructose    O
(    O
fructans    O
)    O
and    O
galactooligosaccharides    O
(    O
GOS    O
,    O
stachyose    O
,    O
raffinose    O
)    O
,    O
disaccharides    O
(    O
lactose    O
)    O
,    O
monosaccharides    O
(    O
fructose    O
)    O
,    O
and    O
sugar    O
alcohols    O
(    O
polyols    O
)    O
,    O
such    O
as    O
sorbitol    O
,    O
mannitol    O
,    O
xylitol    O
and    O
maltitol    B-Glycoside114887305
.    O

They    O
are    O
also    O
used    O
as    O
bulk    O
sweeteners    O
and    O
include    O
isomalt    O
,    O
maltitol    B-Glycoside114887305
,    O
mannitol    O
,    O
sorbitol    O
and    O
xylitol    O
.    O

Rutin    O
is    O
also    O
an    O
antioxidant    O
;    O
compared    O
to    O
quercetin    O
,    O
acacetin    O
,    O
morin    O
,    O
hispidulin    O
,    O
hesperidin    B-Glycoside114887305
,    O
and    O
naringin    B-Glycoside114887305
,    O
it    O
was    O
found    O
to    O
be    O
the    O
strongest    O
.    O

Naringin    B-Glycoside114887305

Naringenin    O
(    O
metabolized    O
from    O
naringin    B-Glycoside114887305
)    O

If    O
the    O
glycone    O
group    O
of    O
a    O
glycoside    O
is    O
glucose    O
,    O
then    O
the    O
molecule    O
is    O
a    O
glucoside    O
;    O
if    O
it    O
is    O
fructose    O
,    O
then    O
the    O
molecule    O
is    O
a    O
fructoside    B-Glycoside114887305
;    O
if    O
it    O
is    O
glucuronic    O
acid    O
,    O
then    O
the    O
molecule    O
is    O
a    O
glucuronide    B-Glycoside114887305
;    O
etc    O
.    O

Cladribine    B-Glycoside114887305
is    O
an    O
anti    O
-    O
neoplastic    O
agent    O
used    O
in    O
the    O
treatment    O
of    O
hairy    O
cell    O
leukemia    O
;    O
its    O
mechanism    O
of    O
action    O
is    O
inhibition    O
of    O
adenosine    O
deaminase    O
.    O

Cladribine    B-Glycoside114887305
and    O
clofarabine    O
are    O
two    O
other    O
drugs    O
being    O
investigated    O
in    O
MCL    O
.    O

Cladribine    B-Glycoside114887305
is    O
a    O
medication    O
used    O
to    O
treat    O
hairy    O
cell    O
leukemia    O
(    O
HCL    O
,    O
leukemic    O
reticuloendotheliosis    O
)    O
and    O
B    O
-    O
cell    O
chronic    O
lymphocytic    O
leukemia    O
.    O

Melitidin    B-Glycoside114887305

Hence    O
,    O
this    O
enzyme    O
has    O
one    O
substrate    O
,    O
UDP-glucuronate    B-Glycoside114887305
,    O
and    O
one    O
product    O
,    O
UDP    O
-    O
D    O
-    O
galacturonate    O
.    O

Hence    O
,    O
this    O
enzyme    O
has    O
one    O
substrate    O
,    O
UDP-glucuronate    B-Glycoside114887305
,    O
and    O
one    O
product    O
,    O
UDP    O
-    O
L    O
-    O
iduronate    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
UTP    O
and    O
1-phospho    O
-    O
alpha    O
-    O
D    O
-    O
glucuronate    O
,    O
whereas    O
its    O
two    O
products    O
are    O
diphosphate    O
and    O
UDP-glucuronate    B-Glycoside114887305
.    O

X-gal    B-Glycoside114887305
plates    O
are    O
differential    O
for    O
lac    O
operon    O
mutants    O
.    O

Typically    O
,    O
the    O
lactose    O
analog    O
is    O
X-Gal    B-Glycoside114887305
,    O
which    O
produces    O
a    O
blue    O
colour    O
when    O
cleaved    O
by    O
beta    O
-    O
galactosidase    O
.    O

When    O
media    O
containing    O
certain    O
galactosides    O
(    O
e.g.    O
X-gal    B-Glycoside114887305
)    O
is    O
added    O
,    O
cells    O
expressing    O
the    O
gene    O
convert    O
the    O
X    O
-    O
gal    O
to    O
a    O
blue    O
product    O
and    O
can    O
be    O
seen    O
with    O
the    O
naked    O
eye    O
.    O

Gluconasturtiin    B-Glycoside114887305

Papulacandin    B-Glycoside114887305
B    I-Glycoside114887305

Brutieridin    B-Glycoside114887305
is    O
a    O
flavanone    O
glycoside    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S-adenosylmethioninamine    B-Glycoside114887305
and    O
propane-1,3-diamine    O
,    O
whereas    O
its    O
two    O
products    O
are    O
5'-methylthioadenosine    O
and    O
bis(3-aminopropyl)amine    O
.    O

These    O
bacteria    O
lack    O
peptidoglycan    B-Glycoside114887305
in    O
their    O
cell    O
wall    O
and    O
have    O
a    O
compartmentalized    O
cytoplasm    O
.    O

As    O
with    O
all    O
other    O
organisms    O
within    O
the    O
order    O
Planctomycetes    O
,    O
the    O
cell    O
wall    O
does    O
not    O
contain    O
peptidoglycan    B-Glycoside114887305
.    O

The    O
muralytic    O
(    O
peptidoglycan    B-Glycoside114887305
-    O
digesting    O
)    O
enzyme    O
,    O
P5    O
,    O
then    O
digests    O
a    O
portion    O
of    O
the    O
cell    O
wall    O
,    O
and    O
the    O
nucleocapsid    O
enters    O
the    O
cell    O
coated    O
with    O
the    O
bacterial    O
outer    O
membrane    O
.    O

OBPgp279    O
is    O
an    O
endolysin    O
that    O
hydrolyzes    O
peptidoglycan    B-Glycoside114887305
,    O
a    O
major    O
constituent    O
in    O
bacterial    O
membrane    O
.    O

It    O
is    O
bactericidal    O
and    O
acts    O
by    O
inhibiting    O
synthesis    O
of    O
the    O
peptidoglycan    B-Glycoside114887305
layer    O
of    O
the    O
bacterial    O
cell    O
wall    O
.    O

This    O
penetration    O
mechanism    O
can    O
involve    O
electrochemical    O
membrane    O
potential    O
,    O
ATP    O
molecules    O
,    O
enzymatic    O
splitting    O
of    O
peptidoglycan    B-Glycoside114887305
layer    O
,    O
or    O
all    O
three    O
of    O
these    O
factor    O
can    O
be    O
vital    O
for    O
the    O
penetration    O
of    O
the    O
nucleic    O
acid    O
inside    O
the    O
bacterial    O
cell    O
.    O

This    O
layered    O
structure    O
is    O
called    O
peptidoglycan    B-Glycoside114887305
.    O

D    O
-    O
glutamate    O
is    O
a    O
monomer    O
of    O
the    O
peptidoglycan    B-Glycoside114887305
layer    O
in    O
prokaryotic    O
cell    O
walls    O
.    O

Its    O
composition    O
is    O
distinct    O
from    O
that    O
of    O
the    O
inner    O
cytoplasmic    O
cell    O
membrane    O
-    O
among    O
other    O
things    O
,    O
the    O
outer    O
leaflet    O
of    O
the    O
outer    O
membrane    O
of    O
many    O
gram    O
-    O
negative    O
bacteria    O
includes    O
a    O
complex    O
lipopolysaccharide    O
whose    O
lipid    O
portion    O
acts    O
as    O
an    O
endotoxin    O
-    O
and    O
in    O
some    O
bacteria    O
such    O
as    O
"    O
E.    O
coli    O
"    O
it    O
is    O
linked    O
to    O
the    O
cell    O
's    O
peptidoglycan    B-Glycoside114887305
by    O
Braun    O
's    O
lipoprotein    O
.    O

Assignment    O
of    O
a    O
strain    O
to    O
the    O
genus    O
"    O
Staphylococcus    O
"    O
requires    O
it    O
to    O
be    O
a    O
Gram    O
-    O
positive    O
coccus    O
that    O
forms    O
clusters    O
,    O
produces    O
catalase    O
,    O
has    O
an    O
appropriate    O
cell    O
wall    O
structure    O
(    O
including    O
peptidoglycan    B-Glycoside114887305
type    O
and    O
teichoic    O
acid    O
presence    O
)    O
and    O
G    O
+    O
C    O
content    O
of    O
DNA    O
in    O
a    O
range    O
of    O
30–40    O
mol%    O
.    O

It    O
inhibits    O
cross    O
-    O
linkage    O
between    O
the    O
linear    O
peptidoglycan    B-Glycoside114887305
polymer    O
chains    O
that    O
make    O
up    O
a    O
major    O
component    O
of    O
the    O
cell    O
wall    O
of    O
Gram    O
-    O
positive    O
bacteria    O
.    O

The    O
holin    O
pores    O
are    O
generally    O
stable    O
and    O
nonspecific    O
,    O
allowing    O
endolysin    O
access    O
to    O
the    O
peptidoglycan    B-Glycoside114887305
.    O

[    O
A    O
]    O
Gram    O
-    O
negative    O
with    O
a    O
peptidoglycan    B-Glycoside114887305
cell    O
wall    O
like    O
Chlorosome    O
.    O

[    O
H    O
]    O
Gram    O
-    O
positive    O
Bacteria    O
:    O
hypertrophy    O
of    O
the    O
wall    O
peptidoglycan    B-Glycoside114887305
,    O
sortasa    O
enzyme    O
and    O
a    O
loss    O
of    O
the    O
outer    O
membrane    O
.    O

[    O
K    O
]    O
Neomura    O
revolution    O
:    O
Replacement    O
of    O
peptidoglycan    B-Glycoside114887305
by    O
glycoproteins    O
and    O
lipoproteins    O
.    O

It    O
has    O
the    O
ability    O
to    O
degrade    O
peptidoglycan    B-Glycoside114887305
.    O

As    O
a    O
cyclic    O
analogue    O
of    O
D    O
-    O
alanine    O
,    O
cycloserine    O
acts    O
against    O
two    O
crucial    O
enzymes    O
important    O
in    O
the    O
cytosolic    O
stages    O
of    O
peptidoglycan    B-Glycoside114887305
synthesis    O
:    O
alanine    O
racemase    O
(    O
Alr    O
)    O
and    O
D    O
-    O
alanine    O
:    O
D    O
-    O
alanine    O
ligase    O
(    O
Ddl    O
)    O
.    O

Holins    O
form    O
pores    O
in    O
the    O
host    O
's    O
cell    O
membrane    O
,    O
allowing    O
lysins    O
to    O
reach    O
and    O
degrade    O
peptidoglycan    B-Glycoside114887305
,    O
a    O
component    O
of    O
bacterial    O
cell    O
walls    O
.    O

The    O
conversion    O
of    O
prophenoloxidase    O
to    O
the    O
active    O
form    O
of    O
the    O
enzyme    O
can    O
be    O
brought    O
about    O
by    O
minuscule    O
amounts    O
of    O
molecules    O
such    O
as    O
lipopolysaccharide    O
,    O
peptidoglycan    B-Glycoside114887305
and    O
beta-1,3-glucans    O
from    O
microorganisms    O
.    O

In    O
these    O
microorganisms    O
,    O
D    O
-    O
amino    O
acids    O
are    O
part    O
of    O
peptidoglycan    B-Glycoside114887305
(    O
a    O
major    O
component    O
of    O
the    O
bacterial    O
cell    O
wall    O
)    O
.    O

This    O
enzyme    O
participates    O
in    O
peptidoglycan    B-Glycoside114887305
biosynthesis    O
.    O

The    O
peptidoglycan    B-Glycoside114887305
layer    O
gives    O
the    O
cell    O
wall    O
its    O
strength    O
,    O
and    O
helps    O
maintain    O
the    O
overall    O
shape    O
of    O
the    O
cell    O
.    O

Its    O
cell    O
wall    O
peptidoglycan    B-Glycoside114887305
is    O
similar    O
to    O
the    O
L    O
-    O
Lys    O
-    O
Gly3    O
-    O
5    O
L    O
-    O
Ser0.6    O
-    O
1.5    O
type    O
found    O
in    O
predominantly    O
human    O
species    O
.    O

Gram    O
-    O
positive    O
bacteria    O
have    O
a    O
thick    O
peptidoglycan    B-Glycoside114887305
layer    O
in    O
their    O
cell    O
wall    O
,    O
which    O
retains    O
the    O
crystal    O
violet    O
during    O
Gram    O
staining    O
,    O
resulting    O
in    O
a    O
purple    O
color    O
.    O

Ceftriaxone    O
selectively    O
and    O
irreversibly    O
inhibits    O
bacterial    O
cell    O
wall    O
synthesis    O
by    O
binding    O
to    O
transpeptidases    O
,    O
also    O
called    O
transamidases    O
,    O
which    O
are    O
penicillin    O
-    O
binding    O
proteins    O
(    O
PBPs    O
)    O
that    O
catalyze    O
the    O
cross    O
-    O
linking    O
of    O
the    O
peptidoglycan    B-Glycoside114887305
polymers    O
forming    O
the    O
bacterial    O
cell    O
wall    O
.    O

The    O
peptidoglycan    B-Glycoside114887305
cross    O
-    O
linking    O
activity    O
of    O
PBPs    O
is    O
a    O
construction    O
and    O
repair    O
mechanism    O
that    O
normally    O
helps    O
to    O
maintain    O
bacterial    O
cell    O
wall    O
integrity    O
,    O
so    O
the    O
inhibition    O
of    O
PBPs    O
leads    O
to    O
damage    O
and    O
destruction    O
of    O
the    O
cell    O
wall    O
and    O
eventually    O
to    O
cell    O
lysis    O
.    O

The    O
cyst    O
walls    O
of    O
bacteria    O
are    O
formed    O
by    O
the    O
thickening    O
of    O
the    O
normal    O
cell    O
wall    O
with    O
added    O
peptidoglycan    B-Glycoside114887305
layers    O
whereas    O
the    O
walls    O
of    O
protozoan    O
cysts    O
are    O
made    O
of    O
chitin    O
,    O
a    O
type    O
of    O
glycopolymer    O
.    O

Beta    O
glucans    O
are    O
carbohydrate    O
polymers    O
that    O
are    O
cross    O
-    O
linked    O
with    O
other    O
fungal    O
cell    O
wall    O
components    O
(    O
The    O
bacterial    O
equivalent    O
is    O
peptidoglycan    B-Glycoside114887305
)    O
.    O

Ticarcillin    O
's    O
antibiotic    O
properties    O
arise    O
from    O
its    O
ability    O
to    O
prevent    O
cross    O
-    O
linking    O
of    O
peptidoglycan    B-Glycoside114887305
during    O
cell    O
wall    O
synthesis    O
,    O
when    O
the    O
bacteria    O
try    O
to    O
divide    O
,    O
causing    O
cell    O
death    O
.    O

It    O
contains    O
icariin    B-Glycoside114887305
,    O
which    O
is    O
a    O
weak    O
PDE5    O
inhibitor    O
"    O
in    O
vitro    O
"    O
.    O

Callistephin    B-Glycoside114887305
,    O
the    O
3-"O    O
"-    O
glucoside    O
of    O
pelargonidin    O
,    O
an    O
orange    O
colored    O
anthocyanidin    O
,    O
is    O
also    O
found    O
in    O
the    O
berry    O
skins    O
of    O
Pinot    O
Noir    O
grapes    O
.    O

Strong    O
red    O
colors    O
for    O
eye    O
products    O
have    O
been    O
produced    O
using    O
the    O
dye    O
carmine    O
,    O
made    O
from    O
carminic    B-Glycoside114887305
acid    I-Glycoside114887305
extracted    O
from    O
the    O
crushed    O
bodies    O
of    O
the    O
cochineal    O
insect    O
.    O

The    O
scale    O
insect    O
"    O
Dactylopius    O
coccus    O
"    O
produces    O
the    O
brilliant    O
red    O
-    O
coloured    O
carminic    B-Glycoside114887305
acid    I-Glycoside114887305
to    O
deter    O
predators    O
.    O

X-Gluc    B-Glycoside114887305
is    O
a    O
chemical    O
compound    O
with    O
the    O
molecular    O
formula    O
C14H13BrClNO7    O
.    O


